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Abstract
Cholesterol gallstones are exceptionally common and cost nearly 10 billion U.S. dollars
annually. Despite a half-century of basic and clinical research questions still remain about
cholesterol gallstone pathogenesis. The purpose of the study presented herein is to
analyze the roles of infection, and immunity in cholelithogenesis. The first two aims of
this work were to analyze the role of enterohepatic Helicobacter spp. and the human
gastric pathogen H. pylori in cholesterol gallstone formation. To test this, we
prospectively infected C57UJ mice with a variety of Helicobacter spp. and fed infected
and uninfected mice a lithogenic diet for eight weeks and analyzed biliary phenotype.
Mice infected with H. bilis or coinfected with H. hepaticus and H. rodentium and fed a
lithogenic diet developed cholesterol gallstones at 80% prevalence compared with
approximately 10% in uninfected controls (P<0.05). Monoinfections with H. hepaticus,
H. cinaedi, H. rodentium, and H. pylori gave a cholesterol gallstone prevalence of 40%
(P<0.05), 30%, 20% and 20%, respectively; with the exception of H. hepaticus,
cholesterol gallstone formation in these groups did not differ significantly from
uninfected animals. These findings suggest that some Helicobacter spp. play a role in the
cholesterol gallstone formation in mice and perhaps humans. We further hypothesized
that inflammation and immunity were important in cholesterol gallstone formation and
that cholelithogenic bacteria were promoting gallstones through immune stimulation. To
test this we utilized BALB/c and isogenic Rag2-/- mice. When fed a lithogenic diet for
eight-weeks, wild-type mice developed cholesterol gallstones (27-80% prevalence)
significantly more than Rag2-/- mice (-5%, P<0.05). Transfer of functional splenocytes,
or T-lymphocytes to Rag2-/- mice markedly increased cholesterol gallstone formation
(26% and 40% respectively, P<0.05) whereas transfer of B-cells did not (13%). The
presence of T-cells and solid cholesterol monohydrate crystals induced proinflammatory
cytokine expression in the gallbladder. These studies indicate that T-cells are critical in
murine cholelithogenesis and function by promoting gallbladder inflammation. In
summary, these results illustrate that microbial pathogens can influence cholesterol
gallstone formation; this most likely occurs by modulating the immune response with T-
cells being a critical component in this immunomodulation.
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Introduction
Bile is a complex aqueous colloidal system essential for a wide range of physiological
functions including the excretion of lipids from the organism and intestinal fat absorption
(23, 24). Bile is formed in hepatic canaliculi, small (1-2um) spaces formed between the
tight junctions of hepatocytes. It is composed principally of water and a variety of lipid
solutes in micellar and vesicular solution including bile salts, phospholipids (mostly
phosphatidylcholine or lecithin), and cholesterol, as well as proteins and bilirubin
conjugates (1.26). Phospholipids and bile salts are essential for the removal from the
organism of otherwise insoluble cholesterol molecules in an aqueous environment by
solubilizing the sterol to form mixed micelles and unilamellar vesicles (23, 24, 126). Bile
is transported from the canaliculi along tubules of increasingly greater diameter until it
egresses into the gut at the mid-duodenum. In animals with gallbladders, about half the
secreted bile is stored and concentrated in the gallbladder during the interdigestive
interval. The gallbladder is connected to the biliary tree via the cystic duct which
functions simultaneously as a gallbladder filling and emptying conduit.(126).
Alterations in the relative or absolute proportions of cholesterol, phospholipids, and bile
salts can lead to an inability to maintain cholesterol in solution in bile. Most frequently
these changes occur due to excess secretion of cholesterol from the liver (120). As
absolute cholesterol concentration increases it can no longer be incorporated into mixed
micelles and the excess may phase separate forming unilamellar vesicles with biliary
phospholipids. Under suitable physico-chemical conditions these can aggregate to form
multilamellar vesicles (lamellar liquid crystals) and eventually cholesterol monohydrate
crystals may separate and grow in the gallbladder (23, 24). These crystals may progress
to form cholesterol gallstones by agglomeration within a mucin gel. Cholesterol gallstone
formation invariably occurs adjacent to the gallbladder wall when cholesterol
monohydrate crystals nucleate in the gelled mucin glycoprotein scaffolding (23, 24). The
majority of cholesterol gallstones form in the gallbladder; however, in rare situations
usually from genetic deficiency of biliary phospholipids, they may form anywhere along
the biliary tree even intrahepatically (126). Although a relative excess of cholesterol is
necessary for cholesterol gallstone formation it is not sufficient. Indeed, "biliary sludge"
composed of agglomerated cholesterol crystals of an ultrasonically-detectable size
(-50tm) suspended in mucin gel can be visualized frequently, it may or may not progress
to cholesterol gallstones (25, 96, 97). In fact, Lee and colleagues (97) studied patients
ultrasonographically for a mean period of over three years and found that only 8% of
patients with "biliary sludge" developed cholesterol gallstones whereas in 17.7% of
patients, biliary sludge disappeared and in 60.4% biliary sludge disappeared and
reappeared.
The study of cholesterol gallstones relies upon multiple methodologies including physical
chemical studies of model bile and ex vivo bile systems, biliary lipid secretory studies,
animal models with particular focus on cholesterol gallstone (Lith) genes and
epidemiological studies analyzing susceptible and resistant human populations (24, 86,
130, 166, 174). These studies provide the basis for the current knowledge underlying our
understanding of the epidemiology and pathogenesis of cholesterol gallstones. Using
these methodologies it is now appreciated that cholesterol gallstone formation is
primarily a polygenic trait with significant contributions from the environment (74, 126).
Although these studies provided a strong basis for our understanding of the pathogenesis
of cholesterol gallstones, many issues remain unresolved. For example, why do so few
individuals with supersaturated bile (as evidenced by biliary sludge) proceed to gallstones
(97)? Additionally, why do genetically identical murine models challenged with the same
lithogenic diet conditions but housed at different research institutions display such
marked differences in their proclivity to form cholesterol gallstones (105)?
We hypothesized that the differences in gallstone prevalence in genetically identical mice
may be due to differences in their colonization status with gastrointestinal microbes.
Initially, we analyzed the ability of enterohepatic Helicobacter spp. to contribute to
lithogenicity and identified some enterohepatic helicobacters that were capable of
contributing to cholesterol gallstones and some that could not (105, 106). Following these
initial studies, we further hypothesized that the host immune system may be the driving
force in the ability of these organisms (and perhaps others) to promote cholesterol
gallstones as well as mucin gel and gallbladder inflammation. Subsequent studies
demonstrated that indeed the response of the immune system was important, and
probably essential since Rag mice that lack T and B cells seldom (<10%, which is 'rare'
on the murine prevalence scale) develop cholesterol gallstones (Chapter 5). A number of
previous studies have analyzed the role of the immune system in cholesterol gallstone
formation. These studies invariably demonstrated that gallbladder inflammation occurred
concomitantly with cholesterol supersaturation and gallstone formation; none however,
conclusively demonstrated that this process was a primary contributing factor rather than
a secondary effect of the lithogenic process (12, 67, 139, 140, 167, 168).
The current review focuses on a new aspect of cholesterol gallstone pathogenesis
examining the role of infection, inflammation and the immune system's response in the
formation of cholesterol gallstones. We analyzed an extensive literature not customarily
viewed as being related to cholesterol gallstones and our own recent work focusing on
mouse models of infection, inflammation and immunity. Furthermore, this review
describes the critical contributions of the gallbladder epithelium to the immune system
which in turn plays a key role in cholesterol gallstone formation.
Biliary epithelium and immunity:
One cannot describe the potential role of biliary inflammation and the immune system on
cholesterol gallstone formation without first describing the interaction of the immune
system and the biliary system in general. Anatomically, the biliary tree is often divided
into intrahepatic and extrahepatic portions with respect to biliary tissue and disease. This
distinction however appears nonessential when describing the interaction of the biliary
epithelium with the immune system, since it appears biliary epithelial cells from either
location, respond to immunogenic stimuli in a similar fashion (10, 145).
Biliary epithelial cells participate in both innate and adaptive immunity (55, 56, 141).
Briefly, the innate immune system is the portion of immunity that induces no
immunological memory for the antigen. This system responds to a variety of
evolutionarily conserved patterns found in foreign antigens. In addition to specific
cellular subsets including neutrophils, macrophages, eosinophils, basophils and natural
killer cells, a variety of proteins also participate in innate immunity including the
complement cascade, cytokines, and the proteins of the acute phase response (5, 50, 73).
In contrast, the adaptive immune response induces memory to the foreign antigen and is
mediated by both B and T lymphocytes. Following activation, the adaptive immune
response may also stimulate the production of a variety of cytokines and the recruitment
of inflammatory cells (14, 39, 44, 45). There is overlap in these two pathways and
perturbation of either pathway may alter the ability of the other to respond appropriately
(45).
Human biliary epithelial cells express all known toll-like receptors (TLR) which are
essential for antigen-pattern recognition responses of the innate immune system (27, 54,
56, 142). Additionally, myeloid differentiation protein 88 (MyD88), which is a key
downstream effector protein of the TLR pathway is also present in these cells (56).
Furthermore, biliary epithelial cells possessing dominant negative MyD88 mutants are
more susceptible to infection with the intracellular biliary pathogen Cryptosporidium
parvum indicating that the TLR/MyD88 system is indeed functional in these cells (142).
The relationship between biliary epithelial cells and the adaptive immune response
requires a variety of receptor-ligand interactions between epithelial cells, T-cells and
'professional' antigen presenting cells (i.e. dendritic cells). Primary tissue culture cell-
lines of human biliary epithelium demonstrate that these cells constitutively express
human leukocyte antigen class I (HLA-I, MHC class I antigens) and little class II
antigens (10, 145). However, after stimulation with proinflammatory cytokines the cells
express a variety of HLA class II antigens including HLA-DR, HLA-DP, and HLA-DQ
(10). Essentially this expression profile demonstrates that biliary epithelial cells are likely
to interact with both CD8+ T-cells (cytotoxic T-cells) as well as CD4+ T-cells (helper T-
cells. In addition to these primary immune receptors, biliary epithelial cells also possess a
variety of costimulatory molecules necessary for functional interaction with these
immune cells including CD40, ICAM-1, LFA-1 and FAS (2, 3, 18, 68, 81, 141). These
protein expression profiles appear to indicate that the biliary epithelium actively
participates in adaptive immunity through interaction with T-cells and local antigen-
presenting cells.
The second portion of adaptive immunity involves the B-cell response. This response is
mediated through immunoglobulins. Immunoglobulins, including IgA, IgG, and IgM, are
commonly found in low concentrations in bile (141). However, biliary epithelial cells
participate minimally in this process In humans, IgA is produced by plasma cells lining
the bile ducts and then bound by the polymeric immunoglobulin receptor (pIgR) at the
basolateral surface of cholangiocytes (71, 117, 122). IgA is then transported to the apical
surface and secreted into bile. Evidence exists that this intracellular transport plays a role
in protection from intracellular pathogens by binding these antigens during intracellular
transit (143). Like IgA, IgM is transported via the pIgR, but in contrast IgG is transported
utilizing the FcRn (143). Immunoglobulins reaching intralumenal bile aid in protecting
bile from colonization with gastrointestinal pathogens (20, 107).
Aside from expressing the necessary receptors and downstream activators to participate
actively in the immune response, biliary epithelial cells also secrete a variety of cytokines
and undergo phenotypic changes in response to these inflammatory mediators. Cultured
murine gallbladder epithelial cells express Tnf-a, Ccl5 (RANTES), and Mip-2
(Macrophage inflammatory protein 2) (149). Following treatment with LPS these cells
upregulate expression of Mip-2 and Tnf-a. Additionally, 1-1f, 11-6 and Mcpl expression
is induced following LPS treatment (149). Interestingly, the Th2 cytokine, Il-10 is not
expressed in resting or LPS stimulated gallbladder epithelium (149). It has been
established that the biliary epithelium possess receptors for some of these cytokines and
chemokines (including TNF-a) indicating that these secreted cytokines may act in both
an autocrine and paracrine manner (141, 154). The addition of exogenous cytokines to
cultured biliary epithelial cells induces phenotypic changes in these cells supporting an
autocrine role for some of these cytokines. For example, the addition of TNF-a, LPS, IL-
la, and prostaglandin E2 to cultured human gallbladder epithelial cells alters the
transport of sodium, and chloride and diminishes the absorptive function of the
gallbladder epithelium (138). A bile duct ligated guinea pig (Cavia porcellus) model
supports these in vitro findings. In this model, the instillation of IL-1 or LPS induces
gallbladder wall inflammation and stimulates the release of myeloperoxidase, water and
prostaglandin E2 into the gallbladder lumen (136). Systemic administration of
proinflammatory cytokines during chemotherapeutic treatment is also associated with
changes in the biliary epithelium. Specifically, IL-2 administration to humans causes
acalculous cholecystitis (29, 32, 132). Finally, the administration of TGF- 13 to cultured
rabbit (Oryctolagous cuniculi) gallbladder epithelium induces a mesenchymal, fibrotic
phenotype (114). This in vitro phenomenon appears to have an in vivo correlate because
TGF-/3 expression is associated with fibrosis and inflammation during human cholesterol
gallstone formation (80).
Highlighting the key immunogenic role of the biliary epithelium are disease states related
to immune-mediated destruction. Specifically, primary biliary cirrhosis, primary
sclerosing cholangitis and graft versus host disease are all characterized by immune
mediated destruction of biliary epithelium (2, 6, 30, 62, 82). Clearly, the biliary
epithelium participates actively in both cellular and humoral immunity through antigen
presentation, cytokine and chemokine production, and immunoglobulin transport.
Morevoer, biliary epithelial cells possess all of the necessary cellular components to
actively partake in the innate immune system and perturbations of innate immunity
appear to predispose to biliary infection (27, 54, 56, 142).
The role of immunity, inflammation and infection in cholesterol gallstone
pathogenesis
Immunoglobulins:
The putative role of biliary immunoglobulins in promoting cholesterol gallstone
formation through cholesterol nucleation has been studied extensively. Studies employing
model bile support the tenet that biliary immunoglobulins, and in particular IgM and IgG
promote the nucleation of supersaturated bile (60, 61). Interestingly, the source of the
immunoglobulins appears to influence greatly the ability of these proteins to nucleate
bile. IgM and IgA from commercial sources are incapable of nucleating supersaturated
bile, conversely commercially available IgG is pronucleating (61, 164). The anatomic
source of immunoglobulin also appears to influence the ability of these molecules to
cause cholesterol crystal phase separation. Specifically, biliary immunoglobulins seem to
promote nucleation more then immunoglobulins isolated from blood (164). Of the biliary
immunoglobulins, IgM demonstrates the greatest ability to induce nucleation, with IgG
displaying slightly less ability, and IgA little activity (60, 61, 164). Differences between
commercially available IgM and IgM from the sera of patients with Waldenstrom's
macroglobulinemia, implies that specific antibodies rather than IgM antibodies per se
may nucleate cholesterol in bile (164).
Prospective studies utilizing animal models generally do not support a role of
immunoglobulins in cholesterol gallstone pathogenesis. In inbred AKR or C57L mice fed
a lithogenic diet there is initially a decrease in the amount of IgM and IgA followed by a
temporal increase in these immunoglobulins (167). In both strains, the level of IgG
remains relatively unchanged. Van Erpecum and colleagues concluded that
immunoglobulins are not likely to participate in cholesterol gallstone formation because
both gallstone resistant (AKR) and susceptible (C57L) mice alter their immunoglobulin
levels with lithogenic diet feeding. Furthermore, gallstone resistant AKR mice actually
demonstrate greater biliary immunoglobulin concentrations than do gallstone susceptible
C57L mice (167). Although these changes appear to negate the role immunoglobulins
play in cholesterol gallstone formation, the data interpretation are made more
complicated by pronounced differences in CSI values between C57L mice (-2.0) and
AKR mice (-.1.5) (127). Therefore, the variable contributions of biliary lipids most likely
confounded these results. However, human studies also suggest that immunoglobulins do
not contribute to cholesterol gallstone formation because ex vivo bile from humans with
gallstones and
immunoglobulins
without failed to demonstrate a correlation between biliary
and cholesterol detection time (111).
A limitation of all of the
focused primarily on the
cholesterol monohydrate
important, it is unlikely to
antigen specificity of the
above studies is that both in vitro and in vivo studies have
effect of changing immunoglobulin concentrations on solid
nucleation. Unfortunately, although concentration may be
be the only factor relevant to this interaction. Importantly, the
immunoglobulins may be crucial. Indeed, Fab fragments of
antibodies isolated from patients with cholesterol gallstones decreased cholesterol crystal
observation time in vitro whereas commercially available Fab fragments did not produce
this effect (99). These data strongly suggest that immunoglobulins may interact with
cholesterol in bile in an antigen specific manner and it is these specific Fab fragments
that contribute to cholesterol nucleation in vitro (99). Therefore, merely quantifying
immunoglobulin concentrations in bile appears to provide very limited functional data.
Recent evidence from our laboratories suggest that in a mouse model of cholesterol
gallstone formation, mice possessing only T-cells (and therefore lacking B-cells and
immunoglobulins) develop gallstones at a greater frequency than do wild-type mice
(Chapter 5). In contrast, mice possessing only B-cells do not recapitulate the prevalence
of gallstones observed in wild-type mice. However, these mice do form mucin gel at
increased levels compared to Rag mice (lacking T and B-cells). These data indicate that
immunoglobulins contribute to in vivo nucleation but are not necessary for cholesterol
gallstone pathogenesis (Chapter 5).
Based upon the literature a reasonable hypothesis may be proposed that antigen-specific
immunoglobulins contribute to the formation of cholesterol monohydrate crystals in a
pronucleating biliary environment. The relative production of these specific antibodies
probably relates to specific antigens to which the host has been exposed. However, as
demonstrated in B-cell deficient mice, immunoglobulins are not necessary for cholesterol
gallstone formation to occur.
The role of mucin glycoproteins:
The most thoroughly analyzed biliary proteins putatively involved in cholesterol
gallstone pathogenesis are the mucin glycoproteins. Mucin proteins are expressed in a
variety of tissues. The ones expressed in human biliary epithelia includes MUC1, MUC2,
MUC3, MUC5AC, MUC5B and MUC6 (7). However, this list is likely to increase as
more mucin genes are characterized and analyzed. These genes encode proteins which
can either be expressed on the surface of epithelial cells or secreted by epithelial cells (7,
172). Furthermore, secreted mucins are often divided into gel-forming mucins and
soluble mucins based upon their ability or inability to produce large self-aggregated
protein lattices or matrices (7, 172). With regard to cholesterol gallstone pathogenesis
these designations appear inconsequential since cell surface expressed mucins are critical
in mucin gel accumulation and the synthesis and secretion of so-called soluble mucins are
up-regulated during cholelithogenesis implying a role for soluble mucins in cholesterol
gallstone formation (175, 176). In both humans and animal models of cholesterol
gallstone formation, mucin gel accumulation appears important in cholesterol gallstone
formation (87, 89, 93, 95, 175, 176). Moreover, these proteins promote nucleation in vitro
(4, 89, 98, 156, 182). Taken together both in vitro and in vivo data support the notion that
mucin gel accumulation precedes and most likely promotes cholesterol gallstone
formation by nucleating cholesterol crystals from supersaturated bile.
In cultured biliary cell systems, many of these mucin genes are regulated by
inflammatory mediators. Specifically, in two different cell-culture systems, both mucin
gel accumulation and mucin gene expression are promoted by exogenous addition of
LPS, and TNF-a. In human biliary cell cultures, expression of MUC2, MUC3 and
MUC5AC are all increased by both LPS and TNF-a (186). In the case of MUC2 and
MUC5AC regulation, upregulation appears to be due, at least in part, to overlapping
signaling pathways, whereas with MUC3 this regulation appears to be through two
independent pathways (186). Utilizing the same cell-culture system, the authors further
demonstrated that TNF-a stimulated protein kinase C (PKC) and PKC appeared to serve
as the messenger responsible for MUC2 and MUC5AC production (186).
Choi and colleagues (28) obtained similar results utilizing cultured canine gallbladder
epithelial cells. The addition of LPS from any of three bacteria stimulated mucin
production in a cultured cholecystocyte system from the dog. There appeared to be
differences in the ability of LPS from different bacterial species to induce mucin
production. For example, LPS from Escherichia coli produces the greatest stimulation
whereas LPS from Pseudomonas aeruginosa stimulates mucin production the least.
Furthermore, TNF-a added to the culture media promoted mucin production, albeit to a
lesser degree than LPS. A diminished response to TNF-a could be due to the use of TNF-
a of human origin rather than canine origin. The authors noted that these changes in
mucin accumulation were not due to cytotoxicity of either LPS or TNF-a since cell death
assays demonstrated survival of the cultured cells (28). The interaction of TLR4 and
CD14 receptors present on biliary epithelium was not examined in either of these studies.
It is reasonable to assume that these receptors participate in the activity of LPS on mucin
expression since both CD14 and TLR4 are expressed on biliary epithelium, and the two
receptors interact in sensing LPS (19, 34, 35).
Further evidence of the role of the immune system in the regulation of mucin genes
comes from in vivo studies with T and B-cell deficient (Rag) mice. In Rag mice Mucl,
Muc3, Muc4, and Muc5ac are all differentially regulated. These genes are generally
down-regulated when compared to immunocompetent mice such as wild-type mice or
mice adoptively transferred with splenocytes or T-cells (Chapter 5). Furthermore,
infection with enterohepatic Helicobacter spp. also alters the mucin gene expression
pattern in these mice (Chapter 5).
It is becoming clear from these in vitro and in vivo studies that the expression of mucin
genes and production and secretion of mucin glycoproteins are influenced markedly by
inflammatory mediators. TNF-a and LPS are likely to be only the "tip of the iceberg"
when it comes to inflammatory mediators stimulating mucin gene production in the
gallbladder. If one can cautiously extrapolate from the well characterized respiratory
epithelium system a veritable "laundry-list" of cytokines, bacteria, bacterial products and
other irritants are known to alter the production of different mucins by upregulating a
variety of respiratory mucin genes (133, 144, 161). Perhaps a more important question in
this regard is not whether or not inflammatory mediators alter mucin production, but
rather under what physiological situations do these inflammatory mediators reach
adequate biliary concentrations to exert their effects?
Other putative pronucleating biliary proteins:
Other proteins have been demonstrated to nucleate cholesterol monohydrate crystals in
vitro; however, like the biliary immunoglobulins, their effects in vivo are incompletely
(or never) characterized with physiological effecter levels. Some of these putative pro-
nucleating agents include haptoglobin, phospholipase C, alphal-acid glycoprotein,
albumin and aminopeptidase N (100, 111, 125). In general, in vivo studies that analyzed
the role of putative pronucleating proteins were hampered by a number of factors: 1)
Only recently has large scale proteomic analysis been undertaken which systematically
analyzed the composition of the protein fraction of gallbladder bile. (187) Therefore only
a handful of proteins have been identified and analyzed to date, 2) Prior methods used to
determine quantitative differences of these proteins in bile and gallbladder tissue are
relatively inse:nsitive and may be inadequate to demonstrate significant concentration
differences, 3) The concentration of individual constituents may not be crucial but rather
a cumulative or cooperative effect of multiple proteins which promote phase-separation
of crystals or liquid crystals in bile thereby promoting cholesterol gallstone formation.
Moreover, there is little understanding of the interactions between these proteins. Large
scale, sensitive proteomic screens (i.e. mass spectroscopy based protocols) are becoming
easier and more widely used in pathophysiological and translational research. The
utilization of these techniques to compare the gallbladder bile of patients with and
without cholesterol gallstones will likely prove fruitful in the future in determining what
role if any, the myriad of secreted proteins may play in cholesterol gallstone formation.
Furthermore, these techniques could potentially identify proteins in bile that are secreted
from the sera in large concentrations during the active stages of gallstone formation.
Although these serological proteins may not participate in cholelithogenesis they could
serve as serological markers to identify those individuals at greater risk for developing
cholesterol gallstones.
Gallbladder inflammation:
In both animal models and humans cholesterol gallstone formation is preceded by
histopathological alteration of the gallbladder wall indicative of inflammation, including
edema, an increases in gallbladder wall thickness, the presence of inflammatory cells and
remodeling with concomitant increased production of TGF-3 (12, 67, 80, 102, 115, 139).
These histological changes are often accompanied by alterations in gallbladder
contractility and modifications in the ability of the gallbladder epithelium to transport a
variety of substances (24, 67, 94, 129, 168). Furthermore, lithogenic bile may alter
mechanisms associated with cytoprotection in the gallbladder muscle as demonstrated by
the ability of the gallbladder muscle to respond to reactive oxygen species (181).
In an extensive histopathological study, it was demonstrated that gallstone susceptible
C57L mice progressively increase gallbladder wall thickness when fed a lithogenic diet.
In contrast, in gallstone resistant AKR mice there is only a mild increase in gallbladder
wall thickness. Both strains accumulate subepithelial inflammatory cells and edema;
however, C57L mice do so to a significantly greater degree. These changes coincide with
decreases in the expression in the gallbladder of two aquaporin genes Aqpl, and Aqp8
(168). These findings suggest that during gallstone formation the gallbladder undergoes
progressive changes which ultimately result in decreased motility, increased edema and
alterations in transport function. The overall contributions of these changes to cholesterol
gallstone formation cannot be elucidated at present because gallstone resistant AKR and
susceptible C57L mice also display marked differences in the degree of bile
supersaturation (127). In FXR'" susceptible mice the gallbladder becomes thickened,
edematous and infiltrated with granulocytes following lithogenic diet feeding for a week
(168). In contrast FXR÷'/ mice are protected from these changes (115). It is therefore
intriguing to hypothesize that FXR participates in gallbladder inflammation as a
consequence of lithogenic diet feeding. Again, this interpretation must be tempered with
the understanding that FXR÷/ ÷ mice failed to supersaturate bile in contrast to their FXR/-
counterparts (115). Additionally, potentially cytotoxic hydrophobic bile salts were also
significantly elevated in FXR ' mice (115).
We believe that it is likely that both cholesterol and hydrophobic bile salts are responsible
for the histopathological changes noted in the murine gallbladder during cholesterol
gallstone formation. Specifically, analysis of ex vivo gallbladders obtained from patients
with cholesterol gallstones revealed that smooth muscle cells contain excess cholesterol
in their plasma membranes. Furthermore, the isolated muscle tissues displayed less
contractility and decreases in the levels of scavengers of reactive oxygen species (181).
These changes appear to be associated with dysfunction in the PGE2 receptor which
prevents the cytoprotective downstream effect that occurs when PGE2 binds to its
receptor. Furthermore, others have noted a positive correlation of gallbladder muscle
dysfunction with elevations in the CSI of bile and the histopathological inflammation
score of the gallbladder in humans (165). Additionally, oxysterols, which have been
demonstrated by Haigh and Lee (53) to be present in lithogenic bile and cholesterol
gallstones from human patients, are capable of inducing apoptosis in cultured gallbladder
epithelial cells (53, 152). The mechanism mediating this appears to be through the
incorporation of these oxysterols into the mitochondria of epithelial cells subsequently
stimulating cytochrome-c mediated apoptosis (152).
All of the above mentioned studies have several limitations. Specifically, the direct role
of cholesterol toxicity in gallstone formation cannot be separated from the biological
ability of cholesterol to induce inflammation. For example, one cannot examine what
occurs when ]identical CSIs are achieved with and without inflammation. However, one
can hypothesize reasonably from the prairie dog model of cholelithogenesis that
inflammation per se is an essential element in cholesterol gallstone formation (95).
Specifically, prairie dogs fed high doses of acetylsalicylic acid (ASA or aspirin) fail to
form gallstones whereas non-aspirin fed controls developed gallstones (95). Since both of
these groups supersaturate gallbladder bile, it is likely that cholesterol supersaturation is
necessary but not sufficient for cholesterol gallstone formation. That is, the downstream
inflammatory effects of cholesterol, and likely other proinflammatory mediators, play an
integral role in cholelithogenesis. Further evidence arises in studies utilizing isogenic
mice deficient in T and B cells (Rag mice) and comparing them to their wild-type
counterparts. These studies indicate that both groups of mice supersaturate bile as
evidenced by the phase separation of liquid crystals; however, only mice possessing T-
cells develop cholesterol gallstones at a high prevalence (40%). Gallstone formation in
this case appears to be due, in part, to a potent Thl immune response which accompanies
the formation of solid cholesterol monohydrate crystals in the murine gallbladder. These
data imply that cholesterol promotes inflammation via the adaptive immune system,
specifically T-cells (Chapter 5).
Hydrophobic bile acids promote inflammation and apoptosis in vitro and likely do so in
vivo (8, 85, 185). In contrast, treatment with the hydrophilic bile acid, ursodeoxycholic
acid decreases mucosal inflammation, and decrease biliary protein concentrations
associated with inflammation and gallstones (72). In Helicobacter spp. infected C57L
mice, the relative concentration of hydrophobic bile salts in hepatic bile is increased and
hydrophilic bile salts decreased when compared to uninfected mice (Chapter 4). It would
appear that one downstream effect of hydrophobic bile salts is the induction of
proinflammatory cytokines (85). Since an increase in hydrophobic bile salts is a
consistent finding in cholesterol gallstone patients and animal models, it is likely that bile
salt mediated inflammation is important in cholelithogenesis (65, 131)
Biliary tract bacterial colonization and gallstones
Bacteria have been implicated in the pathogenesis of cholesterol gallstones for a very
long time; however, a definitive cause and effect relationship remained elusive (110, 137,
151). A major factor contributing to this confusion is the chronic nature of
cholecystolithiasis. That is, the formation of cholesterol gallstones requires a rather long
time period and when they form, they do not disappear spontaneously except by
migration into the duodenum which is invariably followed by reformation. Furthermore,
even after cholesterol gallstones form, the gallstones may never lead to symptoms in the
patient and, when they do so, it could take years (23, 24, 88). Therefore, identification of
bacteria in bile or gallbladder tissue of cholesterol gallstone patients may not indicate
causality. Rather, the bile, gallbladder mucosa and biliary motility may be altered to
allow for subsequent bacterial colonization. Furthermore, bacteria that might have been
present at the time of initial stone formation may be cleared and therefore would not be
detected by conventional culturing techniques. Further confusing this issue is the ability
of some bacteria to directly alter the composition of bile by beta-glucuronidase, cholyl-
glycyl hydrolase, phospholipase Al or urease activity thereby promoting calcium
bilirubinate formation (16, 22, 170). Despite these deficiencies numerous studies have
identified bacteria in bile, cholesterol stones and gallbladder tissue from patients with
cholesterol gallstones.
Most studies analyzing the role of bacteria in cholesterol gallstone disease classify stones
of approximately 50-95% cholesterol as "mixed" stones and any stone >95% cholesterol
as a pure cholesterol stone. The other precipitated material in so-called mixed stones
consist of calcium salts (either calcium bilirubinate or calcium carbonate +/- phosphate)
(76). Based upon these delineations it would seem that bacterial DNA is highly prevalent
in mixed stones appearing in 80-95% of these stones depending upon the study
population ('92, 159, 160, 180). The nature of the bacteria in these stones varies
depending on the study and gram positive, and gram negative, anaerobic and aerobic
bacteria have been identified. Some hypothesize that bacteria, through beta-
glucuronidation are responsible for nucleation and calcium salt deposition (169, 170).
Although this hypothesis is biologically plausible, no studies to date have conclusively
demonstrated that it occurs. In fact, in vitro studies utilizing E. coli or calcium salts failed
to induce cholesterol crystal nucleation (177). So-called pure cholesterol gallstones are
less consistently associated with bacterial DNA and depending on the study between 0%-
90% of stones have been reported to contain DNA (76, 92, 159, 160, 180). Some authors
claim that pure cholesterol gallstones possess only gram positive bacteria while others
identified a variety of bacteria (76, 180). In at least one instance, the presence of bacteria
in the bile of cholesterol gallstone patients was associated with the conversion of
cholesterol into oxysterols suggesting that these organisms contribute to some aspects of
cholesterol gallstone formation such as inflammation (184).
Recently, there has been a great deal of interest in a putative role of the gastric pathogen
H. pylori in relation to cholesterol gallstones (1, 40, 106, 112, 118, 119, 121, 155).
Interestingly, growth of this organism is inhibited by bile salts both in vivo and in vitro
and chemotactic assays demonstrate that bile salts repel the organism (103, 106, 179).
These factors would appear to argue against the ability of this organism to colonize a
healthy gallbladder. Despite this, a number of groups have claimed to have reliably
identified H. pylori DNA in biliary tissue and gallstones (40, 75, 112, 155). Several
problems exist with the data however. First, some samples were collected at endoscopic
retrograde cholangiopancreatography (ERCP) (155). Since H. pylori colonizes the gastric
mucosa of over half the world's population, the statistical chances for sample
contamination by gastric H. pylori is high. Additionally, the use of 16SrDNA genus-
specific primers is commonly used to identify these organisms. Many of these primer sets
amplify other non-H. pylori helicobacters (105, 106). Furthermore, sequence evaluation
of these primer products is generally inadequate to properly speciate H. pylori. This is
due to high genetic homology with non-H. pylori Helicobacter spp (124). For example,
Avenaud and colleagues (11) identified H. pylori-like organisms based upon sequencing
of the 16SrRNA gene in human livers; however, rigorous follow up tests proved that
these organisms were an unclassified Helicobacter sp. (11). The development of
"species-specific" primers to other regions of the genome may alleviate some of these
concerns. Nonetheless species specific primers are only as good as the number of species
that they are proven not to amplify (i.e. having the potential to amplify organisms that
they were not validated against). Finally, like the other organisms discussed above, the
possibility exists that these organisms are secondary invaders following alterations in the
biliary microenvironment and biliary motility secondary to in situ cholesterol gallstones.
Evidence for this exists in a recent description which demonstrated that H. pylori DNA
was present in patients with chronic cholecystitis consistent with bouts of cholestasis, but
not in asymptomatic patients (40).
In addition to the gastric pathogen H. pylori, a variety of enterohepatic helicobacters exist
(46, 157). These reside in the small and large intestines and canalicular space of
experimentally and naturally infected animals including humans (46, 157). DNA from
these organisms were noted in non-Caucasian patients with chronic cholecystitis,
gallstones and malignant biliary tract diseases (47, 104). Our work with experimental
animal models indicate that these organisms are capable of promoting cholesterol
gallstones in vivo (105). In contrast, in this same experimental model H. pylori could not
promote cholesterol gallstone formation (106). Interestingly, a recent study demonstrated
that urease positive Helicobacter spp. are capable of precipitating calcium salts in vitro
(16). The authors proposed that this activity may contribute, at least in part, to the ability
of these organisms to promote a calsium salt nidus for cholesterol gallstone formation in
vivo since to date monoinfection with urease-positive organisms or coinfection with at
least one urease positive organism induces cholesterol gallstones (16).
For many of the studies described for both Helicobacter spp. and other bacteria, PCR was
utilized to identify the bacteria. PCR provides a means to detect relatively small
quantities of bacterial DNA which serves as a surrogate marker for colonization with
organisms that otherwise may not be identified with standard culture methods.
Unfortunately, PCR also makes data interpretation difficult. As mentioned previously,
just because bacterial DNA is present at the time of examination does not mean that it
was a contributing factor to the formation of the stone. Theoretically, analyzing the
"core" of stones may provide more reliable data on the inciting cause; however, due to
the sensitive nature of PCR the mere act of trying to isolate the core may contaminate it
with nucleic acid from the external stone surface or from the examiner. Additionally, to
date, no studies have analyzed the ability of cholesterol gallstones to imbibe DNA. If
stones are capable of imbibing DNA then regardless of the analysis (be it core or
external) the DNA present may only represent the most recent DNA encountered.
Furthermore, when multiple DNA fragments are present and non-specific primers are
used (designed to amplify 16SrDNA genes from multiple bacteria) there is the possibility
that the DNA present at the highest concentration may be preferentially amplified (21).
Since PCR amplification is non-linear, even a small bias in initial amplification may
provide logarithmic differences in final DNA concentration. Unfortunately, the most
prevalent bacteria may not be the most important bacteria or may not be important at all.
The use of more discriminatory PCR techniques such as those utilized to analyze
complex environmental samples may aid in circumventing this problem in the future (31,
78, 158, 188).
One of the classical bacterial pathogens of the biliary tree in humans is Salmonella
enterica ser Typhi, the causative agent of typhoid fever (33, 84). This organism crosses
the intestinal epithelial barrier and invades macrophages and spreads systemically (135).
After colonizing the liver, the organism can be shed into the gallbladder and either cause
acute cholecystitis or chronically colonize the gallbladder (3-5% of those infected) (33,
84). It is well known that chronic colonization with S. typhi is associated with gallstones
(33, 84). It is less clear whether this organism contributes to stones or alternatively if the
presence of gallstones promotes chronic colonization. Recent evidence indicates that
Salmonella forms bacterial biofilms on the surface of cholesterol gallstones (135). This
biofilm formation would allow for chronic colonization and protect the organism during
antibiotic treatment. Biofilm formation is dependent on the presence of bile and
organisms cultured without bile, do not readily form biofilms (135). This indicates that
this organism is exquisitely adapted to survival in a host gallbladder harboring cholesterol
gallstones. Furthermore, biofilm formation is altered when pebbles or glass beads were
utilized instead of cholesterol gallstones. This indicates that both bile and cholesterol
gallstones are essential for pathogenesis of biofilm formation. Moreover, colonization in
the presence of cholesterol gallstones requires expression of several genetic components
(134, 135). These data seem to argue that cholesterol gallstones promote chronic
colonization with S. typhi rather than S. typhi promoting gallstones. Regardless of
whether gallstones promote colonization or vice-versa, the concomitant presence of
gallstones and S. typhi markedly promote gallbladder cancer making the interaction
between S. typhi and cholesterol gallstones of extremely important interest (33, 135).
In summary, a causative role of bacteria in cholesterol gallstone formation in humans is
still unclear. It is likely that some bacteria identified in humans with cholesterol
gallstones are: at least partially responsible for those gallstones, due to their ability to
promote inflammation and precipitate calcium salts. Unfortunately, most of the
aforementioned studies are primarily descriptive and fail to thoroughly analyze the
organisms identified. For example, it would provide considerable insight if it could be
determined whether any of the organisms identified possess virulence factors that would
allow for their invasion or colonization of the non-diseased biliary tree. Additional
information could be garnered by culturing these organisms and utilizing them to
prospectively infect mouse models useful in studying cholesterol gallstone pathogenesis.
The authors of the current review have described such a system utilizing the C57L/J
mouse model (105, 106). When this mouse is acquired directly from The Jackson
laboratory (Bar Harbor, ME) and housed in microisolater cages under SPF conditions and
free of enzootic Helicobacter spp. they rarely (10%) develop cholesterol gallstones.
Purposeful infection with some enterohepatic strains of Helicobacter spp. significantly
increases gallstone prevalence (to a high of 80%) (105, 106). It will prove valuable to test
other putative lithogenic organisms utilizing this model system approach, bearing in mind
the caveat that for the assay to be effective the organisms must be capable of colonizing
the mouse strain under consideration.
Chronic inflammatory conditions and gallstones:
Chronic hepatitis C virus (HCV) infection is associated with gallstone formation (17, 26,
36, 153). The mechanism responsible for this effect may be due to chronic hepatic
damage leading to a loss of liver function and cirrhosis (36, 153). However, recently
studies demonstrated that HCV infection, independent of liver cirrhosis is associated with
increased gallstone prevalence (17, 26). HCV is known to replicate in the gallbladder
epithelium (101, 123) and damage of the biliary tree is noted in 22-91% of biopsy
specimens from patients with HCV (26). It is therefore possible that the association
between non-cirrhotic HCV patients and gallstones is dependent on HCV replication in
biliary epithelium leading to local inflammation, alterations in gallbladder contraction
and inflammatory-mediated alterations in mucin gene production. Interestingly, one such
study notes that the correlation of HCV and gallstones peaks at two-points. The first peak
occurs in patients at 31-40 years old (7% stone prevalence) and the second such peak
occurs much later at 61-70 years of age (16% stone prevalence) (26). Perhaps the first
prevalence peak represents the effect of HCV infection per se whereas the second peak
represents the effect of liver dysfunction and cirrhosis. Like most of the bacteria studied,
the role of HCV in cholesterol gallstone disease relied on studies examining the presence
or absence of gallstones when HCV infection is present. Future studies utilizing modem
biochemical and molecular techniques which focus on changes in the gallbladder itself
may provide greater insight into the mechanistic relationship of HCV infection and
cholesterol gallstones. Further, transgenic mouse models are currently available which
express the HCV genome (52, 79, 173) suggesting that these mouse models could prove
useful in a cause and effect study of HCV and cholesterol lithogenicity.
Patients with Crohn's disease (CD) are at an increased risk for the development of
gallstones (15, 48, 83, 178). Results vary regarding which factors correlate with
cholesterol gallstone formation. Factors mentioned include age, female sex, site of
disease, surgical resection, and duration of disease (independent of age) (48, 69, 83).
Some investigators noted that CD patients with ileal disease or colonic resection
supersaturate their bile, likely due to alterations in cholesterol and bile acid absorption
from the intestinal tract (49, 128). However, several studies describe a decrease in the
cholesterol saturation in the bile of patients with CD especially when the ileum was
involved (90, 91). Furthermore, bile acid composition is altered in CD patients and these
alterations are: often characterized by a decrease in deoxycholic acid and an increase in
ursodeoxycholic acid (90, 91, 128). These changes seem paradoxical as ursodeoxycholic
acid enrichment would seem to favor cholesterol gallstone prevention and dissolution
(66, 70, 146). Unlike CD patients, patients with UC are not at an increased risk for
cholesterol gallstones (15, 83). A hypothesis for the differences in the abilities of UC and
CD to influence gallstone formation is that these diseases cause different inflammatory
changes (13, 63, 64). Specifically, although not absolute, CD is most commonly
associated with a Thl proinflammatory response whereas UC is more often associated
with a Th2 response (13, 63, 64). Currently, no studies are available which describe the
gallbladder inflammatory profile in patients with either UC or CD. These studies would
provide insight into the relationship of CD, Thl inflammation and gallstones.
Inflammation, cholesterol metabolism and Gallstones:
Inflammation, and more specifically the acute phase response, a key component of innate
immunity, produce marked alterations in the metabolism of a variety of proteins and
lipids (77). These changes are extensive and beyond the scope of the current paper;
however, a leading review was recently published (77). Most of the changes associated
with the acute phase response focus on the role of infection on concentrations of
cholesterol, and other lipid constituents of plasma. These changes are important due to
there potential role in atherogenesis. The section will focus only on those changes which
alter cholesterol and bile acid metabolism of the liver as these changes may directly alter
the composition of bile. A caveat with respect to the studies that will be described is that
most were conducted employing exogenous, acute administration of cytokines or LPS
(42, 57, 58, 77, 109). These changes cause rapid (minutes to hours), relatively short-lived
(24 hours or less) alterations in hepatic gene transcription and translation. Although these
changes are significant, it remains to be determined if they exist for prolonged periods
(days to weeks) (77). For example, it is unclear if with chronic cytokine stimulation, gene
transcription levels are down-regulated by compensatory mechanisms. In the case of
cholesterol gallstone formation this could prove to be very important as short-lived
(hours-days) alterations in bile composition are certainly less likely to promote disease
compared to prolonged and sustained alterations.
With this proviso in mind, it is clear from these studies that acute inflammation does alter
the hepatic metabolism of either cholesterol or bile salts. In rodents, administration of
LPS or proinflammatory cytokines (I1-1, TNF) raises serum cholesterol levels and
increases the production of HMG-CoA reductase at both the transcription and
translational levels (41, 42, 58). This change increases de novo cholesterol synthesis.
However, the increase in sterol production is rather modest because other enzymes in
cholesterol biosynthesis including squalene synthase, and enzymes downstream of HMG-
CoA reductase in the mevalonate pathway are down-regulated (41, 42, 109, 183). Some
investigators hypothesize that these changes maintain adequate cholesterol synthesis
while redirecting mevalonate metabolites into non-sterol pathways (77). This hypothesis
is supported by increases in dolichol phosphate and glycosylated plasma proteins during
the acute phase response (113, 148). In contrast to rodents, primates decrease serum
cholesterol levels in response to a variety of proinflammatory mediators (9, 37, 147).
Unfortunately, the mechanism underlying this change is less well understood but may be
due to either alterations in cholesterol secretion or ApoB synthesis (38, 150).
Alterations in bile salt production also occur under these conditions. Specifically, LPS
downregulates both the classic and alternative pathway of bile salt synthesis by
decreasing production of CYP7A1 (classical), and CYP7B1, CYP27A1 (alternative) (43,
108). Additionally, exogenous administration of LPS decreases hepatocellular uptake and
secretion of bile salts by downregulating basolateral and apical bile salt transporters (51,
59, 116, 162., 171). Not surprisingly, because bile salts stimulate the biliary secretion of
both phospholipids and cholesterol, LPS administration also decreases expression of
phospholipid (MDR2) and cholesterol transporters (ABCG5/ABCG8) on the canalicular
membranes of the liver (59, 163, 171).
These changes suggest that acute infections would decrease cholesterol secretion into bile
due to intrahepatic cholestasis. Because cholesterol gallstone formation requires only a
relative excess of cholesterol, these changes may or may not be lithogenic. Additionally,
as discussed previously, these studies are of short duration and may not reflect what
occurs with chronic immune and inflammatory stimulation. In fact, during chronic (10
weeks) infection with enterohepatic Helicobacter spp. both hepatic bile salt secretion rate
and bile salt independent bile flows are increased (Chapter 4). Interestingly, infection also
alters the bile salt pool making it more hydrophobic (consistent with a proinflammatory
response). These findings highlight the differences between acute studies involving
exogenous intravenous administration of cytokines and LPS and those studies involving
chronic infection. Further, these data highlight the need to conduct rigorous experiments
utilizing pathoens which cause both chronic and acute infections which may provide
entirely different data sets compared to studies utilizing exogenous cytokine and LPS
administration.
Lith genes:
Large genetic screens have identified a variety of "Lith" alleles in mice which promote
cholelithogenesis. In the vast majority of cases, these alleles span large chromosomal
regions and the genes responsible for gallstone promotion have not been identified. A
thorough review of these Lith alleles and the potential for them to encode inflammatory
mediators was recently published (102). Unfortunately, the Lith loci discovered to date
occur on virtually every mouse chromosome and span relatively large regions
encompassing numerous genes (174). It is therefore highly probable that inflammatory
genes are located in many if not most of these Lith loci. Unfortunately, the same could be
said for genes involved in a variety of other pathways. Therefore, it is our opinion that a
more plausible and productive approach to study the role of inflammation and gallstones
would be to utilize currently available transgenic and knockout mouse lines with
modulations in genes important in inflammation and immune responses and compare
these to their wild-type counterparts. Despite the current limitations with Lith genetic
loci, with continued inbreeding and creation of well characterized congenic mouse
strains, these genetic loci will become more refined and some may eventually prove
viable in analyzing the influence of inflammation and immunity on cholesterol gallstone
formation.
Conclusions:
The gallbladder despite its overtly simple functionality is a complex organ. Like most
organs as it becomes inflamed and damaged, it loses its ability to function properly
including its concentrating, pH regulation and contractile functions. Unlike most other
organs in the body, the gallbladder may be exposed to rather large concentrations of free
(unesterified) cholesterol and potentially cytotoxic bile salts. These molecules appear to
induce potent inflammatory responses under the appropriate circumstances (8, 85, 168,
185). It would appear that this inflammatory damage, through a variety of undetermined
mediators, induces gallbladder hypomotility and promotes the production of
pronucleating agents (28, 168, 186). Furthermore, chemotherapeutic intervention can
prevent the downstream effects of cholesterol (95). These downstream effects appear to
be due, at least in part, to T-cells and a Thl immune response (Chapter 5). These findings
raise the possibility that serological markers of cholesterol gallstone formation may be
inflammatory mediators or cellular subsets thereof. If identified, these markers may prove
valuable for diagnosis and interventional therapy. Specifically, prevention of prolonged
Thl stimulation may prove useful in the prevention or treatment of cholesterol gallstones
either alone or in conjunction with other lipid composition altering therapies. It is
important to note that many of the studies described within this review have relied
principally upon inbred mice. These mice are genetically homozygous with >99% of their
genomes being identical. In contrast, even the most consanguineous of human
populations is relatively heterogeneous. The role of inflammation in human cholesterol
gallstone disease is therefore likely to be subtle and additive with a variety of
contributing and overlapping factors. Additionally, inflammation and immunity may
contribute to cholesterol gallstone formation both environmentally (exposure to
pathogens and proinflammatory conditions) and genetically (polymorphisms in genes
which promote a greater response to immune stimuli). Clearly, much remains to be
learned in this regard and further in vitro, animal models and human studies are likely to
clarify many of these exciting possibilities.
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Abstract
Helicobacter spp. are common inhabitants of the hepatobiliary and gastrointestinal tracts
of humans and animals and cause a variety of well described diseases. Recent
epidemiological results suggest a possible association between enterohepatic
Helicobacter spp. and cholesterol cholelithiasis, chronic cholecystitis and gallbladder
cancer. To test this, we prospectively investigated the effects of Helicobacter spp.
infection in cholesterol gallstone pathogenesis in the highly susceptible C57LUJ mouse
model. Helicobacter spp.-free adult male C57L mice were infected with several different
enterohepatic Helicobacter spp. or left uninfected and fed either a lithogenic diet or
standard mouse chow for 8 and 18 weeks. At the conclusion of the study, bile was
examined microscopically and diagnostic culture and PCR were performed. Mice
infected with H. bilis or coinfected with H. hepaticus and H. rodentium and fed a
lithogenic diet developed cholesterol gallstones at 80% prevalence by 8 weeks compared
with approximately 10% in uninfected controls. Monoinfections with H. hepaticus, H.
cinaedi and H. rodentium gave a cholesterol gallstone prevalence of 40%, 30% and 20%,
respectively; the latter two groups did not differ significantly from uninfected animals.
Animals fed a chow diet did not develop cholesterol gallstones. Colonization of the
gastrointestinal tract with cholelithogenic Helicobacter spp. promotes cholesterol
gallstone formation; however, this ability is not correlated with the presence of
Helicobacter spp. in the liver. These findings, along with prior epidemiological studies,
suggest that Helicobacter spp. play a role in the pathophysiology of cholesterol gallstone
formation in mice and perhaps humans.
Introduction
Cholesterol gallstones, composed predominantly of cholesterol monohydrate crystals
within a mucin glycoprotein scaffolding, form in the gallbladder following nucleation and
phase separation of cholesterol monohydrate crystals from cholesterol supersaturated bile
(3, 28, 36). A variety of risk factors are documented, including ethnicity, gender, obesity,
weight loss, dietary intake and concurrent medical conditions and treatments (36).
Currently, the only definitive treatment for gallstones is surgical removal of the
gallbladder (cholecystectomy) and the total annual cost of treatment in the United States
alone approaches 10 billion dollars (36). Moreover, an ominous complication of
gallstone disease is gallbladder cancer (4, 31).
Studies elucidating the pathogenesis of cholesterol gallstones rely predominantly on
inbred mouse models (36). In particular, quantitative trait locus (QTL) analysis utilizing
gallstone susceptible and gallstone resistant strains illustrates that cholesterol gallstone
disease is principally a polygenic trait involving multiple susceptibility loci (Lith alleles)
on many chromosomes (25, 36, 37, 54). A strain of particular interest is the C57L/J
(C57L) mouse because of its high susceptibility to cholesterol gallstones, which develop
in 80-100% of males fed a lithogenic diet for eight weeks (23, 48). Additionally, two
congenic strains carrying the Lithl or Lith2 loci from the C57L strain in an AKR/J
(AKR) background recapitulate the phenotype of the C57L parent (36).
Recent evidence from our laboratories suggests an infectious contribution to the gallstone
phenotype in C57L mice. When congenic AKR mice carrying a susceptibility locus
(Lith2) from C57L mice (AK.L-Lith2S) were re-derived and housed under specific
pathogen free (SPF) conditions, they failed to develop gallstones. This was established in
two independent but identical pilot studies under feeding conditions with a lithogenic diet
containing 1% cholesterol, 0.5% cholic acid and 15% dairy fat, lasting 8 weeks (G.
Bouchard, B. Paigen M.C. Carey, unpublished observations, 2003). Because of the
ubiquitous nature of Helicobacter spp. in conventional mouse colonies (41) and the
ability of these organisms to cause hepatobiliary disease (11, 41) we considered them
likely candidates to be involved in cholesterol cholelithogenesis.
Since the discovery of H. pylori, over 25 Helicobacter spp. have been isolated from the
stomach, intestinal tract, and liver of humans, other mammals and birds (9, 11, 13, 41).
Many of these organisms cause extragastric disease and several are able to grow in bile
including H. hepaticus, H. bilis, and H. pullorum (9, 13). These non-gastric
(enterohepatic) Helicobacter spp. generally colonize the distal small intestine, cecum
and large intestine, and subsequently the liver where they have been implicated in, or
suggested to cause, hepatitis, hepatocellular carcinoma, cholecystitis, typhlocolitis, and
colonic adenocarcinoma (9, 11, 13, 41). We demonstrated previously that there is an
association between molecular (DNA) evidence of enterohepatic Helicobacter spp.
colonization and cholecystitis in Chilean women (13). Interestingly, this population is
notable for its high prevalence of gallbladder cancer invariably associated with
cholesterol gallstone disease (13, 36). Additionally, there is a growing body of literature
identifying helicobacter DNA in the gallbladders, bile and stones of patients with
gallstones (2, 6, 33).
Due to the high prevalence of enterohepatic Helicobacter spp. in mice (9, 11, 16, 41) and
the burgeoning evidence in humans (6, 31, 33, 34), we believed it reasonable to
hypothesize that Helicobacter spp. contribute to cholesterol gallstone formation. To test
this hypothesis, prospective infections were performed in the well-characterized, highly
susceptible, dliet-induced, C57L mouse model of gallstone disease (23, 25, 36, 37, 48)
initially utilizing two enterohepatic Helicobacter species, H. hepaticus and H. rodentium
(9, 11, 41). We chose these two species because they were present concurrently in the
colonies at Brigham and Women's Hospital (BWH, Boston, MA) where much of the
original gallstone research was done. Following these coinfection studies we performed
monoinfection studies with these enterohepatic Helicobacter spp. as well as H. bilis and
H. cinaedi which have been identified in humans with gastrointestinal and hepatobiliary
disease (1, 10, 14, 18, 31, 35, 45).
Methods
Animals and diet
Helicobacter spp.-free male C57L mice were acquired from The Jackson Laboratory (Bar
Harbor, Maine, USA), and housed under SPF conditions in an Association for
Assessment and Accreditation of Laboratory Animal Care international (AAALAC)
accredited facility. These SPF conditions included specific absence of Helicobacter spp.,
Salmonella spp., Citrobacter rodentium, and known murine viral pathogens. All animal
protocols met the approval of the institutions' animal care and use committees. Mice
were fed either standard rodent chow, or beginning at 8 weeks of age, a lithogenic diet
containing 15% dairy triglycerides, 1.0% cholesterol, and 0.5% cholic acid. This was
continued for eight weeks (37) for both coinfection and monoinfection studies and for
eighteen weeks for chronic lithogenic studies.
Infection protocols
H. hepaticus strain 3B 1 (ATCC 51499), H. rodentium (ATCC 700285), H. bilis (MU
strain), and H. cinaedi (CCUG 18818) were grown on blood agar plates under
microaerobic conditions at 370C. For coinfection studies, four-week-old mice were either
infected orally three times over five days with approximately 1.0x108-2.0x108 each of H.
hepaticus and H. rodentium suspended in Brucella broth (Becton, Dickinson and
Company, Sparks, MD, USA) or sham-dosed with Brucella broth. For monoinfection
studies, mice were infected three times over five days with approximately 1.5x108-
3.0x10 8 of the individual Helicobacter spp. tested or sham dosed with Brucella broth.
For coinfection studies, mice were subsequently re-dosed with a comparable dose of H.
hepaticus or sham dosed with broth every month thereafter and for monoinfection studies
mice were re-dosed with a comparable dose of the appropriate organism every month
thereafter for two months.
Direct Light and Polarizing microscopy of gallbladder bile and gallstone analysis
At 16 weeks of age (or 26 weeks of age for prolonged lithogenic studies), mice were
euthanized by CO2 overdose and cholecystectomies were performed immediately.
Gallbladders were weighed, opened, and microscopists (M.C.C. and K.J.M.) blinded as to
sample identity examined gallbladder bile by both direct and polarized light microscopy
for the presence of liquid crystals, solid crystals, sandy stones, and cholesterol gallstones
as defined elsewhere (48). Bile was scored microscopically for mucin gel content on an
0-5 arbitrary scale (53). Gallstones were analyzed for cholesterol content by HPLC as
previously described (23).
Histopathological examinations
Sections of each liver lobe as well as gallbladder and ileocecocolic junctions were
harvested at necropsy, fixed overnight in 10% neutral-buffered formalin, processed
routinely, cut into 4 gim thicknesses, and stained with hematoxylin and eosin. Liver
sections were graded for lobular and portal inflammation according to previously defined
criteria (39) by a comparative pathologist (A.B.R.) blinded as to sample source.
Gallbladders were assessed morphologically for inflammation, epithelial disorganization,
hyperplasia, dysplasia, and hyalinosis. Special stains included a pH 2.5 Alcian
blue/periodic acid-Schiff stain for acidic and neutral mucins.
Helicobacter spp. screening tests
DNA was prepared from post-mortem tissue using a "High pure PCR template
preparation kit" (Roche Applied Science, Penberg, Germany) and was either singly
amplified from the cecum with genus-specific (for moninfection studies) or species-
specific prime:rs (for coinfection studies) utilizing previously described conditions (16,
17, 40). DNA was amplified from the liver, gallbladder, or cholesterol gallstones by
nested amplification with an initial genus-specific primer set utilizing previously
described conditions (17). This was followed by a subsequent amplification of 2.5 tl of
this product with internal species-specific primers to H. hepaticus, H. rodentium, or H.
bilis or a second genus specific primer set for H. cinaedi utilizing previously described
reaction conditions (16, 40).
Culture of Helicobacter spp.
Gallbladder and liver were ground in sterile glass tissue grinders with 0.5-1 ml of
brucella broth. Ground tissue was streaked onto blood agar plates and grown under
microaerobic conditions at 370C for three weeks. At that time plates were scrutinized for
bacterial growth.
Statistical analysis
Statistical analyses of mucin score and gallbladder weight were performed by one way
analysis of variance (ANOVA), with the Tukey-Kramer post test using Instat 3.0
software (GraphPad, Inc., San Diego, CA, USA). Cholesterol monohydrate crystal as
well as sandy and true gallstone formation were analyzed by Fisher's exact test utilizing
the same software.
Results
Phenotypic analysis of gallbladder and bile from coinfected animals
Helicobacter spp. infected mice (all n values = 5-10, see Table 2-1) fed the lithogenic
diet developed cholesterol gallstones (48) at a prevalence of 78% and sandy stones at a
prevalence of 56%, and all but a single animal progressed beyond the liquid crystalline
phase (Table 2-1 and Fig. 2-1). In contrast, uninfected mice and mice that ingested a
standard chow diet failed to develop gallstones (Table 2-1 and Fig. 2-1). Interestingly, all
Figure 2-1: Morphologic characterization by direct and polarizing light microscopy (48)
of gallbladder bile and stones of (A) Helicobacter spp. infected C57L mice fed a
lithogenic diet for 8 weeks. Macroscopically visible stones (arrows) up to 2 mm diameter
within a mouse gallbladder. Progressive stages in development of cholecystolithiasis
found in Helicobacter spp. infected C57L/J mice fed a lithogenic diet include (B)
cholesterol monohydrate crystals (48), sandy stones (48) (not shown) and (C ) cholesterol
gallstones (48) (these stones have smooth contoured birefringent edges and dark centers
due to light scattering and absorption). Birefringent aggregated liquid crystals (48) (D)
represent the minimal extent of lithogenesis in uninfected C57L mice fed a lithogenic
diet. bar (p~m)= 500 (A); 100 (B); 170 (C); 50 (D).
Figure 2-1: Morphologic characterization by direct and polarizing light microscopy (48)
of gallbladder bile and stones of (A) Helicobacter spp. infected C57L mice fed a
lithogenic diet for 8 weeks. Macroscopically visible stones (arrows) up to 2 mm diameter
within a mouse gallbladder. Progressive stages in development of cholecystolithiasis
found in Helicobacter spp. infected C57L/J mice fed a lithogenic diet include (B)
cholesterol monohydrate crystals (48), sandy stones (48) (not shown) and (C ) cholesterol
gallstones (48) (these stones have smooth contoured birefringent edges and dark centers
due to light scattering and absorption). Birefringent aggregated liquid crystals (48) (D)
represent the minimal extent of lithogenesis in uninfected C57L mice fed a lithogenic
diet. bar (ljm)= 500 (A); 100 (B); 170 (C); 50 (D).
Histopathological analysis of hepatobiliary tissues
Histological analysis of livers revealed microsteatosis and mild chronic portal
inflammation associated with diet but not with Helicobacter spp. infection status. A
subset of infected and uninfected mice on the lithogenic diet exhibited portal and random
lymphohistiocytic infiltrates attributed to hepatobiliary tissue damage caused by steatosis.
However, there was no association between hepatic inflammation and risk of gallstones
(P=1). In contrast, lesions of the gallbladder including hyalinosis, intestinal metaplasia,
eosinophilic inflammation, hyperplasia, and dysplastic change were limited to
Helicobacter spp. infected mice on the lithogenic diet (Fig. 2-2). Interestingly, many of
these lesions are seen in humans with gallstones and several of them including dysplasia,
hyperplasia, and intestinal metaplasia are considered to be pre-neoplastic (46).
Helicobacter spp. infection status of co-infected mice
Co-infected mice fed either chow or lithogenic diet demonstrated consistent cecal
colonization with both Helicobacter species when screened by PCR (Fig. 2-3) (16, 40).
Molecular (DNA) evidence of enterohepatic Helicobacter spp. was present in a region of
the hepatobiliary tree (either gallbladder or liver) in most infected animals (Fig. 2-3) (16,
17, 40). No uninfected animals demonstrated molecular evidence of colonization in
either the cecum or hepatobiliary tree (Fig. 2-3). PCR analysis of four gallstones from H.
hepaticus plus H. rodentium co-infected mice revealed that helicobacter DNA was
present in 50% of stones (Fig. 2-3). None of the gallbladders of Helicobacter spp. co-
infected animals fed the lithogenic diet (n=5) were culture positive even after prolonged
(3 weeks) incubation.
Figure 2-2: Panels (A-F): Compared with sections from uninfected mice on a lithogenic
diet (A, B, C), histopathologic examination of gallbladder tissue from Helicobacter spp.
infected mice demonstrate (D; arrows) epithelial disorganization with eosinophilic
luminal secretory products, hyperplasia and mucous intestinal-type metaplasia (black
arrows; note absence of mucous staining in hyalinized epithelium, white arrow; E), and
epithelial hyalinosis (glassy pink-red material, black arrows) and patchy eosinophil-
predominant inflammation (white arrows; F). Histologic stains: hematoxylin and eosin
(A, C, D, F) and Alcian blue/periodic acid-Schiff pH 2.5 (B, E); bar (ptm)= 170 ( A, B, D,
E); or 85 (C, F).
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Figure 2-3: Prevalence of helicobacter DNA in various tissues from coinfected
experimental groups. DNA was prepared from tissue using the "high pure PCR template
preparation kit" (Roche Applied Science, Penberg, Germany) and was either singly
amplified from the cecum with species specific primers utilizing previously described
conditions (17) or amplified from the liver, gallbladder, or gallstones by nested
amplification with an initial genus specific primer set utilizing previously described
conditions (17). This was followed by a subsequent amplification of 2.5 tl of this
product with species specific primers to H. hepaticus and H. rodentium with reaction
conditions (16, 40) as previously described. Biliary tree refers to a positive result from
either intrahepatic bile ducts or gallbladder.
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Phenotypic analysis of gallbladder and bile in monoinfected mice
In mice fed a lithogenic diet for eight weeks, the biliary phenotype varied greatly
depending upon the organism the mice were infected with. Specifically, when compared
to uninfected mice, monoinfection with H. rodentium or H. cinaedi did not increase
normalized gallbladder weight, mucin score, cholesterol monohydrate crystal formation,
sandy stone formation, or cholesterol gallstone formation significantly (Table 2-2). In
contrast, monoinfection with H. bilis and H. hepaticus significantly increased cholesterol
monohydrate crystal formation, sandy stone formation and cholesterol gallstone
formation when compared with uninfected mice (Table 2-2). Additionally, H. bilis
infection increased mucin score significantly when compared to uninfected mice (Table
2-2). A sampling of stones (n=2 from infected, and uninfected) was analyzed for
cholesterol content and both infected and uninfected were composed primarily of
cholesterol (monohydrate) confirming that they were indeed cholesterol stones. This was
further corroborated by their creamy white to tan appearance to the unaided eye as well
as the agglomeration of cholesterol monohydrate crystals in sandy and true stones by
polarizing and direct light microscopy.
Histopathological changes in the gallbladder mucosa observed in coinfected animals were
also noted in some monoinfected animals and were rarely detected in uninfected animals.
Almost invariably, these histopathological changes were found concomitantly with sandy
stones or true cholesterol gallstones in both infected and uninfected animals.
Prolonged lithogenic diet feeding
To determine if Helicobacter spp. were merely altering the rates of cholesterol
cholelithogenesis, we fed uninfected mice and H. hepaticus infected mice a lithogenic
diet for 18 weeks. Interestingly, prolonged exposure to the lithogenic diet did not
significantly alter the prevalence of cholesterol gallstone formation in either group when
compared to their counterparts fed the lithogenic diet for eight weeks (Table 2-2). When
compared to uninfected mice, H. hepaticus infected mice displayed a significantly higher
mucin score, with a higher prevalence of both cholesterol monohydrate crystals and
sandy stones (Table 2-2).
Infection status of hepatobiliary and gastrointestinal tissues
All C57L mice infected with Helicobacter spp. were confirmed to be infected by cecal
PCR (except for H. bilis infected animals that were confirmed to be positive by cecal
culture); all uninfected animals tested negative for enterohepatic Helicobacter spp. by
cecal PCR (Table 2-2). The presence of Helicobacter spp. DNA in liver of infected
animals was variable and the presence or absence of DNA in liver did not correlate with
gallstone formation. None of the H. hepaticus (n=10) or H. rodentium (n=10) infected
mice were culture positive for Helicobacter spp. in the liver or gallbladder.
Table 2-2: Biliary phenotype and colonization status of monoinfected and uninfected
male C57L mice on a lithogenic diet
Organism Lith
Diet
(weeks)
H. hepaticus 8
(n=20)
H. rodentium 8
(n= 10)
H. bilis 8
(n=5)
H. cinaedi 8
(n=5)
Uninfected 8
(n=30)
Normalized
Gallbladder
Weight (mg/g)"
0.85 (+0.13)
0.69 (±0.15)
0.73 ( 0.35)
0.72 ( 0.08)
0.59 (+ 0.065)
Mucin
Score
1.20
(+0.12)
1.55
(+ 0.31)
2.00 b
(+ 0.35)
1.40
(±0.19)
0.93
(±0.11)
Liquid
Crystals
95%
100%
80%
100%
100%
Solid
Crystals
65%
40%
100%'
20%
20%
Sandy
Stones
35%
30%
100%'
20%
7%
Cholesterol
Gallstones
40%"
30%
80% c
20%
10%
Cecal
PCR
100%
100%
100%
100%
0%
Liver
PCR
60%
80%
60%
80%
ND
Hepatobiliary
Culture
0% (n=10)
0% (n=10)
NDd
ND
ND
H. hepaticus 18 0.90 (.0.18) 2.45 b 100% 100% c 100% c 50% 100% 67% ND
(n=10) (+0.32)
Uninfected 18 0.57 (± 0.09) 1.55 100% 20% 20% 20 % 0% ND ND
(n=10) (±0.19)
a Numerical data are presented as mean +/- standard error of the mean.
bp<0.05, and CP<0.005 when compared to controls fed the lithogenic diet for the same
time-period.
d N.D. = Not determined
Discussion
This study presents systematic information detailing what appears to be a paradigm shift
in our understanding of cholesterol gallstone pathogenesis, at least in this inbred mouse
model and perhaps in humans. These data demonstrate rigorously that enterohepatic
Helicobacter spp., play a notable role in the development of cholesterol gallstones in the
murine gallbladder. Indeed, without this infection the C57L mouse, the most frequently
used polygenic model of cholesterol gallstone disease, does not acquire gallstones with
any appreciable frequency.
The ability to promote cholesterol gallstones in C57L mice is Helicobacter species
specific. Of the organisms tested, co-infection with H. hepaticus and H. rodentium and
monoinfection with H. bilis displayed the greatest impact in promoting cholesterol
gallstone formation. H. hepaticus was intermediate in its ability, and H. rodentium and
H. cinaedi did not influence cholesterol cholelithogenesis significantly compared with
uninfected controls. We propose the appellation "cholelithogenic" Helicobacter spp. to
differentiate those species that are capable of promoting cholesterol cholelithogenesis
from those that do not. We suspect that with further testing other Helicobacter spp. and
perhaps other related and unrelated microorganisms may prove capable of promoting
cholesterol gallstone formation.
We tested mice at the facilities where most of the original studies were done (BWH) by
anaerobic and aerobic fecal culture. Those results were compared with results of cultures
from mice in the current study to determine if other pathogens may have contributed to
the historical prevalence of gallstones at the prior facility. We found no differences in
pathogen status between the two (BWH and MIT) facilities (data not shown). Moreover,
the only other mouse pathogen present at both MIT and BWH was Klebsiella oxytoca, an
organism rarely associated with disease and then only with utero-ovarian infection in
mice (7). The possible pathogenic roles that the normal microbiota of the gut plays in the
complex process of cholesterol gallstone disease is intriguing but cannot be answered
without prospective studies in gnotobiotic and germ-free animals.
In our studies the ability of some but not all Helicobacter spp. to promote cholesterol
cholelithogenesis implies that promotion of cholesterol gallstone formation is mediated
by species-specific bacterial products or a reaction of the host to these products, possibly
through cytokines and other pro-inflammatory mediators. If promotion of
cholelithogenesis were due to a non-specific host response to colonization then all
Helicobacter organisms tested should have promoted gallstone formation equally. In
particular, an interesting aspect of this phenomenon was that the bacteria tested did not
colonize the biliary tree (at least in the culturable state when tested at sacrifice) and yet
cholelithogenesis was promoted. This is evidenced by the lack of correlation between
bacterial DNA in the liver and stone formation as well as, our inability to culture
organisms even after prolonged incubation and the necessity for nested PCR to identify
DNA in the liver and gallbladder. This raises several questions concerning the
mechanism behind the relationship between these bacteria and cholesterol gallstone
pathogenesis and the manner in which past studies have been conducted in an attempt to
detect a possible infectious contribution to pathogenesis of cholesterol gallstone disease.
Many of these studies relied upon culture and PCR of the hepatobiliary tree to determine
a possible role for Helicobacter spp. and other bacteria in cholesterol gallstone formation
(6, 13, 19, 29, 31, 32). A number of investigators found no correlation between the
presence of Helicobacter spp. DNA in these tissues and the presence of cholesterol
gallstones (6, 32). However, based upon the results of the present study, it is clear that
these organisms do not have to be present in high numbers in the hepatobiliary tree to
promote cholelithogenesis. In fact, our study demonstrates that the most appropriate
anatomic site to determine whether Helicobacter spp. are indeed an epidemiological risk
factor in mouse and human cholelithogenesis would be the distal small intestinal tract,
cecum and proximal large intestine. Furthermore, because our studies suggest a
Helicobacter species-specific effect, future investigations should focus on identifying the
organisms at the species level by acceptable methods and not rely merely on the presence
or absence of helicobacters as a genus.
Several potential mechanisms or combinations thereof could be suggested to explain the
contribution of Helicobacter spp. to cholesterol cholelithogenesis. First, the organisms
may produce a soluble antigen or antigens that modulate key hepatobiliary genes in the
lithogenic pathway. Based upon the present data, an attractive population of genes are
the Muc alleles of the gallbladder epithelium involved in the production of mucin (28,
36). Alternatively, because enterohepatic Helicobacter spp. colonize, among other sites,
the distal ileum they may modulate enterohepatic cycling of conjugated bile acids either
directly or through genetic regulation of absorption at the enterocyte level or by
modulating gastrointestinal transit time. An intestinal role is further suggested by our
finding in this murine model of a lack of correlation between colonization of the
hepatobiliary tree by Helicobacter spp. and cholesterol gallstone formation. In addition
to other possible mechanisms, an antigenic product of Helicobacter spp. or a host
response (e.g. cytokines or other inflammatory mediators) could change the phase
equilibria of bile or accelerate the nucleation kinetics of solid cholesterol monohydrate
crystals from liquid crystals.
Interestingly, :mice infected with both H. rodentium and H. hepaticus developed
cholesterol gallstones at a consistently higher rate (78%) than infection with either of
these organisms alone which produced gallstones only at a moderate prevalence (H.
hepaticus) or rarely (H. rodentium). This implies microbiotic synergism in that
individually, H. rodentium and H. hepaticus may not possess all of the necessary
cholelithogenic factors to promote gallstone formation but together can do so effectively.
Alternatively, colonization by one of these organisms may modulate a host response
towards the other organism. In this regard, studies conducted on gastric Helicobacter
spp. (H. felis) infected animals demonstrate that the presence of other pathogens may
promote or inhibit gastric disease. (12, 42)
The possibility that enterohepatic Helicobacter spp., influence human cholesterol
gallstone formation is a provocative concept for several reasons. First and historically,
the disease was presumed to be solely a physical-chemical phenomenon occurring at the
level of the gallbladder; there then followed the realization that a genetic (polygenic
component) was crucial in altering the secretory rates of biliary lipids from the liver and
now it appears that a "random event" is required. This supports the concept that a
necessary component may also be chronic intestinal infection with an enterohepatic
Helicobacter spp. It is worth noting that at the beginning of the 2 0 th century Lord
Berkeley Moynihan, a notable British surgeon avouched that "a gallstone is a tombstone
erected to the memory of the organism within it" (38). Although this statement exhibits
magnificent prescience by a thoughtful surgeon, it does not hold entirely true with respect
to our findings since not all cholesterol gallstones in the current study contained
helicobacter DNA. Another salient aspect of this concept relates to the fact that the
prevalence of gallbladder cancer is intimately associated with prevalence of gallstone
disease (4, 13, 31). In experimental animals both excess biliary cholesterol and H.
hepaticus produce hepatobiliary cancer (24) and hepatocellular carcinoma (15, 50)
respectively, either by themselves or in the presence of other cocarcinogenic or
promoting cofactors. It is therefore tempting to speculate that Helicobacter spp., some of
which are known carcinogens (43), and cholesterol (or an oxidized product thereof) may
act synergistically to promote tumors of the biliary tree in individuals with lithogenic bile
and cholesterol gallstones. Further evidence supporting this hypothesis derives from
studies involving Japanese and Thai patients with gallstones and biliary tract
malignancies (31) and Chilean women with chronic cholecystitis (13). These populations
have high prevalence rates of gallstones and biliary cancers (13, 31) and both of these
studies found an association between molecular (i.e. DNA) evidence of enterohepatic
Helicobacter spp. infection and neoplastic biliary disease.
In the recent past, a putative role of Helicobacter spp. in human cholesterol gallstone
disease has been proposed and questioned critically because helicobacter DNA has been
amplified in hepatobiliary samples from unaffected individuals (6) and sometimes
helicobacter DNA is not identified in hepatobiliary tissues of cholesterol gallstone
patients (8). However, it is clear from our data that Helicobacter spp. infection per se
plays a role in cholelithogenesis, but is not sufficient in or of itself, to produce cholesterol
gallstones. Moreover, only certain strains of Helicobacter spp. promote cholesterol
cholelithogenesis in the setting of lithogenic bile in vivo. Clearly, genetic background
and non-infectious environmental factors (i.e. the lithogenic diet) are essential in the
mouse model in initiating the physical chemical conditions, i.e. lithogenic bile
predisposing to the disease. Mouse strain is clearly important since cholesterol gallstone
resistant mice: from the original facility (37) were almost certainly colonized with these
Helicobacter spp but their biles are obstinate in developing supersaturation. Genetics
also play a role in how a host responds to infection with Helicobacter spp. For example,
A/JCr mice can develop severe hepatitis and hepatocellular carcinoma when infected
with H. hepalicus; however, some other mice strains display little hepatic disease when
infected (22, 49, 50). Finally, this study utilized the C57L mouse which typically has a
cholesterol saturation index (CSI) of approximately 1.5 at the eight week time-point (48)
of lithogenic diet feeding. This value roughly correlates with CSI values observed in
normal weight individuals with cholesterol gallstones (5); however, the value is lower
than the median found in very obese individuals with gallstones (5). Further work is
needed to determine whether Helicobacter spp. play a similar role at high CSI values
(>1.60) such as those seen in morbidly obese patients (5). On the basis of the present
studies we propose a hypothetical biological model demonstrating that three
pathophysiological factors, environment, genetics, and enterohepatic Helicobacter spp.
infection, contribute to cholesterol gallstone formation in C57L mice, as well as
metaplasia, dysplasia and potentially the progression to gallbladder cancer.
Of interest is that in the past a number of investigators have identified the presence of
bacteria (non-Helicobacter spp.) in the extrahepatic biliary tree, gallbladder and
gallstones of humans and hypothesized on their putative role in so-called "mixed" (i.e.
plus calcium bilirubinate) cholesterol gallstone formation (27, 30, 44). In particular Lee
and colleagues tentatively identified E. coli and Pseudomonas spp. principally in "mixed"
cholesterol gallstones containing 65-94% cholesterol and brown pigment gallstones with
16 and 25% cholesterol harvested from human gallbladders without current cholecystitis.
These authors hypothesized that bacteria may indeed play a role in "mixed" cholesterol -
bilirubinate gallstone formation (27). However, to date none of the organisms identified
in these studies have been analyzed prospectively and because the bacteria identified are
among the normal microbiota inhabiting the human distal small intestine and colon, their
presence in the biliary tree may be secondary to recurrent biliary stasis and subclinical
cholecystitis from cholesterol gallstones leading to the "mixed" bilirubinate-cholesterol
gallstones (27, 30, 44). Development of this mouse model should allow for a prospective
analysis of the primary versus secondary roles of these and other components of the gut
microbiota in relation to gallstone pathogenesis.
Based on our data (Table 2-1), we believe we can now propose a realistic hypothesis for
the role of Helicobacter spp. (and perhaps other bacteria) in cholesterol gallstone
pathogenesis. We suggest that certain helicobacters change the thermodynamics of
cholesterol crystal nucleation from the liquid crystalline state (i.e. the initial phase
separation) in gallbladder bile (Table 2-1). Cholesterol supersaturation of bile is a
necessary but not sufficient event for cholesterol gallstone formation, and both
gallbladder hypomotility and accumulation of mucin gel (as a nucleation matrix) are also
required. Theoretically, nucleation of solid cholesterol monohydrate crystals can occur
homogeneously, but this is thermodynamically unfavorable and might require a
enormous degree of cholesterol supersaturation (26). Alternatively, a far more favorable
event thermodynamically is heterogeneous nucleation which involves a nucleating
agent(26) that: provide a hydrophobic surface for molecular deposition and these agents
can nucleate bile with only modest degrees of supersaturation. Multiple studies have
suggested the presence of nucleating agents in humans with cholesterol gallstones (26).
Likely nucleating agents identified previously include mucins, immunoglobulins and
other biliary proteins, some of which have been functionally and chemically
characterized (20, 26, 28, 55). We have demonstrated in the current study that particular
Helicobacter spp. significantly increase mucin production in C57L mice fed a lithogenic
diet (Table 2-1). Additionally, we showed earlier that H. hepaticus infection causes a
three-fold increase in biliary IgA production, and it is logical to presume that H. bilis
would have a similar effect (52). Furthermore, it is provocative to suggest that
Helicobacter spp. may produce other pronucleating agonists in response to biliary
exposure or, alternatively, that these organisms may induce production in the host of
nucleating agents either directly or through chronic immune stimulation. Most
importantly, it has been demonstrated that different Helicobacter spp. exhibit very
divergent protein expression profiles in response to their exposure to bile (21). Perhaps
this difference in part explains why some, but not all, of these related organisms
promoted cholesterol gallstone formation in our studies. Additionally, preliminary data
(KJ Maurer, MC Carey JG Fox unpublished observations, 2004) from our laboratories
suggest that global changes occur in hepatic gene expression from enterohepatic
helicobacter infection even without inclusion of a lithogenic diet, including genes thought
to play a role in cholesterol homeostasis. It is theoretically possible that one or more of
these upregulated genes may play a role in altering biliary lipid composition either
qualitatively or quantitatively.
In conclusion, our work represents a provocative new dimension in our understanding of
cholesterol gallstone pathogenesis in C57L mice, and that these findings are likely to be
applicable to humans. Dissecting the mechanisms responsible for these observations,
including physical-chemical, petrological, genomic/proteomic and infectious will require
further critical hypothesis and experimentation in several mouse models with different
enterohepatic as well as gastric Helicobacter spp. and related organisms. Provided the
new concept holds true for human gallstone disease, as some earlier epidemiological
evidence would imply, then a paradigm shift may be in the offing that may lead to major
modifications in the prevention and treatment of cholesterol gallstone disease, and
possibly prevention and management of gallbladder and other hepatobiliary diseases
including hepatobiliary and perhaps pancreatic cancers.
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Abstract
Recently we demonstrated that cholesterol gallstone prone C57L/J mice rarely develop
gallstones unless they are infected with certain cholelithogenic enterohepatic
Helicobacter species. Since the common gastric pathogen H. pylori has been identified
in the hepatobiliary tree of cholesterol gallstone patients, we wished to ascertain if H.
pylori is cholelithogenic, by prospectively studying C57L infected mice fed a lithogenic
diet. Weanling, Helicobacter spp.-free male C57L mice were either infected with H.
pylori SS1 or sham dosed. Mice were then fed a lithogenic diet (15% dairy triglycerides,
1.0% cholesterol and 0.5% cholic acid) for eight weeks. At 16-weeks of age, mice were
euthanatized, the biliary phenotype was analyzed microscopically, and tissues were
analyzed histopathologically. H. pylori infection did not promote cholesterol
monohydrate crystal formation (20% vs. 10%), sandy stone formation (0% for both) nor
gallstone formation (20%) when compared to uninfected mice fed the lithogenic diet
(10%). Additionally, H. pylori failed to stimulate mucin gel accumulation in the
gallbladder or alter gallbladder size when compared with uninfected animals. H. pylori
infected C57L mice developed moderate to severe gastritis by 12 weeks and the
lithogenic diet itself produced forestomach lesions which were exacerbated by the
infection. We conclude that H. pylori infection does not play any role in murine
cholesterol gallstone formation. Nonetheless, the C57L mouse develops severe lesions of
both the glandular and non-glandular stomach in response to H. pylori infection and the
lithogenic diet respectively.
Introduction
Gallstones are an exceptionally common cause of morbidity worldwide and cholelithiasis
with or without cholecystitis is the most common gastrointestinal disease requiring
inpatient treatment in the United States (45). Despite five decades of intense basic and
clinical research (6, 11, 27, 41, 42) there is currently no effective non-surgical treatment
for definitive management of gallstones, hence the disease is a serious surgical and
economic burden with the median per patient cost exceeding 10,000 U.S. dollars (45).
The term gallstones or cholelithiasis is a generic description encompassing both pigment
and cholesterol gallstones (41). Cholesterol gallstones are the most common gallstones
encountered in the Western world (41). These stones result from cholesterol
supersaturation of bile and phase separation of cholesterol-rich liquid crystals and solid
crystals with subsequent crystal agglomeration and stone growth in the gallbladder within
a mucoglycoprotein gel scaffold (8, 9, 41). Cholesterol gallstone formation is a
polyfactorial disease with heterogeneous contributions from both genetics and
environment (41). Specifically, genetic susceptibility to cholesterol gallstones is, with
very rare exceptions inherited as a polygenic trait (6, 10, 11, 27, 41, 42, 54). Cholesterol
gallstone susceptibility genes require environmental triggers including diet, obesity,
estrogenic dnrugs and other complex factors to express the cholesterol gallstone phenotype
(41).
The C57L/J mouse is utilized extensively to investigate cholesterol gallstone genetics and
pathogenesis (25, 42, 51, 52). When fed a lithogenic diet containing 1.0% cholesterol
and 0.5% cholic acid for eight weeks, this animal model historically develops cholesterol
gallstones with an 80% prevalence rate (25, 51). Our initial studies with this model were
conducted at facilities where the mice were enzootically infected with enterohepatic
Helicboacter spp (33). Recently, we demonstrated that in the absence of infection with
specific enterohepatic Helicobacter spp., prevalence of cholesterol gallstones was much
less than we reported previously, approximating 10% (33).
We and others, found serological and molecular evidence that enterohepatic Helicobacter
spp. may be associated with several chronic hepatobiliary diseases of humans (3, 15, 30,
32, 38, 50). Others have reported the identification of H. pylori in hepatobiliary tissue
from patients with benign and malignant hepatobiliary disease (7, 39, 47). In some of
these studies, bile precurement and sample processing had the potential to bias the results
towards identification of H. pylori. For example, endoscopic retrograde
cholangiopancreatography (ERCP), was utilized to collect bile samples from patients
with known gastric H. pylori colonization, leading to potential contamination of bile
samples with H. pylori from the gastric mucosa; particularly so when sensitive detection
methods such as PCR are utilized (7). Moreover, in some cases, H. pylori was identified
on the basis of sequencing segments of its 16SrRNA gene (47). However, this method is
known to be unsatisfactory for properly speciating helicobacters due to high 16SrRNA
sequence homology among organisms in this large genus (40). Moreover, in vitro studies
have revealed that H. pylori is sensitive to bile and is chemotactically repelled by pure
solutions of both conjugated and unconjugated bile salts (22, 55). Because of these
equivocal findings in humans and our recent identification of a number of enterohepatic
Helicobacter spp. that promote murine cholelithogenesis, we wished to ascertain
whether H. pylori infection exhibited the ability to induce cholesterol gallstones in the
C57L mouse model of "infectious" cholesterol cholelithogenesis (33) .
Methods
Animal sources and husbandry
All animal protocols were reviewed and approved by the MIT Committee on Animal
Care. Three to four-week old Helicobacter spp. free C57L/J mice were purchased from
The Jackson ]Laboratory (Bar Harbor, ME). Mice were divided into three groups for
study. In the first group mice remained uninfected and were fed a standard lithogenic
diet containing 15% dairy fat, 1.0% cholesterol and 0.5% cholic acid (n=10) (25). The
second group was infected with H. pylori SS1 (28) and fed a rodent chow diet (n=5), and
the third group was infected with H. pylori SS1 and fed a standard lithogenic diet (n= 10).
Group numbe:rs were chosen based upon a power of 90-95% to statistically detect similar
changes in gallstone prevalence compared to changes noted in our initial studies (33).
Mice were housed in polycarbonate microisolator cages under specific pathogen free
(SPF) conditions (free of Helicobacter spp., Citrobacter rodentium, Salmonella spp.,
endoparasites, ectoparasites and known murine viral pathogens) in an Association for the
Assessment and Accreditation of Laboratory Animal Care International (AAALAC)
accredited facility. Mouse rooms were kept at constant temperature and humidity on a
12-hour regular light to dark cycle and mice received food and water ad libitum. Animals
were fasted for 12 hours prior to CO 2 induced euthanasia. Mice were fed a standard
rodent chow (Purina Mills, St. Louis MO) containing less than 0.05% cholesterol until
eight weeks of age. At this time point mice were either continued on a standard rodent
chow or converted to the lithogenic diet.
H. pylori infection
H. pylori strain SS1 (28) was grown for 24-48 hours in Brucella broth (Becton Dickinson,
Co., Franklin Lakes NJ) containing 5% heat inactivated fetal calf serum. Broth cultures
were centrifuged at 8000 rpm for 20 minutes at 40C and the bacterial pellet was
resuspended in Brucella broth at a turbidometric (O.D.= 660 nm) reading of between 0.6-
1.2. Four to five wk old mice were infected with 0.2mL of resuspended bacteria (n= 15)
or sham dosed with 0.2 mL Brucella broth (n=10) by oral gavage three times over a five-
day period. At monthly intervals thereafter mice were given 2 more doses of H. pylori
SS1 by gavage utilizing the same protocol.
Bile Analysis and tissue processing
Mice were euthanatized with CO 2 in the fasting state at 16 weeks of age. A ventral
midline incision was made and the gallbladder was removed intact. Full gallbladders
were weighed and their contents were examined under direct and polarized light
microscopy by a microscopist (KJM) blinded as to sample identity. Bile was scored for
mucin content, presence of liquid crystals, solid cholesterol monohydrate crystals, sandy
stones, and true cholesterol gallstones as described (27, 52). Statistical analyses of mucin
score and gallbladder weight were performed by one way analysis of variance (ANOVA),
with the Tuke:y-Kramer post test using Instat 3.0 software (GraphPad, Inc., San Diego,
CA, USA). Cholesterol monohydrate crystals as well as sandy and true gallstone
formation were analyzed by Fisher's exact test utilizing the same software. Stomachs
were removed aseptically, and opened longitudinally along the greater curvature.
Approximately 30 mg of glandular stomach was flash frozen in liquid N2 and stored at -
800C for subsequent quantitative PCR. Three, 10 mg segments of the liver from different
liver lobes were collected aseptically and frozen at -200C for subsequent PCR.
Histopathology
At necropsy, liver, gallbladder, stomach, duodenum, pancreas, and ileocecocolic junction
were collected, trimmed and fixed in 10% neutral-buffered formalin. Tissues were
processed routinely, paraffin embedded, cut at 4 Lm thickness, and stained with
hematoxylin and eosin (H&E). Additional stomach and gallbladder sections were stained
with Alcian blue/periodic-acid Schiff (pH 2.5) for acidic and neutral mucins (18).
Tissues were evaluated by a comparative pathologist blinded as to sample identity
(ABR). Gastritis was scored on an ascending 0--4 scale using previously defined criteria
(17). Inflammation of the squamous forestomach was scored using criteria similar to
those for the glandular compartment. Squamous epithelial hypertrophy/hyperkeratosis
was scored as 0: normal thickness, 1: 2X normal thicknes, 2: 3X normal thickness, 3: 4X
normal thickness, or 4: >4X normal thickness. The presence or absence of intraepithelial
microabscesses was also recorded. Mean histologic grades were compared between
multiple groups by Kruskal-Wallis one-way analysis of variance followed by Dunn's
post-test using Prism 3.0c for Macintosh (GraphPad, Inc., San Diego, CA). Direct
comparisons were made with Mann Whitney U test. Prevalence of microabscesses was
evaluated using Fisher's exact test. P values < 0.05 were considered statistically
significant.
Real Time Quantitative PCR
Chromosomal DNA from broth-grown H. pylori SS1 and total DNA from mouse
stomachs were prepared using the "High Pure Template Preparation Kit" according to the
supplier's instructions (Roche Molecular Biochemicals, Indianapolis, IN, USA). To
quantify colonization levels of H. pylori strain SS1 within gastric mucosa, a real-time
Quantitative PCR assay (Q-PCR) was developed based upon the nucleotide sequence of
H. pylori ureB gene in the ABI Prism TaqMan 7700 sequence detection system (A/B
Applied Biosystem, Foster City,CA). Two primers (Forward: 5'-
CAAAATCGCTGGCATTGGT-3'; Reverse: 5'-CTTCACCGGCTAAGGCTTCA-3')
and an internal probe (5'-AACAAAGACATGCAAGATGGCGTTAAAAACA-3') were
designed to hybridize within the 100-bp region (nucleotides 273 to 373) of the single
copy ureB gene (AF508016) of H. pylori SS1 using Primer Express software (Applied
Biosystem, Foster City, CA) (40). Q-PCR conditions were described previously (20). The
specificity of these oligonucleotides for H. pylori was tested using DNA isolated from H.
felis (ATC49179), H. mustelae (ATCC43772), and 'H. heilmannii'. Serial 10-fold
dilutions (from 5 x 105 to 5) of the H. pylori SS1 genome copies, estimated from an
average mass value (1.66 Mb) obtained from the two published H. pylori genomes, were
used to generate a standard curve (2, 49). Copy numbers of gastric mucosal H. pylori
SS1 DNA in mice were then calculated and normalized to gg of murine chromosomal
DNA determined by Q-PCR, using the mammalian 18S rRNA gene-based primers and
probe mixture (Applied Biosystems, Foster City,CA) described elsewhere (53).
Liver PCR
Livers were harvested and DNA was extracted using the Roche DNA "High Pure
Template Preparation Kit" (Roche Molecular Biochemicals, Indianapolis, IN, USA) per
the manufacturer's recommendations. Two rounds of PCR amplification were
performed: The first round of amplification utilized the genus specific primer set C97
and C05 which amplifies an approximately 1200 bp amplicon (16, 19). PCR reactions
were performed utilizing 51.L template DNA and "PuRe Taq Ready To-Go PCR beads"
(Amersham Biosciences, Uppsula, Sweden) utilizing previously described reaction
conditions (16, 19). Following this initial reaction, a second nested amplification was
performed utilizing the genus specific C97 and C98 primer sets which amplify an
approximately 400 bp amplicon (16, 19). This reaction utilized 1 pgL of template DNA
from the first reaction and followed conditions described previously (16, 19). Known H.
pylori SS1 colonized murine gastric tissue was included as positive control and known
uninfected mouse tissue was used as negative control.
Results
Biliary phenotype
Regardless of infection status, the gallbladder bile of all mice fed the lithogenic diet,
displayed cholesterol-phospholipid liquid crystals indicating supersaturated bile (Figure
1). Mice fed a chow diet did not develop liquid crystals in bile, confirming the well
known requirement for a modified diet to supersaturate gallbladder bile and induce solid
crystal phase-separation in this mouse strain (33, 51). H. pylori infected mice fed the
lithogenic diet developed slightly more cholesterol monohydrate crystals (20%) and true
cholesterol gallstones (20%) when compared to control animals (10% for each), but these
changes were not statistically significant (P=1.0, Fig. 3-1). Moreover, no differences in
sandy stone formation were noted (0% for both groups, Fig. 3-1). Mucin gel scores and
normalized gallbladder weight for animals fed the lithogenic diet were statistically
greater than those fed a standard chow diet (P<0.05), however, neither differed among
animals fed the lithogenic diet regardless of infection status (P>0.05) (Fig. 3-2). H.
pylori infected animals fed a chow diet did not develop mucin gel formation (score of 0,
Fig. 3-2) and had a similar normalized gallbladder weight compared to uninfected mice
fed a chow diet as described in our previous studies (Fig. 3-2, (33)).
Real-time quantitative PCR
To validate the specificity and sensitivity of the Q-PCR assay for H. pylori, H. pylori SS 1
DNA in parallel with the DNA templates from three gastric helicobacters, H. felis, H.
mustelae, and 'H. heilmanii', was detected using the primers and probes designed for the
ureB gene. The quantitative PCR assay detected a minimum of 5 copies of the H. pylori
SSI genome (Lane 6, Fig. 3-3), whereas there was no amplification from 10 ng
(approximately equal to 5 x 105 genome copies based on the size of the H. pylori
genome) of DNA from H. felis, H. mustelae, or 'H. heilmanii' ((Lane 7-9, Fig. 3-3). The
mean number of H. pylori organisms per ptg of host DNA in the gastric corpus of chow
fed infected animals was 2.46x105 whereas in lithogenic fed infected animals those
numbers were reduced significantly by approximately 1 log unit (P<0.05) with only
6.01x10 4 organisms per ptg of host DNA (Fig. 3-4).
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Figure 3-1: Biliary phenotype determined by polarized light microscopy of gallbladder
bile. Mice infected with H. pylori and fed a lithogenic diet do not differ in biliary
phenotype when compared to uninfected animals fed the same diet. Data for H. pylori
infected animals fed a chow diet are not displayed because chow fed C57L mice fail to
supersaturate their bile with cholesterol and therefore do not demonstrate any of the
ascribed biliary phenotypes.
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Figure 3-2 (preceeding page): Mucus gel score and normalized gallbladder weight (mg
of gallbladder/g of mouse) of all groups of mice. Lithogenic diet feeding, independent of
H. pylori status increases mucin accumulation and normalized gallbladder weight
(*P<0.05) when compared to animals fed a standard chow diet. H. pylori infection does
not significantly increase mucin content or normalized gallbladder weight when
compared to uninfected animals fed the same diet (P>0.05). All data are presented as the
mean +/- SEM.
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Figure 3-3: A standard curve detailing the sensitivity and s ecificity of the quantitative
PCR assay developed. Plots 1 to 6: 5 x 105, 5 x 104, 5 x 10 , 5 x 10 , 50 and 5 copies of
the H. pylori SS1 genome were used as the initial template in these reactions; plots 7 to 9:
10 ng of genomic DNA from H. felis, 'H. heilmannii', and H. mustelae were the initial
template. All of these failed to amplify and are illustrated by the red dots following the
y-intercept. The r2 from the linear regression is >0.99.
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Figure 3-4: Data are presented as log numbers of Helicobacterpylori organisms per jig
of host DNA +/- SEM. Lithogenic diet fed animals show significantly less organism
numbers present in the gastric mucosa than rodent chow fed animals (*P<0.05).
Liver PCR
Livers of infected animals were uniformly negative on initial PCR screening..
Subsequent nested amplification also failed to amplify any H. pylori DNA from either the
infected group fed chow or the infected group fed the lithogenic diet (data not shown).
This contrast markedly with the positive PCR screens from the livers of enterohepatic
Helicobacter infected C57L mice in our earlier study (33)
Histopathology : Liver and Gallbladder
The livers of C57L mice fed the lithogenic diet demonstrated a lobular pattern of
hepatocellular microsteatosis concentrated in acinar zones 2 and 3 (mid-zonal and
centrilobular, respectively; Fig. 3-5a). In contrast, macrosteatosis characterized by
medium to large round clear cytoplasmic lipid vacuoles was mild, patchy, and usually
most prominent in the periportal regions. Mild-to-moderate portal mononuclear
inflammation was noted in a subset of mice on the lithogenic diet, but its occurrence was
recorded equally in H. pylori infected and uninfected animals (Fig.5a). Small
lipogranulomata comprised of macrophages with phagocytosed lipofuscin-like material
were sometimes seen (Fig. 3-5a). Mild and inconsistent gallbladder lesions were evident
in some mice fed the lithogenic diet. Microscopic findings included eosinophilic and
lymphocytic cholecystitis (Fig. 3-5b), small islands of mucous metaplasia, and scattered
epithelial cell hyalinosis with rare intraluminal crystals (data not displayed). Unlike the
severe gallbladder lesions in mice fed the lithogenic diet infected with specific
enterohepatic Helicobacter spp. (33), gallbladder lesions in the present study were
inconsistent, mild, and unassociated with H. pylori infection status. Moreover, there were
no hepatobiliary lesions in H. pylori infected mice on the chow diet. Duodenum,
pancreas and ileocecocolic junction were within normal limits in all mice regardless of
diet or infection status.
Histopathology: Stomach
Two distinct histological patterns of disease were produced in the stomach, one
associated with H. pylori infection and the other with the lithogenic diet. Compared with
uninfected mice on the lithogenic diet (Fig. 3-5c), H. pylori infected mice on either chow
or lithogenic diet developed moderate mixed mononuclear and granulocytic proliferative
gastritis of the cardia and corpus with oxyntic gland atrophy and mucous metaplasia (Fig.
3-5d). No significant intestinal metaplasia or dysplasia was evident. Using H&E
staining, mucous metaplasia of the oxyntic mucosa was characterized by foamy change in
the cytoplasm of parietal cells (Fig. 3-5e). Mucous metaplasia was confirmed by Alcian
blue/PAS staining at pH 2.5, demonstrating transformation of surface mucins from the
neutral gastric-type (red) to the acidic intestinal-type (blue). Additionally, there was
heavy production of mixed mucins in the parietal cell zone, with intestinal-type mucins
concentrated at the upper and lower boundaries of the cellular columns and gastric-type
mucins in the middle (Fig.5f). Compared to uninfected controls, scores of the lesions in
the glandular stomach incorporating all criteria were significantly increased in H. pylori
infected mice, regardless of diet (P<0.05; Fig. 3-6). However, there were no differences
in mean scores between infected groups on different diets except for an additive effect of
the lithogenic diet on mucous metaplasia (P<0.05; Fig. 3-6).
The second pattern of gastritis, associated with the lithogenic diet, affected the anterior
squamous compartment (forestomach). Histologic changes consisted of moderate mixed
inflammation and edema of the lamina propria and submucosa, and hypertrophy of the
squamous epithelium with orthokeratotic hyperkeratosis and frequent intraepithelial
abscesses (Fig. 3-5h). Microabscesses, generally 1-2 mm, were composed of degenerate
neutrophils and epithelial cells, often with a central core of keratotic debris (Fig. 3-5h). In
some instances, microabscesses contained embedded hair shafts or vegetative material
from the diet., although it was not clear whether the foreign bodies induced the
inflammation or became entrapped within pre-existing lesions. In contrast, no squamous
defects developed in H. pylori infected mice on the chow diet (Fig. 3-5g). However, in
mice ingesting the lithogenic diet, there was a statistically significant additive effect of H.
pylori infection on the degree of squamous hyperkeratosis (P_<0.05; Fig. 3-7) and
inflammation (P_<0.05). H. pylori infected mice on the lithogenic diet were twice as likely
to develop microabscesses of the squamous stomach as uninfected mice (80% vs. 40%,
respectively), although this difference did not reach statistical significance (P=0.17).
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Figure 3-5 (preceeding page): Histopathology of liver, gallbladder and stomach from
mice on lithogenic diet and/or infected with H. pylori and euthanatized at 16 weeks of
age. (a) Hepatic lobule in liver of H. pylori infected mouse on lithogenic diet with
centrilobular and midzonal microsteatosis (arrow), patchy macrosteatosis (larger clear
vacuoles), mild portal mononuclear inflammation (arrowhead, right) and lipogranulomas
(arrowheads, lower left). Identical lesions were present in uninfected mice on the
lithogenic diet (not shown). (b) Gallbladder from (a) with mild eosinophilic and
lymphocytic inflammation in the lamina propria (arrows). (c) Histologically normal
gastric corpus from uninfected mouse on lithogenic diet. (d) Moderate-to-severe
inflammation and hyperplasia in H. pylori infected C57L mouse on chow diet. (e)
Marked mucous metaplasia in H. pylori infected mouse on lithogenic diet. Note
cytoplasmic foamy change in parietal cell zone. (f) pH 2.5 Alcian blue/PAS stain of (e).
Abnormal intestinal-type acidic mucins (blue) on the gastric surface, and cytoplasmic
accumulation of both acidic and neutral mucins in the parietal cell zone. (g)
Histologically normal squamous stomach in H. pylori infected mouse on chow diet. (h)
Hypertrophic pleating and marked hyperkeratosis associated with mucosal and
submucosal inflammation and edema of squamous stomach from H. pylori infected
mouse on lithogenic diet. Note intraepithelial microabscess comprised of degenerate
epithelial and polymorphonuclear inflammatory cells (arrow).
SI- T Infected + Chnw Dliet
q 2.0
1.5
1.0
0.5.
0.0
T" " T Infected + Lithogenic Diet
S Uninfected + Lithogenic Diet
T
*
m_
-2.0
-1.5
-1.0
-0.5
*n n
Inflammation Oxyntic Mucous Hyperplasia
atrophy metaplasia
Figure 3-6: Comparison of lesion grades in the glandular stomach of C57L mice. Mean
grade of all lesion criteria was increased by H. pylori infection compared with sham
inoculation (*P•0.05). An additive effect of lithogenic diet with H. pylori infection was
observed for mucous metaplasia (tP_0.03).
101
U.v
EM Infected + Chow Diet
M Infected + Lithogenic Diet
2.0, Uninfected + Lithogenic Diet 100
2-I _ ..,-I T
qjS1.5.
1.0
0.5
0.C -*
i
t
*i
Ir,
50
0
Inflammation Hyperkeratosis Microabscesses
Figure 3-7: Comparison of the lesion grades in the squamous stomach of C57L mice.
The lithogenic diet induced squamous hypertrophy and hyperkeratosis, inflammation and
intraepithelial abscesses. H. pylori infection increased severity of lesions in mice on the
lithogenic diet (tP<0.05). In contrast, H. pylori-infected mice on the chow diet did not
develop lesions in the squamous forestomach.
Discussion
The literature ascribing a role of H. pylori in causing human hepatobiliary disease has
been both confusing and inconclusive (4, 7, 13, 39, 47). In this study, we demonstrated
that H. pylori, unlike some enterohepatic Helicobacter spp. (33) does not promote
cholesterol cholelithogenesis in the C57L mouse model. H. pylori does not increase
cholesterol gallstone formation nor does it promote any of the preliminary stages
(cholesterol monohydrate crystals, sandy stones) in cholelithogenesis. One might argue
that a doubling of the prevalence of cholesterol gallstone formation in infected mice
would be important when dealing with a large population (such as humans with H.
pylori); however, since H. pylori does not increase gallbladder mass (a surrogate marker
of gallbladder motility), nor mucin gel accumulation (in fact infected animals had less
mucin gel accumulation than uninfected animals) which are markers of cholelithogenesis
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it is likely that this increase is merely due to population variation (as our statistical
analyses indicate). In addition, our PCR data indicate that H. pylori does not colonize the
hepatobiliary tree. This finding is not surprising since to date there is not one single
report of successful bacterial isolation of these organisms from the liver or biliary tree of
experimentally infected animals and only a single letter reporting the isolation of H.
pylori from a human liver with Wilson's disease (44).
In the past, authors claimed to have identified H. pylori like organisms in hepatobiliary
tissue by 16SrRNA amplification and sequencing. (47). Unfortunately, speciating
Helicobacter based on sequencing a small (400-1000 base pair) segment of the 16SrRNA
gene is fraught with error since this region is highly conserved among the Helicobacter
spp. (40). Highlighting this concern, Avenaud and colleagues (4) identified organisms
that appeared to be H. pylori based upon sequencing of the 16SrRNA gene from the liver
of humans. Based upon stringent follow up tests, these investigators discovered that these
organisms were a previously unidentified (and still unclassified) Helicobacter sp. that is
phylogenetically related to, but not, H. pylori (4).
We hypothesize that the presence of H. pylori in the biliary tree and liver of human
patients with cholesterol gallstones is either a secondary colonizer (due to biliary changes
from gallstones, cholestasis, or chronic cholecystitis), or the DNA denotes one or more
related Helicobacter spp. Perhaps, in the presence of disease induced by other
Helicobacter spp. or other factors, the biliary microenvironment changes to allow for
secondary invasion by H. pylori. For example, we demonstrated previously (33) that
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some cholelithogenic Helicobacter spp. increase gallbladder mucin gel accumulation
significantly as well as contributing to mucinous metaplasia of the gallbladder in C57L
mice fed the lithogenic diet. An increase in mucin gel accumulation, or a change in
mucin species may promote attachment of H. pylori to the biliary epithelium.
Interestingly, others have noted that the type of mucin produced in the stomach is pivotal
for H. pylori colonization and in fact some normal gastric mucins are bactericidal (24).
Consistent with a possible alteration of the biliary microenvironment leading to
secondary invasion by H. pylori, Myung and colleagues (39) found that patients that are
PCR positive for H. pylori exhibit a significantly lower bile pH than those that were PCR
negative. Further evidence for secondary invasion by H. pylori was recently
demonstrated by multiplex PCR in an Iranian population (14). H. pylori-like DNA could
be amplified from bile of gallstone patients with pathologic evidence of chronic
cholecystitis but not from the bile of asymptomatic gallstone patients (14). These authors
did not attempt to culture for bacteria other than Helicobacter spp. However, others (21,
37, 46) have cultured the biliary tree and bile from humans and experimental animal
models with cholecystitis and demonstrated numerous bacterial species which are
considered part of the normal distal gastrointestinal tract, and nasopharyngeal microbiota
(21, 37, 46). These organisms often colonize the biliary tree secondarily, especially
following obstructive cholestasis or sphincter of Oddi ablation. It is likely that H. pylori
behaves in a similar manner and may colonize the biliary tree due to impaired biliary
drainage, changes in mucus content or character and other biochemical alterations
affecting the nature and concentration of biliary lipids. To validate or disprove these
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hypotheses a thorough chemical and physical-chemical analysis of bile in the presence
and absence Helicobacterpylori DNA in the hepatobiliary tree will be necessary.
In planning the present experiments, we were concerned that the lithogenic diet would
inhibit H. pylori colonization, because in vitro studies have demonstrated bactericidal
effects of bile acids on H. pylori (22). Indeed, in the present work, there was a significant
log unit decrease in the number of H. pylori organisms in the stomachs of lithogenic diet
fed infected mice when compared to the chow fed group (Fig 4). Interestingly, there was
no significant change in the extent or severity of glandular gastritis between the two
infected groups. In fact, in both lithogenic diet- fed and chow- fed mice a robust gastritis
was noted. Historically, the H. pylori SS strain causes minimal lesions in susceptible
mouse strains at 3 months (12 weeks) post-infection and C57BL/6 mice which are
characterized as a susceptible strain, often require six months of H. pylori infection to
demonstrate moderate gastric inflammation (28). The C57L mouse appears to be
exquisitely susceptible to H. pylori induced gastritis (regardless of diet fed) and displays
similar lesion scores to INS-GAS hypergastrinemic mice at this early time-point (17).
This observation merits further investigation in view of the established fact that INS-GAS
mice progress to adenocarcinoma after 6 months of colonization with H. pylori (17).
In addition to infectious gastritis in both chow fed and lithogenic fed animals, non-
infected mice that received the lithogenic diet developed lesions of the squamous
forestomach. These lesions included hypertrophy, hyperkeratosis, and inflammation with
microabscess formation of the epithelium. Furthermore, some of these diet- induced
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lesions were exacerbated significantly by infection with H. pylori. Moreover, the
squamous epithelial lesions are reminiscent of the lesions caused in part by diet and stress
in the pars esophagea of swine which consist of hyperkeratosis and ulceration (12).
Swine stomachs are commonly colonized by Helicobacter suis; however, the contribution
of these helicobacters to gastric disease in swine is not completely understood (26, 43).
We propose that in domestic swine, like the inbred mice in this study, dietary
composition induces lesions in the pars esophogea and that H. suis exacerbates these
lesions. The lesions in the squamous stomach demonstrate that under modified dietary
conditions, H. pylori can exacerbate disease in areas in close anatomic proximity to
where these organisms colonize typically, i.e. the glandular stomach. The squamous
forestomach of the mouse is a non-glandular area separated anatomically from the
glandular gastric compartment by the limiting ridge (29). Histologically, this region is
lined by stratified squamous epithelium (29). Due to its anatomic separation and
histological appearance, it is essentially an extension of the mouse esophagus and is
similar to the esophagus of humans. This raises the possibility that this mouse model
could be used to study the influence of diet and H. pylori to contribute to chronic
esophageal diseases such as esophagitis and esophageal cancer.
Diet and H. pylori status in C57L mice also appeared to exhibit synergism in causing
lesions of the glandular stomach, most notably metaplasia. The cholic acid, triglyceride,
and cholesterol components of the diet may either singly or together be contributing to
gastric lesions. For example, cholic acid promotes azoxymethane induced aberrant crypt
foci in rats (5, 48). However, analysis of the forestomach of bile acid-fed rats did not
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demonstrate any notable lesions (56). Interestingly, diets high in fat and cholesterol (so
called "Western diets") have been correlated with risk for esophageal adenocarcinoma,
gastric cardia adenocarcinoma, esophageal squamous cell carcinoma, and common
gastric adenocarcinoma (31, 34, 35). Additionally, cholesterol free radicals are known to
promote a variety of diseases including atherogenesis (1, 23, 36). It is therefore
reasonable to hypothesize that inflammation from H. pylori induced gastritis may
promote oxidation of cholesterol or fatty acids in humans consuming high cholesterol or
high animal triglyceride diets. These oxidized products could then further contribute to
gastric and potentially esophageal cancers, possibly due in part to free radical damage.
In summary, H. pylori infection does not contribute to cholesterol gallstone formation in
the C57L mouse model. We believe that the purported suggestions in the literature that
H. pylori causes cholesterol gallstones in humans are suspect and like many other
bacteria, H. pylori is likely to be a secondary colonizer of the hepatobiliary tree following
complicated gallstone disease and/or iatrogenic interventions. In addition, the C57L
mouse is highly susceptible to H. pylori induced gastritis and dietary induced
nonglandular lesions of the squamous forestomach. This mouse strain may provide an
important new model to study the effects of diet and chronic H. pylori inflammation on
the development of gastric and esophageal cancers.
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Abstract
Infection with Helicobacter hepaticus and H. rodentium significantly promotes
cholesterol gallstones in C57UJ mice by as much as 70%. One possible mechanism to
explain this finding is that these organisms alter the concentration of biliary lipids to
promote a more favorable lithogenic environment. To test this hypothesis we infected 4-5
week-old C57L/J mice with both H. hepaticus and H. rodentium and compared them to
uninfected mice. Both groups were fed the lithogenic diet for 6 weeks. After 6 weeks of
lithogenic feeding hepatic bile was collected in anesthetized mice for 20 minutes. Bile
flow, the concentrations of bile salts, phospholipids and cholesterol were calculated.
Infected mice did not differ from uninfected mice with regard to the concentration of bile
salts, phospholipids, and cholesterol. However, infected mice displayed a significant
increase in (P<0.05; 88.5%) the percentage of hydrophobic bile when compared to
uninfected mice (86%). Furthermore, infected mice secreted bile and bile salts
significantly more (P<0.05; 0.6313 [tmol/hr/100g, 25.07 mL/hr/100g) when compared to
uninfected mice (0.5145 Lmol/hr/100g BW and 16.50 mJihr/100g). Biliary secretion is
increased in a bile salt independent manner based upon a bile salt independent flow rate
of 283.0 pL/Jhr/100g in uninfected mice and 379.1 rLJhr/100g. These data indicate that
although Helicobacter spp. infection do physiologically alter hepatic bile and bile
secretion these changes are unlikely to explain the ability of these organisms to promote
cholesterol gallstone formation.
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Introduction
Some Helicobacter spp. are capable of promoting cholesterol gallstones in mouse models
(15, 16). One possible mechanism to explain this finding is that these organisms alter the
concentration of biliary lipids. Several findings support this hypothesis. First, preliminary
microarray data generated from livers of H. hepaticus and H. rodentium infected and
uninfected mice indicates that chow fed C57L/J mice alter a variety of enzymes
regulating lipid metabolism (14). Furthermore, rodent models of inflammation
demonstrate that proinflammatory cytokines alter the production of hepatic cholesterol
(5-7, 10, 11). It is currently unclear whether these changes in gene expression correspond
to alterations in biliary phenotype. Furthermore, unlike these models of acute infection
enterohepatic Helicobacter spp. are chronic Thl inducing pathogens and it is unclear if
lipid metabolism and transport are altered similarly in chronic infection (8, 27).
Therefore, this study tests not only how Helicobacter spp. may contribute to cholesterol
gallstones but also furthers the understanding of how biliary transport is affected by
chronic infection.
Methods
Animal Housing and Husbandry
C57L/J mice were acquired from The Jackson Laboratory (Bar Harbor, ME). Mice were
housed in an Association for the Assessment and Accreditation of Laboratory Care
(AAALAC) facility and received food and water ad libitum.
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Infection protocol and lithogenic diet feeding
Mice were infected with both H. hepaticus and H. rodentium at 4-5 weeks-old as
described previously and boosted with H. hepaticus at monthly intervals thereafter (15,
16). Four weeks following initial infection mice were fed a lithogenic diet containing 1%
cholesterol 0.5% cholic acid and 15% dairy triglyceride. Mice were fed the lithogenic
diet for 6 weeks.
Bile collection
Mice were anesthetized with Avertin (2-2-2 Tribromoethanol, 0.4-0.75 mg/g)
intraperitoneally. Following anesthetic administration mice were clipped and aseptically
prepared with alternating iodine scrub and 70% isopropyl alcohol. Mice were placed
supine underneath a dissecting microscope. The skin and abdominal wall were
longitudinally incised along the midline. The common bile duct was identified and
isolated. The cystic duct was ligated and the common bile duct was ligated at its egress.
A small hole was made in the common bile duct proximal to the ligature and the bile duct
was cannulated. Hepatic bile was collected for 20 minutes. At the completion of surgery
mice were euthanized and collected bile was stored at -200C for future analysis.
Analysis of cholesterol, bile salts and phospholipids
Cholesterol was isolated as described previously (21) and quantified by high-performance
liquid chromatography (HPLC) (25). Total bile salts were calculated by the 3 alpha-
hydroxysteroid dehydrogenase assay and bile salt species were calculated by HPLC (18,
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22). Phospholipids were calculated via Bartlett's assay (2). Bile cholesterol saturation
index (CSI) was calculated using the critical tables (3).
Results
Bile salt, cholesterol and phospholipids concentration
The concentrations of bile salts, cholesterol and phospholipids did not vary between
infected or uninfected groups (Fig. 4-1). This was verified in two independent studies
analyzing the: concentration of these constituents in hepatic bile. Although the total
concentration of bile salts did not differ, infected mice displayed a significant decrease in
hydrophilic bile salts (Fig. 4-2A, P<0.05; a and 0 muricholate and ursodeoxycholate) and
a significant increase in hydrophobic bile salts (Fig. 4-2B, P<0.05, taurocholate,
taurochenodeoxycholate, and taurodeoxycholate). Both infected and uninfected mice
developed supersaturated hepatic bile and the groups did not demonstrate significant
differences in CSI (Fig. 4-3). Both groups plot within the two-phase zone of the phase
diagram (Fig. 4-4) indicating phase separation into micelles and liquid crystals.
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Figure 4-1: Concentration of bile salts (A), phospholipids (B) and cholesterol (C) from
hepatic bile of H. hepaticus and H. rodentium infected and uninfected mice. No
significant differences were noted between uninfected and infected mice.
Uninfected Infected Uninfected Infected
Figure 4-2: Percent of hydrophilic (A, tauro a muricholate,tauro 13
muricholate,t;auroursodeoxycholate) and hydrophobic (B, taurocholate,
taurochenodeoxycholate, taurodeoxycholate) bile salts present in hepatic bile of H.
hepaticus and H. rodentium infected and uninfected mice. Infected mice display
significant decreases in percent of hydrophilic and significant decreases in percent
hydrophobic bile salts.
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Figure 4-3: Hepatic bile cholesterol saturation index (CSI) in H. hepaticus and H.
rodentium infected and uninfected mice. Infection does not significantly alter the CSI of
hepatic bile.
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Figure 4-4: Triangular coordinates and phase diagram in H. hepaticus and H. rodentium
infected and uninfected mice. Both infected and uninfected mice plot within the 2 phase
region of the diagram indicating that both micelles and liquid crystals are present.
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Bile salt, cholesterol, and phospholipids secretion rates
Significant differences in bile salt excretion were noted between infected and uninfected
mice with infected mice increasing bile salt excretion (*; P<0.05, Fig. 4-5A). No
significant changes were noted in either cholesterol or phospholipids excretion between
the groups. Bile secretion was significantly increased in infected mice when compared to
uninfected mice (*; P<0.05, Fig. 4-5A). It appears from linear regression that the increase
in bile flow is bile salt independent in infected animals (Fib. 4-5B). Furthermore, the
slope of the line, which is inversely proportional to micellar size is greater in uninfected
mice indicating that infected mice possess larger micelles. This data is consistent with the
greater hydrophobicity of the bile in these mice.
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Figure 4-5: A: Bile salt, phospholipids, cholesterol secretion (left Y-axis) and total bile
secretion (right Y-axis) rate in hepatic bile from H. hepaticus and H. rodentium infected
and uninfected mice. Infection significantly increases the secretion of bile salts and
overall bile secretion rate (*; P<0.05). B: A plot of bile salt output vs. overall bile flow of
infected and uninfected mice. Linear regression was used to extrapolate the bile flow at
the Y-intercept which indicates bile salt independent flow. Note infected mice
demonstrate greater bile salt independent flow and a lowered slope of the extrapolated
line indicating larger micelles in bile.
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Discussion
The overall concentration of biliary lipids was not significantly altered between infected
and uninfected mice. Therefore, it would seem unlikely that Helicobacter spp. promote
cholelithogenesis by altering the concentration of lipids in hepatic bile. However, based
upon the current data it cannot be discounted that further alterations of lipids occur in the
gallbladder and thus promote cholesterol gallstone formation. Aside from these findings
two interesting changes did occur with infection. Specifically, infection increases the
amount of hydrophobic bile salts in hepatic bile and infection increases bile salt
independent bile flow and secretion of bile salts. An increase in hydrophobic bile salts is
consistent with promotion of a proinflammatory biliary environment and with previous
descriptions of cholesterol gallstone formation (13, 23, 24). Also, it appears that chronic
infection induces an increase in bile salt excretion rather then the decrease that is
frequently noted in acute models of infection (9, 12, 17, 20, 26). Unlike models of acute
infection chronic infection does not appear to induce intrahepatic cholestasis (4, 17).
Increasing secretion of bile could be due to either an increase in glutathione or
bicarbonate in bile creating an osmotic gradient (1). It is intriguing that H. hepaticus
posses a urease enzyme and reside at the bile canaliculus and thus may alter the
concentration of bicarbonate through conversion of urea and hydroxyurea to CO 2 which
would be converted to bicarbonate at bile pH.
Recent evidence indicates that a Thl inflammatory response of the gallbladder is
important in cholesterol gallstone formation (Chapter 5). These findings were conducted
in Rag2-/- and wild-type BALB/c mice. Helicobacter spp. are not nearly as essential in
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BALB/c mice since they do not alter production of cholesterol monohydrate or sandy
stone formation and only modestly increase cholesterol gallstone formation. However,
based upon the Rag mouse model and the current study it appears likely that Helicobacter
spp. promote cholesterol gallstone formation by promoting a Th mediated immune
response. This seems likely due to the known ability of these organisms to promote Thl
immunity, and the new knowledge that these Thl immune responses are vital in
cholesterol gallstone formation (8, 19, 27). Perhaps the C57L/J mouse requires
Helicobacter spp. infection to promote this immune response whereas BALB/c mice do
not. This data is supported by histopathological evidence of inflammation appearing only
in the gallbladders of infected C57L/J mice whereas inflammation occurs in both infected
and uninfected BALB/c gallbladders (15). These data point out that inflammation may
participate in cholelithogenesis at both the genetic and environmental level. Specifically,
some strains of mice (BABL/c) appear to be highly susceptible to biliary inflammation
without infection. This could be due to genetic polymorphisms of inflammatory genes. In
contrast, C57L/J mice appear resistant to gallbladder inflammation in the Helicobacter
spp. uninfected state and therefore require environmental pathogens to promote
cholesterol gallstone formation.
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Abstract
The formation of cholesterol gallstones is complex involving contributions from genes
and environmental factors. Although gallbladder inflammation is believed common
during cholelithogenesis, the role of immunological factors in cholesterol gallstone
formation is unknown. Here we analyzed the role of adaptive immunity in cholesterol
cholelithogenesis utilizing immunocompetent BALB/c and isogenic Rag2-/- mice. When
fed a lithogenic diet for eight-weeks, wild-type mice developed cholesterol gallstones
(27-80% prevalence) significantly more so than Rag2-/- mice (-5%, P<0.05). Transfer of
functional splenocytes, or T-lymphocytes to Rag2-/- mice markedly increased cholesterol
gallstone formation (26% and 40% respectively, P<0.05) whereas transfer of B-cells was
not cholelithogenic (13%). The adaptive immune response increased the expression of
Muc genes and accumulation of mucin gel. In addition, the presence of T-cells and solid
cholesterol monohydrate crystals induced proinflammatory cytokine expression in the
gallbladder. These studies show that T-cells are critical in murine cholelithogenesis and
act through modulation of gallbladder inflammation.
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Introduction
Cholesterol gallstones are composed predominantly of cholesterol monohydrate crystals
within a mucin glycoprotein scaffolding (30). They form following nucleation and phase
separation of cholesterol monohydrate crystals from supersaturated bile (30). Despite a
half-century of basic and clinical research there is currently no satisfactory, non-surgical
treatment for definitive management of gallstone patients; as a consequence, the disease
continues to be a serious economic burden with an annual cost in the United States
approaching 10 billion dollars (30).
Most commonly, gallstones result from the interaction of multiple genes and
environmental factors (30). A large twin study proposed that in symptomatic gallstones,
genes contribute 25% to the phenotype, shared environmental factors 13%, and unique
environmental factors 62% (20). Regardless of the predisposing causes, cholesterol
gallstones form when excess hepatically-secreted cholesterol phase-separates in bile as
unilamellar vesicles which eventually fuse into multilamellar vesicles (liquid crystals)(4,
30). Cholesterol gallstone formation proceeds when these liquid crystals nucleate
cholesterol monohydrate crystals in an inflamed and hypomotile gallbladder (3, 4, 18,
30). Biliary proteins, in particular mucin glycoproteins, promote cholesterol nucleation
and precipitation (24, 45). In addition, a variety of other proteins including biliary
immunoglobulins may be pronucleating (14-16).
In vivo studies analyzing the pathogenesis of cholesterol gallstones rely predominantly on
inbred mouse models (27, 30). These models allow investigators to analyze genetic
127
differences in cholelithogenesis under well-defined conditions. However, despite these
controlled environments, different cholesterol gallstone susceptibility prevalence rates are
often noted in inbred mice under seemingly identical conditions (27). Recently we
demonstrated that several murine enterohepatic bacterial pathogens, specifically
Helicobacter hepaticus, H. bilis, and coinfection with H. hepaticus and H. rodentium
increase cholesterol gallstone formation by as much as 70% in C57L/J mice. These
organisms likely contributed to the susceptibility differences noted historically (27).
Enterohepatic Helicobacter spp. are enzootic in mouse colonies worldwide and colonize
the intestine and bile canaliculi (10). Interestingly, the human gastric pathogen H. pylori,
and two urease negative enterohepatic helicobacters are not able to promote cholesterol
gallstone formation in this model (1, 27, 28). Aside from the gallstone phenotype, the
most notable findings in mice infected with cholelithogenic Helicobacter spp. is an
increase in gallbladder mass (a surrogate marker for gallbladder stasis), mucin gel,
inflammation, and hyperplasia of the gallbladder epithelium (27). However, Helicobacter
spp. infection does not alter the absolute or relative compositions of biliary lipids (26).
Helicobacter spp. generally cause disease by inducing a Type 1 (Thl) mediated pro-
inflammatory immune response (11, 46). In many cases, disease is mediated by the
adaptive immune system. Most notably, without an adaptive immune response, H. pylori
fails to produce gastritis (9). When adaptive immunity is restored by splenocyte transfer,
gastritis ensues. In the case of H. pylori this effect is mediated by T-cells (8, 9).
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Based upon these data we hypothesized that the promotion of cholesterol gallstones by
Helicobacter spp. occurs via adaptive immunity. Further, we hypothesized that
mechanistically, such promotion could occur in one of two ways: Either by increased
production of pronucleating immunoglobulins; or T-cell mediated production of pro-
inflammatory cytokines altering mucin production (or other unidentified pronucleating
proteins) and promoting gallbladder inflammation and hypomotility.
Methods:
Animal maintenance and husbandry
Mice were housed in an Association for the Assessment and Accreditation of Laboratory
Animal Care (AAALAC) accredited facility. Animals were provided with rodent chow
(Purina Mills, St. Louis MO) and water ad libitum and housed in micro-isolator cages
under SPF conditions (free of known bacterial, including Helicobacter spp., viral and
parasitic mouse pathogens). Mice were fasted for approximately 12 hours prior to being
euthanized via CO 2 overdose followed by necropsy.
Helicobacter spp. infection studies
Helicobacter hepaticus 3Bland H. rodentium ATCC 700285 were grown on blood agar
plates (Remel; Lenexa, KS) under microaerobic conditions at 370C. Bacteria were
removed from plates and suspended in Brucella broth (Becton, Dickinson and Company,
Franklin Lakes, NJ) to a final optical density of 0.6-2.0 at 660nm. Mice were infected as
previously described at 4-6 weeks of age via gavage and redosed at 4-week intervals with
H. hepaticus (27, 28).
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Bile analysis, tissue harvest, and histopathological analysis
Gallbladders were removed intact and weighed. Bile was removed from full gallbladders
and analyzed for mucin gel accumulation and biliary lipid phenotype by direct and
polarized light microscopy. Mucin gel was scored visually by microscopy on a scale of 0-
5 (0=0% mucin , 1=20% of the gallbladder filled with mucin, 2= 40% of the gallbladder
filled with mucin , 3=60% of the gallbladder filled with mucin, 4=80% of the gallbladder
filled with mucin and 5=100% of the gallbladder filled with mucin) (27, 28, 44). Empty
gallbladders were immediately flash-frozen in liquid N2 and stored at -800C for
transcription analysis or they were fixed in 10% neutral-buffered formalin. Formalin
fixed gallbladders were routinely processed and stained with hematoxylin and eosin.
Gallbladder sections were analyzed by a comparative pathologist blinded to sample
identity (ABR).
BALB/cJ and Rag mouse studies
BALB/cJ mice were purchased from The Jackson Laboratory (Bar Harbor, ME; referred
to as Jackson) and C.129S6(B6)-Rag2tmlFwa N12 (Rag mice) were bred at MIT following
acquisition from Taconic Farms, Inc. (Germantown, NY; referred to as Taconic). Each
mouse strain was divided into two groups, one infected with both Helicobacter hepaticus
and H. rodentium and the other group uninfected, thereby providing four groups (n=15-
18 mice per group). Mice were fed a standard rodent chow diet until 8-10 weeks of age,
at which time they were converted to the lithogenic diet (containing 0.5% cholic acid, 1%
cholesterol and 15% dairy derived triglyceride). Mice were fed the lithogenic diet for 8
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weeks and were then euthanized with CO2 and analyzed for biliary phenotype as
described (27, 28).
BALB/cAnNTac, Rag, Nude, and Adoptive Transfer Studies
BALB/cAnNTac, and C.Cg/AnNTac-Foxnlnu N9 (nude mice) were acquired from
Taconic. Rag mice were either acquired directly from Taconic or were bred at MIT from
mice originally obtained from Taconic. All mice for these studies were infected with both
H. hepaticus and H. rodentium. Adoptive transfer of splenocytes, T-cells or B-cells
occurred when Rag mice were approximately 8-9 weeks of age (approximately one-week
prior to initiation of feeding lithogenic diet). Seven mouse groups in total were included
in these studies: Rag mice (n=36), Rag mice receiving splenocytes (n=27), nude mice
(n=12), Rag mice receiving T-cells (n=15), Rag mice receiving B-cells (n=15), and Wild-
type mice (n=15). Mice were fed a standard rodent diet (Purina Mills, St. Louis MO)
until 9-10 weeks of age at which time they were converted to the lithogenic diet. Mice
were fed the lithogenic diet for 8 weeks and were then humanely euthanized and the
biliary phenotype analyzed (27, 28, 44).
Splenocyte transfer
Splenocytes prepared from naive BALB/cAnNTac donors were adoptively transferred
into Rag recipients. Spleens were aseptically removed from euthanized donor mice and
single cell suspensions from the pooled spleens were prepared in RPMI-1640 medium
supplemented with 10% fetal bovine serum. After osmotic lysis of red blood cells,
splenocytes were washed and examined for viability with Trypan blue exclusion. Cell
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number was quantified by an automated cell-counter and validated by counting with a
hemocytometer. Finally, the cell concentration was adjusted such that each mouse
received 2x10 6 viable splenocytes intraperitoneally in 0.2 ml serum-free Hanks balanced
salt solution (HBSS pH 7.2).
T-cell transfer
For T-cell transfer studies, splenocytes were prepared first as described above. Initial
enrichment utilized Dynal@ Mouse T Cell Negative Isolation Kit (Invitrogen
Corporation; Carlsbad, CA) per the manufacturer's recommendations. Briefly, the
splenocytes were incubated with a cocktail of magnetized-beads coupled to antibodies
that bind non-T-cell populations. The bead-bound non-T cell fraction was then separated
from the T-cell enriched fraction by placing the sample on a magnetic column. This
initial purification provides a highly purified T-cell population. Following this initial
negative selection strategy, a second flow cytometry-based approach was used to further
eliminate contaminating B-cells. The T-cell enriched fraction was incubated with Cy-
labeled anti-B220 antibody (Pharmingen, BD Biosciences, San Diego, CA) and subjected
to cell-sorting to "gate out" B cells stained with the antibody. An aliquot of the collected
cells was stained with FITC labeled pan-T-cell specific c3p+ TCR-specific antibody
(Cedarlane, Burlington, NC) confirming a T cell population of >95% purity. Finally,
these highly purified T cells were injected retroorbitally with 2x10 6/0.2 ml HBSS into
recipient mice. anesthetized with isoflurane.
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B-cell transfer
For B-cell transfer, splenocytes were first prepared as described. Initial enrichment
utilized Dynal@ Mouse B Cell Negative Isolation Kit (Invitrogen Corporation;
Carlsbad, CA) per the manufacturer's instructions. Briefly, the splenocytes were
incubated with a cocktail of magnetized-bead coupled antibodies that bind non-B-cell
populations and the bead-bound non-B cell fraction was retained on magnetic column as
described. Further, to remove any residual T cells, the B-cell enriched fraction was
incubated with FITC-labeled pan-T-cell specific ~ap TCR-specific antibody (Cedarlane,
Burlington, NC). During sorting, the FITC-labeled T cells were eliminated and B cells
were isolated. An aliquot of the sorted cells was labeled with anti-B220 antibody
(Pharmingen, BD Biosciences, San Diego, CA) and shown to contain >95% pure B-cell
population on re-analysis. Finally, these highly purified B cells with 2x10 6/0.2 ml HBSS
were injected retroorbitally into recipient mice anesthetized with isoflurane.
mRNA preparation and cDNA preparation
The mouse gallbladder is small and as a result contains minute concentrations of RNA.
To maximize RNA yield, the RNeasy Micro Kit (Qiagen Corporation; Valencia, CA), a
kit designed to maximize RNA yield from small tissue samples was utilized per the
manufacturer's recommendations. Following mRNA isolation, cDNA was prepared
utilizing SuperScriptTM III First-Strand Synthesis System (Invitrogen Corporation;
Carlsbad, CA) according to the manufacturer's recommendation for Muc gene analysis or
ReactionReadyTM First Strand cDNA Synthesis Kit (Superarry Bioscience; Frederick,
MD) for cytokine gene expression analysis.
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Muc gene expression analysis
To determine mucin (Muc) gene expression, four murine mucin gene (Muc 1, Muc 3,
Muc 4, and Muc 5ac) Fam-labeled primer-probe sets were acquired (Applied Biosystems;
Foster City, CA). Quantitative PCR (QPCR) was performed utilizing the ABI-Prism
7700, and Muc gene expression levels were normalized to Gapdh expression; differences
between groups (n= >10 per group) were analyzed via AA CT method utilizing either
uninfected Rag mice or infected Rag mice as the comparative delta value.
Inflammatory gene expression analysis
Large scale transcriptional screening of genes involved in immunity and inflammation
was performed utilizing the RTY ProfilerTM PCR Array Mouse Inflammatory Cytokines &
Receptors (Superarray Bioscience; Frederick, MD). This kit is a SYBR green 96 well
based quantitative PCR assay which includes 84 immune and inflammatory based genes,
5 housekeeping genes (Gusb, Hprtl, Hspcb, Gapdh, Actb) and appropriate controls.
Expression of each gene of interest is normalized to the housekeeping genes. Groups
(n=5-6 per group) are compared by the AA CT method for each individual gene utilizing
Rag mice that developed cholesterol monohydrate crystals as the comparative delta.
Additionally, relative expression of three common, well characterized Thl cytokine
genes (Il-lf/, Ifn-y, and Tnf-a) and three common, well characterized Th2 cytokine genes
(I1-4, 11-10, and 11-13) were analyzed to determine the relative Thl/Th2 balance of each
group.
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Statistical analyses
All statistical analyses were performed utilizing GraphPad Prism (GraphPad, Inc; San
Diego, CA). Cholesterol monohydrate, sandy stone and cholesterol gallstone formation
were compared by Fisher's exact test. Non-parametric data were analyzed by the Mann-
Whitney Test. Gene expression analysis was performed utilizing one-way analysis of
variance and individual data pairs were analyzed by the unpaired t-test. Data were
considered statistically significant if the P value was < 0.05.
Results
Biliary phenotype of BALB/cJ mice compared to Rag mice
To determine the role of adaptive immunity in cholesterol gallstone formation, BALB/cJ
(The Jackson Laboratories, Bar Harbor, ME; Jax) mice were compared to T and B-cell
deficient Rag mice (C.129S6(B6)-Rag2tm1FwaN12) on a BALB/c background. Regardless
of infection status, BALB/cJ mice display significant increases in mucin gel
accumulation, and increased prevalence of cholesterol monohydrate crystals, sandy
stones and true cholesterol gallstones when compared to Rag mice (P<0.05; Fig. 5-1 A-
F). Infected BALB/cJ mice significantly increase cholesterol gallstone formation
compared to their uninfected counterparts (P<0.05; Figure 5-1 A); however, infection
does not significantly alter any of the other phenotypic parameters analyzed. Gallbladders
from BALB/cJ mice were infiltrated with modest numbers of infiltrating eosinophils and
lymphocytes, and developed mild mucosal hyperplasia compared to Rag mice that
displayed little or no inflammation and lacked hyperplasia (Fig. 5-1 G-H). These data
strongly suggest that adaptive immunity is important in cholesterol gallstone formation
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and in BALB/cJ mice Helicobacter spp. infection plays a minimal role since changes
were noted only in the terminal stage of cholelithogenesis.
Biliary phenotype of Rag mice following splenocyte transfer
To determine: whether transfer of wild-type lymphocytes could restore cholesterol
gallstone susceptibility, splenocytes were harvested from BALB/cAnNTac (WT) mice
and transferred to their Rag counterparts. Since we wished to utilize a genetically
homogeneous group to eliminate any genetic effects on phenotype, mice from Taconic
Farms Inc. (Germantown, NY; Taconic) were chosen because we utilized Rag mice of
Taconic genetic origin. Additionally, nude mice (C.Cg/AnNTac-FoxnlnuN9) on a
BALB/c background were analyzed to determine if B-cells, in the absence of T-cells, are
relevant in cholelithogenesis.
Both WT and Rag mice receiving splenocytes (ST) exhibit a statistically higher
prevalence of gallstones when compared to Rag mice (P<0.05, Fig. 5-2A). The ST group
also significantly increase cholesterol monohydrate crystal formation compared to Rag
mice (P<0.05, Fig. 5-2A). WT, nude and ST mice all display significant increases in
mucin-gel accumulation when compared to Rag mice (P<0.05, Fig. 5-2B). Interestingly,
infected WT (BALB/cAnNTac) mice express a lower prevalence of cholesterol
monohydrate crystals, sandy stones and true cholesterol gallstones when compared to
BALB/cJ mice (Fig. 5-1A and 5-2A). These data indicate that restoration of the
cholesterol gallstone phenotype occurs with transfer of functional lymphocytes.
Furthermore, B-cells alone are not capable of inducing the gallstone phenotype, although
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they do promote mucin gel accumulation. Finally, cholelithogenesis is substrain
dependent in the BALB/c mouse.
Mucin gene expression analysis
Uninfected BALB/cJ mice upregulate Mucl when compared to either uninfected or
infected Rag mice (P<0.05, Fig. 5-3A) and upregulate Muc4 compared to all other groups
(P<0.05, Fig. 5-3C). In contrast, infected BALB/cJ mice increase Muc3 expression
compared to uninfected Rag mice (P<0.05, Fig. 5-3B).
Mucin gene expression patterns differ in WT mice and ST mice (P<0.05, Fig. 5-3E-H).
ST mice upregulate Muc3 when compared to all other groups (P<0.05, Figure 5-3F),
Muc4 when compared to WT mice (P<0.05, Fig. 5-3G), and Muc5ac when compared to
either nude or Rag mice (P<0.05, Fig. 5-3H). Nude mice increase expression of Mucl
compared to ST mice (Fig. 5-3E). Finally, WT mice display an increased expression of
Muc5ac compared to Rag mice (P=0.06, Fig. 5-3H). These data demonstrate that
expression of mucin genes is dependent upon the commercial source of the inbred mice,
immune status and status of Helicobacter spp. infection.
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Figure 5-1 (following page): Data represent percent prevalence of liquid crystals (LC),
cholesterol monohydrate crystals (CM), sandy stones (SS) and cholesterol gallstones
(CG) (A) and mucin gel score (B) (0-5). Virtually all mice formed liquid crystals (A, C
white arrowhead) indicating that bile is supersaturated with cholesterol and phase
separated. Those mice without liquid crystals developed cholesterol monohydrate crystals
(D white arrowhead, E) or beyond indicating that they possessed lithogenic bile;
however; they rapidly progressed beyond the liquid crystalline stage. Either uninfected
(UI-WT) or infected BALB/cJ (I-WT) mice formed cholesterol monohydrate (A, D),
sandy stones (A, D white arrow, E), and cholesterol gallstones (A, F) significantly more
frequently then uninfected (UI-Rag) or infected Rag mice (I-Rag) and accumulated
significantly more mucin gel (B) then Rag mice. Infected BALB/cJ mice also had an
increased prevalence of cholesterol gallstones when compared to uninfected BALB/cJ
mice. Gallbladder tissue of infected mice (G) was infiltrated by a mixed
eosinophilic/lymphocytic tissue population. Additionally, these tissues were typically
thickened and mild mucosal hyperplasia was noted. In contrast, Rag mice (H) rarely
possessed inflammatory infiltrates in the gallbladder and mucosa of Rag mice generally
consisted of cuboidal epithelium that was rarely hyperplastic.
G,H: Bars= 60 AtM
*: P<0.05 compared to Rag mice
**:P<0.05 compared to uninfected BALB/cJ mice
A B
q)
a)
'U Itx
*L
C WT-Tac M Rag ST = Nude
Figure 5-2: Data represent percent prevalence of cholesterol monohydrate crystals,
sandy stones and cholesterol gallstones (A) and mucin gel score (B) in BALB/cAnNTac
(WT), Rag mice, Rag mice receiving splenocytes (ST), and nude mice. All mice
developed liquid crystals (not shown). Mice receiving splenocytes formed cholesterol
monohydrate crystals, sandy stones, and cholesterol gallstones significantly more
frequently then Rag mice. Further, WT mice displayed an increased prevalence of
cholesterol gallstones when compared to Rag mice. WT, ST, and nude mice all
significantly increased mucin gel accumulation when compared to Rag mice as indicated
by the mucin gel score (B). BALB/cAnNTac mice exhibited a lower prevalence of
cholesterol monohydrate crystals, sandy stones and cholesterol gallstones when compared
to BALB/cJ mice (Fig lA and Fig 2A). *: P<0.05 when compared to Rag mice
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Figure 5-3 (preceding page): Data represent gallbladder expression of Mucl (A), Muc3
(B), Muc4 (C), and Muc5ac (D) from the BALB/cJ study or Mucl (E), Muc3 (F), Muc4
(G), and Muc5ac (H) from the second BALB/cAnNTac and splenocyte transfer study.
Gene expression is normalized to Gapdh expression and groups are compared by the AA
CT method utilizing uninfected Rag (UI-Rag) mice (A, B, C, and D) or infected Rag mice
(I-Rag) (E, F, G, and H) as the baseline (i.e. 1) expression level. Uninfected BALB/cJ
mice (UI-WT) significant upregulated Mucl (A) and Muc4 (C) when compared to Rag
mice of either infection status. Additionally, uninfected BALB/cJ mice significantly
increased expression of Muc4 (C) when compared to infected BALB/cJ (I-WT) mice.
Infected BALB/cJ mice significantly increased Muc3 expression when compared to
uninfected Rag mice (B). Infected BALB/cJ mice also upregulated Mucl expression to a
nearly significant level compared to infected Rag mice (A). ST mice demonstrated
significant increases in Muc3 (F) compared to all other groups, Muc4 compared to wild-
type mice, (G) and Muc5ac compared to either nude or Rag mice (H). Wild-type mice
significantly increased expression of Muc5ac compared to Rag mice (H). Nude mice
demonstrated a significant increase in Mucl compared to ST mice (E).
*:P<0.05 when compared to bracketed group
+: P<0.06 when compared to infected Rag mice
Biliary phenotype of Rag mice adoptively transferred with T or B-cells
To determine whether T or B-cells alone are critical effectors in cholesterol gallstone
formation, individual cell types were harvested, purified and transferred to Rag mice. Rag
mice receiving T-cells (T-cell) form cholesterol monohydrate crystals significantly more
frequently compared to Rag mice or mice receiving B-cells (B-cell) (P<0.05, Fig. 5-4A).
Moreover, they demonstrate a significant increase in cholesterol gallstone prevalence
compared to Rag mice (P<0.05, Fig. 5-4A). Both B and T-cell reconstituted mice
increase accumulation of mucin gel compared to Rag mice (P<0.05, Fig. 5-4B). These
data indicate that although both B and T-cells induce mucin gel accumulation, only T-
cells increase cholesterol gallstone formation.
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Figure 5-4: Data represent percent prevalence of cholesterol monohydrate crystals, sandy
stones and cholesterol gallstones (A) and mucin gel score (B) in Rag mice receiving T-
cells only (T-cell), Rag mice receiving B-cells only (B-cell), or Rag mice receiving no
cells. All mice developed liquid crystals (not displayed). Mice receiving T-cells only
demonstrated an increased prevalence of cholesterol monohydrate crystals, sandy stones,
and cholesterol gallstones when compared to Rag mice. Further, these mice had an
increased prevalence of cholesterol monohydrate crystals when compared to B-cell mice
(A). Both T-cell and B-cell mice significantly accumulated mucin gel when compared to
Rag mice (B).
*:P<0.05 when compared to Rag mice
**: P<0.05 when compared to B-cell mice
Cytokine and inflammatory gene product expression analysis
Others have described the ability of cholesterol monohydrate crystals to induce
inflammation in otherwise healthy gallbladders (35). To determine if T-cell mediated
cholesterol gallstone formation could be due, at least in part, to their ability to promote
local cytokine production following solid cholesterol phase separation as cholesterol
monohydrate crystals, sandy stones or cholesterol gallstones, cytokine expression was
analyzed in gallbladder tissue. Mice were divided into four groups based upon
lymphocyte status (T-cell positive or Rag) and biliary phenotype (formation of liquid
crystals or progressing beyond the liquid crystalline stage). Therefore, the following four
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groups were analyzed: 1. Rag mice developing cholesterol monohydrate crystals whether
free or agglomerated into stones (Rag CM); 2. Rag mice developing only liquid crystals
(Rag LC); 3. T-cell mice developing cholesterol monohydrate crystals (T-cell CM); 4. T-
cell mice developing only liquid crystals (T-cell LC).
T-cell CM mice consistently increase expression of genes indicative of a Thl
inflammatory response (Fig. 5-5). In contrast, T-cell LC mice dampen their Thl response
(Fig. 5-5). Furthermore, in the absence of T-cells (Rag mice), solid cholesterol crystals do
not promote a Thl inflammatory response (Fig. 5-5). Essentially, Rag CM mice respond
to solid cholesterol crystals in an opposing manner to mice with T-cells (Fig. 5-5). These
global changes are easily demonstrated by comparing the mean expression of three well-
described Thl cytokines (Illf,, Ifn-y. Tnf-a) with three well described Th2 cytokines (114,
1110, 1113). Thl cytokines are highly expressed in T-cell CM mice compared to all other
groups (P<0.05, Fig. 5-5N). In contrast, common Th2 cytokines are not expressed
differentially nor are they expressed to any large degree in any group (Fig. 5-50).
Additionally, Tgf-f, which was shown previously to be expressed during cholesterol
gallstone induced gallbladder damage and fibrosis (22) is highly expressed in T-cell CM
mice (Table 5-1).
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Figure 5-5 (preceding page): Data represent gallbladder expression of genes generally
involved in a Thl immune response. Expression values are normalized to five control
genes included in the assay and compared to Rag CM mice by the AACT method and
logarithmically converted and expressed in relation to Rag CM mice (A-M). Common
Thl cytokines (Ill-fl, Ifn-y, and Tnf-a) (N) and Th2 cytokines (11-4, Il-10, 11-13) (0) are
analyzed by taking the mean CT value of each gene group relative to the five control
genes, logarithmically converting this value and multiplying by 104 for ease of display.
All graphs depict mean expression +/- standard error of the mean (both calculated prior to
logarithmic conversion). T-cell mice which developed cholesterol monohydrate crystals
significantly increase Thl cytokines compared to all other groups analyzed. Additionally,
for all groups analyzed Thl cytokines are expressed 10 fold or greater compared to Th2
cytokines (N-O).
*:P<0.05 when compared to bracketed group
#:P<0.05 when compared to all Rag mice (Rag CM + Rag LC)
A:P<0.05 when compared to all other groups
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Table 5-1: Fold changes of gallbladder inflammatory gene expression relative to Rag CM
I
genes
Crp
Undefined
genes
Ill f6
Ill r2
ILI 7b
T-cell expressed
genes
Tnfsf5 (CD40L)
Rag LC T-cell LC T-cell CM
mice
Gene Namea
Thl genes
Caspl
Ccll
Ccl5
Ccr5
Cxcl 5
Cxcl9
CxcllO
Cxc111
Cxcr 3
Ifni-y
Illli
IL8 rb
Tnf-a
Th2 genes
Cc122
Ccr3
IllOra
Mixed function
Genes
Ccl2
Ccl8
Ccl9
Ccrl
Ccr2
Ccr4
Cxcl 4
Il2rg
11 15
IL16
Ltb
Tgffl
Innate immune
4.3
8.3
5.2
(3.4-5.5)$
(5.7-12.1)$
(3.8-6.9)4:
19.5 (12.1-31.4)$
25.2 (16-40)
7.9 (4.5-14.1)$
2.1 (1.5-2.8)*
11.8 (7.8-17.7)4$
7.7 (2.0-29.0)
0.9 (0.7-1.0)
3.7 (2.4-5.7)$
7.9 (5.4-11.5)$
8.7 (6.7-11.1)$
5.8 (4.2-8.0)$:
1.6 (1.3-2.0)
2.5 (2.3-2.8)$,*,**,Y
2.0 (0.8-5.0)
4.7 (2.6-8.4)
32.4 (19.2-54.9) $,*
0.52 (0.2-1.3)
6.3 (3 .9-9.5)b
1.3 (0.4-4.1)
23.3 (13.8-38.9)$
3.8 (2.5-5.7)$
0.6 (0.4-0.8)
27.6 (8.8-86.6)
6.2 (3.5-11.1)
29.8 (15.8-56.2)$
9.6 (6.0-15.6)$
30.7 (15.4-57.9)$
3.1 (2.3-4.0)$
2.7 (0.6-12.8)
6.7 (3.2-13.8)
4.1
0.7
1.3
(2.9-5.8)
(0.2-1.9)
(0.4-4.0)
2.3 (1.4-3.5)
0.9 (0.4-1.9)
8.0 (4.4-14.4)
1.1 (0.5-2.2)
1.0 (0.5-1.8)
4.4 (1.1-18.0)
1.0 (0.4-2.6)
15.4 (7.3-32.6)
2.7 (0.9-8.3)
3.3 (0.8-13.5)
1.1 (0.7-1.7)
1.5 (0.4-5.1)
2.0 (1.1-3.7)
0.5 (0.2-1.4)
2.0 (1.1-3.7)
2.8 (2.1-3.8)
1.9 (0.6-5.4)
10.2 (4.7-22.0)
1.3 (0.7-2.6)
0.6 (0.4-0.8)
2.5 (1.3-4.9)
15.9 (7.7-32.8)
0.45 (0.3-0.8)
1.1 (0.6-2.1)
3.3 (2.5-4.3)
5.1 (3.8-6.9)
2.0 (1.2-3.2)
0.7 (0.5-1.0)
1.5 (1.3-1.7) 0.7 (0.5-1.1)
73.4 (28.2-191.2)t,+,t
22.1 (7.8-62.9)$,*,?
44.0 (14.6-132.3)$
40.8 (16.1-103.5) $,+,?21.4 (8.3-55.0)$,+,t
a: Only genes demonstrating significant changes are displayed: Abcfl, Bcl6, Blrl, C3,
Ccl3, Ccl4, Ccl6,Ccl7, Ccll2, Ccll7, Cc119, Ccl20, Cci22, Ccl24, Cc125,Ccr6,Ccr7,
Ccr8, Ccr9, Cxcll, Cxcll2, Cxcll3, Cxcll5, Gpr2, Illa, Illf8, Illrl, Il2rb, 113, 114, 110,
IllOra, IllOrb, Illl, Il2rb, 1113, IL13ral, I15ra, II6ra, Il6st, 1118, 1120, Itgam, Itgb2, Lta,
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9.9 (6.7-13.8)*
32.9 (7.3-147.9)t
26.4 (16.8-40.9)$
5.2 (3.8-7.1)$
19.0 (5.5-65.7)t
40.3 (22.3-72.8)$
14.9 (7.8-28.2)$,*
133.9 (63.9-280.7)$
24.2 (8.4-69.2)$
125.4 (55.8-266.1)$,*
6.7 (4-11.3) 4,*
43.0 (20.7-89.4)t,*,t
31.0 (14.4-66.8) $,*,t
11.7 (4.3-31.6)
7.2 (4.7-11.1)$
6.8 (4.5-10.3)$
16.0 (8.6-29.7)$
43.0 (22.1-83.7)$
3.5 (1.8-6.9)
2.2 (1.4-3.4)
12.8 (9.2-17.9)$,*
226.8 (85.2-603.4)$,t
2.3 (1.5-3.6)*
5.5 (3.6-8.4)$
10.9 (4.3-27.9)
8.7 (5.2-14.4)$
5.2 (3.5-7.7)$
2.1 (1.7-2.5)*
Mif, Scyel, Sppl, Tnfrsfla, Tnfrsflb, Tollip, and Xcrl did not demonstrate any significant
changes between any of the groups and are not displayed.
b: Data represent fold changes and ranges compared to Rag mice developing cholesterol
monohydrate crystals (expression of 1 for each gene). Ranges are based on plus or minus
standard error of the mean prior to logarithmic conversion.
*: P<0.05 vs. T-cell LC mice
t: P<0.05 vs. Rag mice (combined)
$: P<0.05 vs. Rag CM mice
**: P<0.05 vs. T-cell CM mice
+: P<0.05 vs. Rag LC mice
V: P<0.05 vs. T-cell mice (combined)
Discussion
This study provides the first detailed description linking adaptive immunity to cholesterol
gallstone pathogenesis. It is clear from the data that T-cells promote cholesterol gallstone
formation markedly. Additionally, we demonstrate that T-cells and solid cholesterol
crystal phase separation induce a potent, Thl-mediated, local inflammatory response.
However, in the absence of T-cells, solid cholesterol crystals down-regulate
inflammatory genes. This downregulation likely prevents subsequent cytokine-mediated
damage and ensuing gallbladder motility defects.
The potential influence of inflammation and the immune system on cholesterol gallstone
formation was first evidenced by Lee and coworkers in a diet-induced prairie dog model
of cholesterol gallstones (25). When treated with high-dose acetylsalicylic acid (ASA),
these rodents maintained supersaturated bile but did not nucleate solid cholesterol
monohydrate crystals or form cholesterol gallstones (25). However, ASA has a wide
range of in vivo activities and the exact mechanism whereby it prevented cholesterol
gallstone formation was never elucidated (13). Additional publications attempting to link
the immune system to cholesterol gallstone formation have suggested the importance of
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immunoglobulins in promoting nucleation (14-16, 29, 41). However, the in vivo role of
immunoglobulins in cholesterol gallstone pathogenesis has never been demonstrated.
Moreover, additional in vitro studies indicated that inflammatory products influence
mucin production in cultured gallbladder epithelial cells (21, 37). The influence of
inflammatory mediators on mucin gene expression is also well established in studies on
the respiratory tract epithelium (38). Moreover, in several previous investigations,
attempts were made to examine the in vivo influence of inflammation on cholesterol
gallstone pathogenesis (42, 43). These investigations invariably concluded that
gallbladder inflammation and immunoglobulin production occurred when mice were fed
a lithogenic diet (42, 43). By their design, these investigations could not definitively
determine a role for inflammation and immunity; Both gallstone susceptible (C57L) and
resistant (AKR) strains were studied (42, 43) and these strains of mice display marked
differences in their ability to supersaturate bile. Therefore, the influence of genes
responsible for bile supersaturation could not be eliminated from consideration in these
models (42, 43). The current murine study eliminates this variable by utilizing isogenic
strains of mice differing only in their ability to mount an adaptive immune response.
In the present study, B-cells and therefore immunoglobulins were not needed to achieve a
high prevalence of cholesterol gallstone formation in our models. Although B-cells do
promote mucin gel formation it appears, that the in vivo role of biliary immunoglobulins
in promoting cholesterol gallstone formation is minor.
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Gallbladder mucin gel formation differs in mice depending on the commercial source of
the mouse as well as the immune status. Although four Muc genes were examined in the
current study, no single gene appeared to play a central role in cholesterol gallstone
pathogenesis. However, our expression data indicated a general trend of increased Muc
gene expression in mice with a functioning adaptive immune system. Also, there are
more than four Muc genes expressed in the murine gallbladder (45). However, the
complete Muc and Muc-like genes are extensive and their complete expression profile in
the murine gallbladder remains to be elucidated (6).
It is unclear from the present results whether a Th1 response promotes cholesterol
monohydrate crystal formation or is the result of cholesterol monohydrate crystal
formation on the gallbladder mucosa (i.e. an immune response to a noxious stimulus). It
is possible that the Thl response may be both promoted by and in turn promote
cholesterol monohydrate crystal formation thus creating a repetitive injurious cycle.
Promotion of cholesterol monohydrate crystals could occur through modulation of Muc
genes and accumulation of mucin gel. This event, although likely important, does not
appear sufficient in cholelithogenesis because mice possessing only B-cells accumulate
mucin gel, albeit to a lesser degree than mice with only T-cells. A plausible mechanism
for these observations based upon our data is that mucin gel accumulation promotes
cholesterol monohydrate crystal formation; but it is the subsequent cytokine response to
accumulated cholesterol monohydrate crystals that determines progression of the disease.
Our data from Rag mice that developed cholesterol monohydrate crystals illustrates that
these mice down-regulate Thl cytokines, chemokines and receptors and as a result do not
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progress to cholesterol gallstone formation. Interestingly, mice adoptively transferred
with T-cells and developing only liquid crystals displayed less pronounced cytokine
expression then Rag mice that developed liquid crystals. These mice may represent a
population with a greater percentage of regulatory T-cells, thereby dampening the
immune response. Regardless of the inciting cause, it is clear that cholesterol gallstone
pathogenesis in this model is strongly associated with the stimulation of a robust Thl-
mediated immune response.
The data in the current study parallel several important findings in the well-established
paradigm underlying pathogenesis of Helicobacter pylori. In the absence of T-cells, H.
pylori-mediated gastritis is markedly attenuated (9). However, when T-cells are
transferred into the host, gastritis ensues and occurs via a Thl-mediated immune
response(8, 9). Additionally infected Severe Combined Immunodeficiency (SCID) mice
which, like Rag mice, lack functional T and B cells, develop more severe disease than
infected wild-type mice transplanted with splenocytes (8, 9). Indeed mice receiving T-
cells demonstrated a higher prevalence of cholesterol gallstones then their wild-type
counterparts. This result may represent transfer of a subset of T-cells that promote
inflammation (T-effector cells) or clonal expansion of a reactive subset of cells in the
host. Demonstrated previously is the effect of such T-effector populations in mouse
models of inflammatory bowel disease and cancer (33, 34).
BALB/cJ (Jackson) and BALB/cAnNTac (Taconic) mice demonstrate markedly different
cholesterol gallstone prevalence rates. These differences could be due to either genetic or
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environmental influences. Genetic differences may derive from either contamination
prior to the separation of these two substrains, or due to genetic drift (the cumulative
effect of spontaneous mutations over time), after the lines separated. Although genetic
drift cannot be discounted, a lack of genetic contamination of BALB/c mice was
demonstrated previously and therefore seems unlikely (17). Alternatively, environmental
factors could be important. Specifically, husbandry practices differ between Taconic and
Jax. Taconic rederives their mice in a germ-free state and then colonizes them
purposefully with altered Schaedler flora (ASF) containing eight defined gastrointestinal
bacteria (7, 40). These mice are then maintained within a specific pathogen free (SPF)
barrier, where they may become colonized with other non-pathogenic microbes. In
contrast, Jax does not rederive their mice into a germ-free state nor do they colonize the
mice with ASF. Instead, they are maintained in a SPF environment and possess an
undefined gut microflora (40). Indeed microbial differences were confirmed in a recent
analysis of Jax mice, which demonstrated that they possessed a diverse population of
intestinal microbes (23). Interestingly, Jax mice were found to be free of lactobacilli
which account for 2 of the 8 bacteria in ASF (39). Lactobacilli protect against Thl-
mediated disease and diminish proinflammatory cytokine production (31, 32). It is
intriguing to hypothesize that these organisms afford mice of Taconic origin protection
against cholesterol gallstone formation. In support of this hypothesis, is the observation
that a variety of inbred strains of Taconic mice were resistant to infection with Giardia
lamblia whereas isogenic Jax mice were susceptible. When these mice were co-housed
Giardia spp. resistance was transferred to the Jax mice indicating that resistance was
transmissible (40). Further evidence for the role of indigenous microbes was
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demonstrated in studies using BALB/cAnNCr (from the National Cancer Institute,
Bethesda, MD) mice which are genetically most closely related to BALB/cAnNTac mice
(both are of the BALB/cAnN lineage). However, BALB/cAnNCr (of unknown
Helicobacter spp. status), unlike BALB/cAnNTac mice (27% gallstone prevalence when
infected with Helicobacter spp.), develop 100% prevalence of cholesterol gallstones
when fed a diet containing 1% cholesterol and 0.5% cholic acid (35). Therefore these
mice behave phenotypically more like the genetically less related BALB/cJ strain (80%
gallstone prevalence when infected with Helicobacter spp).
In summary, T-cell function appears critical in the pathogenesis of murine cholesterol
gallstones. We propose a biological model whereby adaptive immunity alters the
production of mucin gel and expression of mucin genes. The presence of T-cells and
cholesterol monohydrate crystals leads to gallbladder inflammation that promotes tissue
damage and subsequent gallbladder motility defects as well as further production of
pronucleating agents. Furthermore, we hypothesize that infectious agents and other Th 1-
inducing conditions are likely to contribute to cholesterol gallstone formation in this
model as well as humans. For example in humans, hepatitis C virus infection and Crohn's
disease, both chronic Thl-inducing diseases, are correlated positively with increased
prevalence of cholesterol gallstones (2, 5, 12, 19). To date no detailed population studies
have focused on analyzing the inflammatory environment of the human gallbladder in the
presence or absence of cholesterol crystals and/or gallstones. The current study argues
poignantly for the importance of conducting such studies. Our systematic research
describes a hitherto unappreciated new dimension in cholesterol gallstone pathogenesis
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which may prove crucial in human patients. Understanding the importance of the
adaptive immune system in cholesterol gallstone formation may change not only the way
we study cholesterol gallstone pathogenesis and disease, but could alter the paradigms
whereby the disease is treated and possibly prevented. The findings in the present study
are reminiscent of other diseases in both mouse models and humans (i.e. gastric ulcers,
diabetes mellitus, atherosclerosis) which were once thought to represent merely
disturbances in biochemistry, biophysical-chemistry and metabolism but can now be
clearly identified as polyfactorial conditions with strong immunologic components (36,
47).
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Chapter 6
Conclusion
It is clear from the studies described that cholesterol gallstone formation is a complex
polyfactorial disease. Based upon the literature and the data described in this manuscript
it appears that at a minimum supersaturated bile and an intact adaptive immune system
are required for cholesterol gallstone formation. Furthermore, it seems likely that the type
of immune response generated is critical. Specifically, a polarized Thl response is
generated in response to cholesterol monohydrate crystals when the host possesses
functional T-cells. Like cholesterol supersaturation, which occurs because of both genetic
and environmental factors, the immune system also appears to be influenced by both of
these factors. In BALB/cJ mice environmental pathogens are not necessary to develop a
high prevalence of cholesterol gallstones (-40%) whereas without infection with
cholelithogenic Helicobacter spp. C57L/J mice rarely develop stone (-10%).
The studies described in this thesis analyzed only a narrow spectrum of murine pathogens
and further analyzed only the adaptive arm of the immune system. Three critical areas not
addressed in the current study are the role of other pathogens, the role of the indigenous
microbiota, and the role of the innate immune response in cholesterol gallstone
formation. Based upon differences in cholesterol gallstone susceptibility between
substrains of BALB/c mice it appears likely that the indigenous microbiota of the host is
important in susceptibility and resistance to cholesterol gallstones. Furthermore, since the
biliary epithelium possesses all the components of adaptive immunity it seems likely that
this system may too be important in cholelithogenesis.
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Utilizing the data acquired in these murine studies it is possible to extrapolate and
hypothesize about the role of infection and inflammation in human cholesterol gallstone
formation. It is likely that genetic polymorphisms in genes involved in the immune
system influence cholesterol gallstone formation. For example, a person who is
genetically more predisposed to develop a Thl immune response may be more
susceptible to cholesterol gallstone formation. Environmental exposure to Thl inducing
agents will further contribute. A caution to these scenarios is that without supersaturated
bile inflammation cannot contribute to cholesterol gallstone formation.
In conclusion I propose the following biological model to describe the relationship
between bile supersaturation, the immune system and cholesterol gallstones (Fig. 6-1).
Genes and environmental factors (diet, rapid weight loss, others) promote supersaturation
of bile. As bile becomes supersaturated cholesterol monohydrate crystals form. In a Thl
favorable environment the formation of these crystals promotes inflammation which
causes gallbladder wall damage, an increase in mucin gel production and the production
of other pronucleating substances. These conditions in turn increase cholesterol
monohydrate crystal formation by promoting a favorable nucleating environment. As
inflammation progresses the gallbladder wall becomes increasingly damaged and
nonfunctional leading to an inability to clear mucin gel and cholesterol monohydrate
crystals and eventual progression to cholesterol gallstones. In contrast, when the
gallbladder is not polarized in a Thl manner the gallbladder remains functional and there
is no or little increase in mucin gel. Cholesterol monohydrate crystals can then be
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expelled or chronically harbored in the gallbladder and cholesterol gallstones do not
form.
Cholesterol Supersaturation of Bile
(Genes and environment)
I
Cholesterol Monohydrate Crystal Formation
I I
Thl favorable environment: Thl unfavorable environment:
I
Increased mucin gene expression;
gallbladder wall damage;
promotion of pronucleating agents
I
Nucleation and gallbladder
motility defects
I
Cholesterol Gallstone Formation
I
No increase in mucin genes,
gallbladder wall not damaged
I
Cholesterol monohydrate crystals
do not progress and are either
chronically harbored or expelled by
gallbladder contraction
I
No cholesterol gallstones
Figure 6-1:
A schema depicting a proposed biological model of the formation of cholesterol
gallstones under Thl favorable and unfavorable conditions in the gallbladder
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Background &Aims: Helicobacter spp are common
inhabitants of the hepatobillary and gastrointestinal
tracts of humans and animals and cause a variety of
well-described diseases. Recent epidemiologic results
suggest a possible association between enterohepatic
Helicobacter spp and cholesterol cholelithiasis,
chronic cholecystitis, and gallbladder cancer. To test
this, we prospectively investigated the effects of Hel-
icobacter spp infection in cholesterol gallstone patho-
genesis in the highly susceptible C57L/J mouse
model. Methods: Helicobacter spp-free adult male C57L
mice were infected with several different enterohepatic
Helicobacter spp or left uninfected and fed either a litho-
genic diet or standard mouse chow for 8 and 18 weeks. At
the conclusion of the study, bile was examined microscop-
ically and diagnostic culture and polymerase chain reac-
tion were performed. Results: Mice infected with Helico-
bacter bills or coinfected with Helicobacter hepaticus and
Helicobacter rodentium and fed a lithogenic diet devel-
oped cholesterol gallstones at 80% prevalence by 8 weeks
compared with approximately 10% in uninfected controls.
Monoinfections with H hepaticus, Helicobacter cinaedi,
and H rodentium gave a cholesterol gallstone prevalence
of 40%, 30%, and 20%, respectively; the latter 2 groups did
not differ significantly from uninfected animals. Neither
infected nor uninfected mice fed a chow diet developed
cholesterol gallstones. Conclusions: These findings, along
with prior epidemiologic studies, suggest that Helicobacter
spp play a major role in the pathophysiology of cholesterol
gallstone formation in mice and perhaps humans.
Cholesterol gallstones, composed predominantly of
cholesterol monohydrate crystals within a mucin
glycoprotein scaffolding, form in the gallbladder follow-
ing nucleation and phase separation of cholesterol mo-
nohydrate crystals from cholesterol supersaturated
bile.' A variety of risk factors are documented, includ-
ing ethnicity, sex, obesity, weight loss, dietary intake,
and concurrent medical conditions and treatments. 2 Cur-
rently, the only definitive treatment for gallstones is
surgical removal of the gallbladder (cholecystectomy)
and the total annual cost of treatment in the United
States alone approaches $10 billion. 2 Moreover, an omi-
nous complication of gallstone disease is gallbladder
cancer.,1,
Studies elucidating the pathogenesis of cholesterol
gallstones rely predominantly on inbred mouse models."
In particular, quantitative trait locus analysis using gall-
stone-susceptible and gallstone-resistant strains shows
that cholesterol gallstone disease is principally a poly-
genic trait involving multiple susceptibility loci (Lith
alleles) on many chromosomes. 2`' " A strain of particular
interest is the C57L/J (C57L) mouse because of its high
susceptibility to cholesterol gallstones, which develop in
80%-100% of male mice fed a lithogenic diet for 8
weeks.^ "' Additionally, 2 congenic strains carrying the
Lithl or Lith2 loci from the C57L strain in an AKR/J
(AKR) background recapitulate the phenotype of the
C57L parent.'
Recent evidence from our laboratories suggests an
infectious contribution to the gallstone phenotype in
C57L mice. When congenic AKR mice carrying a sus-
ceptibility locus (Lith2) from C57L mice (AK.L-Lith2s)
were re-derived and housed under specific pathogen-free
Abbreviations used in this paper: PCR, polymerase chain reaction.
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conditions, they failed to develop gallstones. This was
established in 2 independent but identical pilot studies
lasting 8 weeks under feeding conditions with a litho-
genic diet containing 1% cholesterol, 0.5% cholic acid,
and 15% dairy fat (G. Bouchard, B. Paigen, M. C. Carey,
unpublished observations, 2001-2002). Because of the
ubiquitous nature of Helicobacter spp in conventional
mouse colonies" and the ability of these organisms to
cause hepatobiliary disease,' 1.2" we considered them
likely candidates to be involved in cholesterol cholelitho-
genesis.
Since the discovery of Helicobacter pylori, more than
25 Helicobacter spp have been isolated from the stom-
ach, intestinal tract, and liver of humans, other mam-
mals, and birds. Many of these organisms cause
extragastric disease and several are able to grow in
bile, including Helicobacter hepaticus, Helicobacter bilis,
and Helicobacter pullorum.' ~·-I These nongastric (entero-
hepatic) Helicobacter spp generally colonize the distal
small intestine, cecum, and large intestine and subse-
quently the liver, where they have been implicated in,
or suggested to cause, hepatitis, hepatocellular carci-
noma, cholecystitis, typhlocolitis, and colonic adeno-
carcinoma. '' I' We showed previously that there is an
association between molecular (DNA) evidence of en-
terohepatic Helicobacter spp colonization and cholecys-
titis in Chilean women.' :' Interestingly, this popula-
tion is notable for its high prevalence of gallbladder
cancer invariably associated with cholesterol gallstone
disease. 2 ',  Additionally, there is a growing body of
literature identifying Helicobacter DNA in the gall-
bladders, bile, and stones of patients with gall-
stones. " - "
Due to the high prevalence of enterohepatic Helico-
bacter spp in mice',2"" 4,' X  and the burgeoning evi-
dence in humans,'•- 5•'7. 9 we believed it reasonable to
hypothesize that Helicobacter spp contribute to choles-
terol gallstone formation. To test this hypothesis,
prospective infections were performed in the well-
characterized, highly susceptible, diet-induced, C57L
mouse model of gallstone disease-' 7 "' initially using 2
enterohepatic Helicobacter spp: H hepaticus and Helico-
bacter rodentium."'2,11 We chose these 2 species be-
cause they were present concurrently in the colonies at
Brigham and Women's Hospital (Boston, MA), where
much of the original gallstone research was per-
formed. 2' Following these coinfection studies, we per-
formed monoinfection studies with these enterohe-
patic Helicobacter spp as well as H bilis and Helicobacter
cinaedi, which have been identified in humans with
gastrointestinal and hepatobiliary disease. 2" 21
Materials and Methods
Animals and Diet
Helicobacter spp-free male C57L mice were acquired
from The Jackson Laboratory (Bar Harbor, ME) and housed
under specific pathogen-free conditions in an Association for
Assessment and Accreditation of Laboratory Animal Care In-
ternational accredited facility. These specific pathogen-free
conditions included specific absence of Helicobacter spp, Salmo-
nella spp, Citrobacter rodentium, and known murine viral patho-
gens. All animal protocols met the approval of the institutions'
animal care and use committees. Mice were fed either standard
rodent chow or, beginning at 8 weeks of age, a lithogenic diet
containing 15% dairy triglycerides, 1.0% cholesterol, and
0.5% cholic acid. This was continued for 8 weeks" for both
coinfection and monoinfection studies and for 18 weeks for
chronic lithogenic studies.
Infection Protocols
H hepaticus strain 3B 1 (ATCC 51499), H rodentium
(ATCC 700285), H bilis (MU strain), and H cinaedi (CCUG
18818) were grown on blood agar plates under microaerobic
conditions at 370 C. For coinfection studies, 4-week-old mice
were either infected orally by gavage 3 times over 5 days with
approximately 1.0 X 108 to 2.0 X 108 each of H hepaticus and
H rodentium suspended in Brucella broth (Becton Dickinson
and Co, Sparks, MD) or sham dosed with Brucella broth. For
monoinfection studies, mice were infected 3 times over 5 days
with approximately 1.5 X 10" to 3.0 X 108 of the individual
Helicobacter spp tested, or sham dosed with Brucella broth. For
coinfection studies, mice were subsequently redosed with a
comparable number of H hepaticus or sham dosed with broth
every month thereafter; for monoinfection studies, mice were
redosed with a comparable number of the appropriate organ-
ism every month thereafter for 2 months.
Direct Light and Polarizing Microscopy of
Gallbladder Bile and Gallstone Analysis
At 16 weeks of age (or 26 weeks of age for prolonged
lithogenic studies), mice were killed by CO 2 overdose and
cholecystectomies were performed immediately. Gallbladders
were weighed and opened, and microscopists (M.C.C. and
K.J.M.) who were blinded as to sample identity examined
gallbladder bile by both direct and polarized light microscopy
for the presence of liquid crystals, solid crystals, sandy stones,
and cholesterol gallstones as defined elsewhere."' Bile was
scored microscopically for mucin gel content on a 0-5 arbi-
trary scale.-"' Gallstones were analyzed for cholesterol content
by high-performance liquid chromatography as previously de-
scribed.l
Histopathologic Examinations
Sections of each liver lobe as well as gallbladder and
ileocecocolic junctions were harvested at necropsy, fixed over-
night in 10% neutral-buffered formalin, processed routinely,
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Table 1. Phenotypic Characterization of Murine Gallbladders and Their Contents
Gallbladder weight (mg)/
mouse weight (g) Mucin Liquid crystals Solid crystals Sandy stones Cholesterol
(mean _ SEM) (mean _ SEM) (%) (%) (%) gallstones (%)
Infected + lithogenic diet 0.93 ± 0.14a  1.94 _ 0.3 3b 7/9 (78) 8/9 (89)8 5/9 (5 6 )b 7/9 (78)8(n = 9)
Uninfected + lithogenic diet 0.58 + 0.05 1.11 ± 0.07 9/9 (100) 1/9 (11) 0/9 (0) 0/9 (0)
(n = 9)
Infected + mouse chow 0.54 + 0.05 0.15 + 0.15 0/10 (0) 0/10 (0) 0/10 (0) 0/10 (0)
(n = 10)
Uninfected + mouse chow 0.42 ± 0.03 0 + 0 0/5 (0) 0/5 (0) 0/5 (0) 0/5 (0)
(n = 5)
NOTE. Male C57L mice uninfected and coinfected with H hepaticus and H rodentium were studied.
Numbers are significantly greater (BP < .005 and bp < .05) compared with uninfected mice fed the same diet or mice fed a standard mouse chow.
cut into 4-izm thicknesses, and stained with H&E. Liver
sections were graded for lobular and portal inflammation ac-
cording to previously defined criteria2" by a comparative pa-
thologist (A.B.R.) blinded as to sample source. Gallbladders
were assessed morphologically for inflammation, epithelial dis-
organization, hyperplasia, dysplasia, and hyalinosis. Special
stains included a pH 2.5 alcian blue/periodic acid-Schiff stain
for acidic and neutral mucins.
Helicobacter Spp Screening Tests
DNA was prepared from postmortem tissue using a
high pure polymerase chain reaction (PCR) template prepara-
tion kit (Roche Applied Science, Penberg, Germany) and was
either singly amplified from the cecum with genus-specific
primers (for monoinfection studies) or species-specific primers
(for coinfection studies) using previously described condi-
tions. 1'1",'" DNA was amplified from the liver, gallbladder, or
cholesterol gallstones by nested amplification with an initial
genus-specific primer set using previously described condi-
tions.2' This was followed by a subsequent amplification of 2.5
pL of this product with internal species-specific primers to H
hepaticus, H rodentium, or H bilis or a second genus-specific
primer set for H cinaedi using previously described reaction
conditions. '" •
Culture of Helicobacter Spp
Gallbladders and livers were ground in sterile glass
tissue grinders with 0.5-1 mL of Brucella broth. Ground
tissue was streaked onto blood agar plates and grown under
microaerobic conditions at 370 C for 3 weeks. At that time,
plates were scrutinized for bacterial growth.
Statistical Analysis
Statistical analyses of mucin score and gallbladder
weight were performed by one-way analysis of variance with
the Tukey-Kramer posttest using Instat 3.0 software (Graph-
Pad, Inc, San Diego, CA). Cholesterol monohydrate crystal
formation as well as sandy and true gallstone formation were
analyzed by Fisher exact test using the same software.
Results
Phenotypic Analysis of Gallbladder and Bile
From Coinfected Animals
Helicobacter spp-infected mice (all n values =
5-10; see Table 1) fed the lithogenic diet developed
cholesterol gallstones"' at a prevalence rate of 78% and
sandy stones at a prevalence rate of 56%, and all but a
single animal progressed beyond the liquid crystalline
phase (Table I and Figure 1). In contrast, uninfected
mice fed a lithogenic diet and infected or uninfected
mice that ingested a standard chow diet failed to develop
gallstones (Table I and Figure 1). Interestingly, all un-
infected mice fed the lithogenic diet progressed to the
liquid crystalline phase in the nucleation sequence,"' but
only one mouse progressed beyond that to cholesterol
monohydrate crystals (Table I and Figure 1). Infected, or
uninfected mice that ate standard chow diets, did not
develop lithogenic bile, confirming the need for a mod-
ified diet in the development of gallstones in C57L
mice" (Table 1). Infected animals fed a lithogenic diet
displayed significantly higher (P < .05) mucin scores",
compared with uninfected animals or those ingesting
standard mouse chow, and gallbladders of infected ani-
mals consuming the lithogenic diet were significantly
larger (P < .005) than those of uninfected animals or
those fed standard chow diets (Table I).
Histopathologic Analysis of Hepatobiliary
Tissues
Histologic analysis of livers revealed microsteatosis
and mild chronic portal inflammation associated with diet
but not with Helicobacter spp infection status. A subset of
infected and uninfected mice on the lithogenic diet exhib-
ited portal and random lymphohistiocytic infiltrates attrib-
uted to hepatobiliary tissue damage caused by steatosis.
However, there was no association between hepatic inflam-
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Figure 1. Morphologic characterization by direct and polarizing light microscopy' 0 of gallbladder bile and stones of (A) Helicobacterspp-infected
C57L mice fed a lithogenic diet for 8 weeks. Macroscopically visible stones (arrows) up to 2 mm in diameter within a mouse gallbladder.
Progressive stages in development of cholecystolithiasis found in Helicobacter spp-infected C57L/J mice fed a lithogenic diet include (B)
cholesterol monohydrate crystals,'0 sandy stones'0 (not shown), and (C) cholesterol gallstones'0 (these stones have smooth contoured
birefringent edges and dark centers due to light scattering and absorption). (D) Birefringent aggregated liquid crystals'0 represent the minimal
extent of lithogenesis in uninfected C57L mice fed a lithogenic diet. Bars: A, 500 pIm; B, 100 ipm; C, 170 pm; D, 50 pCm.
mation and risk of gallstones (P = 1). In contrast, lesions of
the gallbladder, including hyalinosis, intestinal metaplasia,
eosinophilic inflammation, hyperplasia, and dysplastic
changes, were limited to Helicobacter spp-infected mice on
the lithogenic diet (Figure 2). Interestingly, many of these
lesions are observed in humans with gallstones; several of
them, including dysplasia, hyperplasia, and intestinal meta-
plasia, are considered to be preneoplastic. . 2
Helicobacter Spp Infection Status of
Coinfected Mice
Coinfected mice fed either chow or the lithogenic
diet showed consistent cecal colonization with both Hel-
icobacter spp when screened by PCR (Figure 3).'" •~' Mo-
lecular (DNA) evidence of enterohepatic Helicobacter spp
was present in a region of the hepatobiliary tree (either
gallbladder or liver) in most infected animals (Figure
i).'" 9 No uninfected animals showed molecular evi-
dence of colonization in either the cecum or the hepato-
biliary tree (Figure 3). PCR analysis of 4 gallstones from
H hepaticus plus H rodentium coinfected mice revealed that
Helicobacter DNA was present in 50% of stones (Figure
3). None of the gallbladders of Helicobacter spp coinfected
animals fed the lithogenic diet (n = 5) were culture
positive even after prolonged (3 weeks) incubation under
appropriate microaerobic conditions.
Phenotypic Analysis of Gallbladder and Bile
in Monoinfected Mice
In mice fed a lithogenic diet for 8 weeks, the
biliary phenotype varied greatly depending on the or-
ganism with which the mice were infected. Specifically,
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Figure 2. Compared with (A-C) sections from uninfected mice on a lithogenic diet, histopathologic examination of gallbladder tissue fromHelicobacter spp-infected mice shows (D; arrows) epithelial disorganization with eosinophilic luminal secretory products, (E) hyperplasia andmucous intestinal-type metaplasia (black arrows; note absence of mucous staining in hyalinized epithelium, white arrow), and (F) epithelialhyalinosis (glassy pink-red material, black arrows) and patchy eosinophil-predominant inflammation (white arrows). Histologic stains: A, C, D, andF, H&E; B and E, alcian blue/periodic acid-Schiff pH 2.5. Bars: A, B, D, and E, 170 ipm; C and F, 85 p~m.
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Figure 3. Prevalence of Helicobacter DNA in various tissues from
coinfected experimental groups. DNA was prepared from tissue using
the high pure PCR template preparation kit and was either singly
amplified from the cecum with species-specific primers using previ-
ously described conditions28 or amplified from the liver, gallbladder,
or gallstones by nested amplification with an initial genus-specific
primer set using previously described conditions.2 8 This was followed
by a subsequent amplification of 2.5 pIL of this product with species-
specific primers to H hepaticus and H rodentium with reaction condi-
tions as previously described. 18, 2 9 Biliary tree refers to a positive
result from either intrahepatic bile ducts or gallbladder.
when compared with uninfected mice, monoinfection
with H rodentium or H cinaedi did not significantly in-
crease normalized gallbladder weight, mucin score, cho-
lesterol monohydrate crystal formation, sandy stone for-
mation, or cholesterol gallstone formation (Table 2). In
contrast, monoinfection with H bilis and H hepaticus
significantly increased cholesterol monohydrate crystal
formation, sandy stone formation, and cholesterol gall-
stone formation when compared with uninfected mice
(Table 2). Additionally, H bilis infection increased mucin
score significantly when compared with uninfected mice
(Table 2). A sampling of stones (n = 2 per group) was
analyzed for cholesterol content and stones were com-
posed primarily of cholesterol (monohydrate), confirming
that they were indeed cholesterol stones. This was further
;·i
··' ~
i
i
.·· I
Table 2. Biliary Phenotype and Colonization Status of Monoinfected and Uninfected Male C57L Mice on a Lithogenic Diet
Normalized
gallbladder Liquid Solid Sandy Cholesterol Cecal Liver
Lithogenic weight (mg/g) Mucin score crystals crystals stones gallstones PCR PCR Hepatobiliary
Organism diet (wk) (mean ± SEM) (mean ± SEM) (%) (%) (%) (%) (%) (%) culture (%)
H hepaticus (n = 20) 8 0.85 ± 0.13 1.20 ± 0.12 95 65b 35 a  408 100 60 0 (n = 10)
H rodentium (n = 10) 8 0.69 ± 0.15 1.55 ± 0.31 100 40 30 30 100 80 0 (n = 10)
H bills (n = 5) 8 0.73 ± 0.35 2.00 a8 0.35 80 100l 1008 80b 100 60 ND
H cinaedi (n = 5) 8 0.72 ± 0.08 1.40 ± 0.19 100 20 20 20 100 80 ND
Uninfected (n = 30) 8 0.59 ± 0.065 0.93 ± 0.11 100 20 7 10 0 ND ND
H hepaticus (n = 10) 18 0.90 ± 0.18 2.45 a + 0.32 100 1000 1008 50 100 67 ND
Uninfected (n = 10) 18 0.57 ± 0.09 1.55 ± 0.19 100 20 20 20 0 ND ND
ND, not determined.
ap < .05 and bp < .005 when compared with controls fed the lithogenic diet for the same time period.
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corroborated by their creamy white to tan appearance to
the unaided eye and the agglomeration of cholesterol
monohydrate crystals in sandy and true stones by polar-
izing and direct light microscopy.
Histopathologic changes in the gallbladder mucosa
observed in coinfected animals were also noted in some
monoinfected animals and were rarely detected in unin-
fected animals. Almost invariably, these histopathologic
changes were found concomitantly with sandy stones or
true cholesterol gallstones in both infected and unin-
fected animals.
Prolonged Lithogenic Diet Feeding
To determine if Helicobacter spp were merely al-
tering the rates of cholesterol cholelithogenesis, we fed
uninfected mice and mice infected with H hepaticus a
lithogenic diet for 18 weeks. Interestingly, prolonged
exposure to the lithogenic diet did not significantly alter
the prevalence of cholesterol gallstone formation in either
group when compared with their counterparts fed the
lithogenic diet for 8 weeks (Table 2). When compared
with uninfected mice, H hepaticus-infected mice dis-
played a significantly higher mucin score, with a higher
prevalence of both cholesterol monohydrate crystals and
sandy stones (Table 2).
Infection Status of Hepatobiliary
and Gastrointestinal Tissues
At the termination of experiments all mice in-
fected with Helicobacter spp were confirmed to be infected
by cecal PCR (except for H bilis-infected animals, which
were confirmed to be positive by cecal culture); all un-
infected animals tested negative for enterohepatic Heli-
cobacter spp by cecal PCR (Table 2). The presence of
Helicobacter DNA in the liver of infected animals was
variable, and the presence or absence of DNA in the liver
did not correlate with gallstone formation. None of the
H hepaticus- (n = 10) or H rodentium- (n = 10) infected
mice were culture positive for Helicobacter spp in the liver
or the gallbladder.
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Discussion
This study presents systematic information detail-
ing what appears to be a paradigm shift in our under-
standing of cholesterol gallstone pathogenesis, at least in
this inbred mouse model and perhaps in humans. These
data show rigorously that enterohepatic Helicobacter spp
play a notable role in the development of cholesterol
gallstones in the murine gallbladder. Without this in-
fection, the C57L mouse, the most frequently used poly-
genic model of cholesterol gallstone disease,2 does not
acquire gallstones with any appreciable frequency.
The ability to promote cholesterol gallstones in C57L
mice is Helicobacter spp specific. Of the organisms tested,
coinfection with H hepaticus and H rodentium and monoin-
fection with H bilis displayed the greatest impact in
promoting cholesterol gallstone formation. H hepaticus
was intermediate in its ability, and H rodentium and H
cinaedi did not influence cholesterol cholelithogenesis
significantly compared with uninfected controls. We
propose the appellation "cholelithogenic" Helicobacter spp
to differentiate those species that are capable of promot-
ing cholesterol cholelithogenesis from those that do not.
We suspect that, with further testing, other Helicobacter
spp and perhaps other related and unrelated microorga-
nisms may prove capable of promoting cholesterol gall-
stone formation.
We tested mice housed at the facilities (Brigham and
Women's Hospital) where most of the original studies2-1
were performed by anaerobic and aerobic fecal culture.
Those results were compared with results of cultures
from mice in the current study to determine if other
pathogens may have contributed to the historical preva-
lence of gallstones at the prior facility.2'- We found no
differences with respect to other pathogens between the
2 facilities (Brigham and Women's Hospital and Massa-
chusetts Institute of Technology) (data not shown).
Moreover, the only other mouse pathogen present at both
Massachusetts Institute of Technology and Brigham and
Women's Hospital was Klebsiella oxytoca, an organism
rarely associated with disease and then only with utero-
ovarian infection in mice." The possible pathogenic roles
that the normal microbiota of the gut play in the com-
plex process of cholesterol gallstone disease is intriguing
but cannot be answered without prospective studies in
gnotobiotic and germ-free animals.
In our studies, the ability of some but not all Helico-
bacter spp to promote cholesterol cholelithogenesis im-
plies that promotion of cholesterol gallstone formation is
mediated by species-specific bacterial products or a reac-
tion of the host to these products, possibly through
cytokines and other proinflammatory mediators. If pro-
motion of cholelithogenesis were due to a nonspecific
host response to colonization, then all Helicobacter orga-
nisms tested should have promoted gallstone formation
equally. In particular, an interesting aspect of this phe-
nomenon was that the bacteria tested did not colonize
the biliary tree (at least in the culturable state when
tested at the time the mice were killed) and yet chole-
lithogenesis was promoted. This is evidenced by the lack
of correlation between bacterial DNA in the liver and
stone formation and our inability to culture organisms
even after prolonged incubation and the necessity for
nested PCR to identify DNA in the liver and the gall-
bladder. This raises several questions concerning the
mechanism behind the relationship between these bac-
teria and cholesterol gallstone pathogenesis and the man-
ner in which past studies have been conducted in an
attempt to detect a possible infectious contribution to
the pathogenesis of cholesterol gallstone disease. Many of
these studies relied on culture and PCR of the hepato-
biliary tree to determine a possible role for Helicobacter
spp and other bacteria in cholesterol gallstone forma-
tion. " '.S" 3" A number of investigators found no cor-
relation between the presence of Helicobacter DNA in
these tissues and the presence of cholesterol gall-
stones."', " However, based on the results of the present
study, it is clear that these organisms do not have to be
present in high numbers in the hepatobiliary tree to
promote cholelithogenesis. In fact, our study shows that
the most appropriate anatomic site to determine whether
Helicobacter spp are indeed an epidemiologic risk factor in
mouse and human cholelithogenesis would be the distal
small intestinal tract, cecum, and proximal large intes-
tine. Furthermore, because our studies suggest a Helico-
bacter spp-specific effect, future investigations should
focus on identifying the organisms at the species level by
acceptable methods and not rely on the presence or
absence of Helicobacter as a genus.
Several potential mechanisms or combinations thereof
could be suggested to explain the contribution of Heli-
cobacter spp to cholesterol cholelithogenesis. First, the
organisms may produce a soluble antigen or antigens
that modulate key hepatobiliary genes in the lithogenic
pathway.2 Based on the present data, an attractive pop-
ulation of genes is the Muc alleles of the gallbladder
epithelium involved in the production of mucin.' 2 Al-
ternatively, because enterohepatic Helicobacter spp colo-
nize, among other sites, the distal ileum, they may
modulate enterohepatic cycling of conjugated bile acids
either directly or through genetic regulation of absorp-
tion at the enterocyte level or by modulating gastroin-
testinal transit time. An intestinal role is further sug-
gested by our finding in this murine model of a lack of
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correlation between colonization of the hepatobiliary tree
by Helicobacter spp and cholesterol gallstone formation. In
addition to other possible mechanisms, an antigenic
product of Helicobacter spp or a host response (eg, cyto-
kines or other inflammatory mediators) could change the
phase equilibria of bile or accelerate the nucleation ki-
netics of solid cholesterol monohydrate crystals from
liquid crystals (see Table 1).
Interestingly, mice infected with both H rodentium and
H hepaticus developed cholesterol gallstones at a consis-
tently higher rate (78%) than infection with either of
these organisms alone, which produced gallstones only at
a moderate prevalence (H hepaticus) or rarely (H roden-
tium). This implies microbiotic synergism in that, indi-
vidually, H rodentium and H hepaticus may not possess all
of the necessary cholelithogenic factors to promote gall-
stone formation but together can do so effectively. Al-
ternatively, colonization by one of these organisms may
modulate a host response toward the other organism. In
this regard, studies conducted on gastric Helicobacter spp
(Hfelis)-infected animals show that the presence of other
pathogens may promote or inhibit gastric disease." ' , •"
The possibility that enterohepatic Helicobacter spp in-
fluence human cholesterol gallstone formation is a pro-
vocative concept for several reasons. First and histori-
cally, the disease was presumed early on to be solely a
physical/chemical phenomenon occurring at the level of
the gallbladder'* ; there then followed the realization
that a genetic (polygenic) component was crucial in
altering the secretory rates of biliary lipids from the
liver,' and now it appears that a "random event" is
required, supporting the concept that a necessary com-
ponent may also be chronic intestinal infection with an
enterohepatic Helicobacter spp. It is worth noting that at
the beginning of the 20th century, Lord Berkeley Moyni-
han, a notable British surgeon, avouched that "a gall-
stone is a tombstone erected to the memory of the
organism within it."" Although this statement exhibits
magnificent prescience by a thoughtful surgeon, it does
not hold entirely true with respect to our findings be-
cause not all cholesterol gallstones in the current study
contained Helicobacter DNA. Another salient aspect of
this current findings relates to the fact that the preva-
lence of gallbladder cancer is intimately associated with
the prevalence of gallstone disease.-'~•·  In experimental
animals, both excess biliary cholesterol and H hepaticus
produce hepatobiliary cancer1" and hepatocellular carci-
noma,' .12" respectively, either by themselves or in the
presence of other cocarcinogenic or promoting cofactors.
It is therefore tempting to speculate that Helicobacter spp,
some of which are known carcinogens,' and cholesterol
(or an oxidized product thereof) may act synergistically
to promote tumors of the biliary tree in individuals with
lithogenic bile and cholesterol gallstones. Further evi-
dence supporting this hypothesis derives from studies
involving Japanese and Thai patients with gallstones and
biliary tract malignancies' and Chilean women with
chronic cholecystitis.' . These populations have high
prevalence rates of gallstones and biliary cancers,-'' and
both of these studies found an association between mo-
lecular (DNA) evidence of enterohepatic Helicobacter spp
infection and neoplastic biliary disease.
In the recent past, a putative role of Helicobacter spp in
human cholesterol gallstone disease has been proposed
and questioned critically because Helicobacter DNA has
been amplified in hepatobiliary samples from unaffected
individuals,'" and sometimes Helicobacter DNA is not
identified in hepatobiliary tissues of patients with cho-
lesterol gallstones."l However, it is clear from our data
that Helicobacter spp infection per se plays a role in
cholelithogenesis but is not sufficient in or of itself to
produce cholesterol gallstones. Moreover, only certain
strains of Helicobacter spp promote cholesterol cholelitho-
genesis in the in vivo setting of lithogenic bile. Clearly,
genetic background and noninfectious environmental
factors (ie, the lithogenic diet) are essential in the mouse
model in initiating the physical/chemical conditions (ie,
lithogenic bile) predisposing to the disease. Mouse strain
is clearly important because cholesterol gallstone-resis-
tant mice from the original facility" were almost cer-
tainly colonized with these Helicobacter spp but their bile
is obstinate in developing supersaturation."' Genetics
also play a role in how a host responds to infection with
Helicobacter spp. For example, A/JCr mice can develop
severe hepatitis and hepatocellular carcinoma when in-
fected with H hepaticus; however, some other mouse
strains display little hepatic disease when infected. ' 1. 41 'i,
Finally, this study used the C57L mouse, which typically
has a cholesterol saturation index of approximately 1.5 at
the 8-week point'" of lithogenic diet feeding. This value
roughly correlates with cholesterol saturation index val-
ues observed in normal-weight individuals with choles-
terol gallstones"; however, the value is lower than the
median found in very obese individuals with gallstones. 7
Further work is needed to determine whether Helicobacter
spp play a similar role at high cholesterol saturation
index values (>1.60), such as those seen in morbidly
obese patients."7 On the basis of the present work, we
propose a hypothetical biologic model showing that 3
pathophysiologic factors (environment, genetics, and en-
terohepatic Helicobacter spp infection) all contribute to
cholesterol gallstone formation in C57L mice, as well as
metaplasia, dysplasia, and potentially the progression to
gallbladder cancer.
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Of interest is that, in the past, a number of investi-
gators have identified the presence of bacteria (non-
Helicobacter spp) in the extrahepatic biliary tree, gallblad-
der, and gallstones of humans and hypothesized on their
putative role in so-called "mixed" (ie, plus calcium bil-
irubinate) cholesterol gallstone formation. ' -"'" In partic-
ular, Lee et al tentatively identified Escherichia coli and
Pseudomonas spp principally in "mixed" cholesterol gall-
stones containing 65%-94% cholesterol and brown pig-
ment gallstones with 16% and 25% cholesterol har-
vested from human gallbladders without current
cholecystitis. These investigators hypothesized that bac-
teria may indeed play a role in "mixed" cholesterol-
bilirubinate gallstone formation.)" However, to date,
none of the organisms identified in these studies have
been analyzed prospectively and, because the bacteria
identified are among the normal microbiota inhabiting
the human distal small intestine and colon, and hydro-
lyze conjugated bilirubin to unconjugated bilirubin,
their presence in the biliary tree may be secondary to
recurrent biliary stasis and subclinical cholecystitis from
cholesterol gallstones leading to the "mixed" bilirubi-
nate-cholesterol gallstones.4 -- ' Development of this
mouse model should allow for a prospective analysis of
the primary versus secondary roles of these and other
components of the gut microbiota in relation to gallstone
pathogenesis and complications.
Based on our data (Table 1), we believe we can now
propose a realistic hypothesis for the role of Helicobacter
spp (and perhaps other bacteria) in cholesterol gallstone
pathogenesis. We suggest that the most likely scenario is
that certain Helicobacters change the kinetics of choles-
terol crystal nucleation from the liquid crystalline state
(ie, the initial phase separation) in gallbladder bile (Table
1). Cholesterol supersaturation of bile is a necessary but
not sufficient event for cholesterol gallstone formation,
and both gallbladder hypomotility and accumulation of
mucin gel (as a nucleation matrix) are also required.2 '.3
Theoretically, nucleation of solid cholesterol monohy-
drate crystals can occur homogeneously, but this is
thermodynamically unfavorable and might require an
enormous degree of cholesterol supersaturation.5s Alter-
natively, a far more favorable event thermodynamically is
heterogeneous nucleation, which involves a nucleating
agent'" that provides a hydrophobic surface for molecular
deposition, and these agents can nucleate bile with only
modest degrees of supersaturation. Multiple studies have
suggested the presence of nucleating agents in humans
with cholesterol gallstones.5 ' Likely nucleating agents
identified previously include mucins, immunoglobulins,
and other biliary proteins, some of which have been
functionally and chemically characterized.' ~ " We have
shown in the current study that particular Helicobacter
spp significantly increase mucin production in C57L
mice fed a lithogenic diet (Table 1). Additionally, we
showed earlier that H hepaticus infection causes a 3-fold
increase in biliary immunoglobulin A production, and it
is logical to presume that H bilis would have a similar
effect. "- Furthermore, it is provocative to suggest that
Helicobacter spp may produce other pronucleating ago-
nists in response to biliary exposure or, alternatively, that
these organisms may induce production in the host of
nucleating agents either directly or through chronic im-
mune stimulation. Most importantly, it has been shown
that different Helicobacter spp exhibit very divergent pro-
tein expression profiles in response to their exposure to
bile."5 Perhaps this difference explains in part why some,
but not all, of these related organisms promoted choles-
terol gallstone formation in our studies. Additionally,
preliminary data (K.J.M., M.C.C., J.G.F., unpublished
observations, 2004) from our laboratories suggest that
global changes occur in hepatic gene expression from
enterohepatic Helicobacter infection even without exhibi-
tion of a lithogenic diet, including genes believed to play
a role in cholesterol homeostasis. It is theoretically pos-
sible that one or more of these differentially expressed
genes may play a role in altering biliary lipid composi-
tion either qualitatively or quantitatively.
In conclusion, our work represents a provocative new
dimension in our understanding of cholesterol gallstone
pathogenesis in C57L mice and these findings are likely
to be applicable to humans. Dissecting the mechanisms
responsible for these observations, including physical/
chemical, petrological, genomic/proteomic, and infec-
tious, will require further critical hypothesis and exper-
imentation in several mouse models with different
enterohepatic and gastric Helicobacter spp, as well as
related organisms. Provided the new concept holds true
for human gallstone disease, as some earlier epidemio-
logic evidence would imply, then a paradigm shift may
be in the offing that may lead to major modifications in
the prevention and treatment of cholesterol gallstone
disease and possibly prevention and management of gall-
bladder and other hepatobiliary diseases, including hepa-
tobiliary and perhaps pancreatic cancers.
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Recently, we demonstrated that cholesterol gallstone-prone C57L/J
mice rarely develop gallstones unless they are infected with certain
cholelithogenic enterohepatic Helicobacter species. Because the com-
mon gastric pathogen H. pylori has been identified in the hepatobiliary
tree of cholesterol gallstone patients, we wanted to ascertain if H.
pylori is cholelithogenic, by prospectively studying C57L infected
mice fed a lithogenic diet. Weanling, Helicobacter spp.-free male
C57L mice were either infected with H. pylori SSI or sham dosed.
Mice were then fed a lithogenic diet (1.0% cholesterol, 0.5% cholic
acid, and 15% dairy triglycerides) for 8 wk. At 16 wk of age, mice
were euthanatized, the biliary phenotype was analyzed microscopi-
cally, and tissues were analyzed histopathologically. H. pylori infec-
tion did not promote cholesterol monohydrate crystal formation (20%
vs. 10%), sandy stone formation (0% for both), or true gallstone
formation (20%) compared with uninfected mice fed the lithogenic
diet (10%). Additionally, H. pylori failed to stimulate mucin gel
accumulation in the gallbladder or alter gallbladder size compared
with uninfected animals. H. pylori-infected C57L mice developed
moderate to severe gastritis by 12 wk, and the lithogenic diet itself
produced lesions in the forestomach, which were exacerbated by the
infection. We conclude that H. pylori infection does not play any role
in murine cholesterol gallstone formation. Nonetheless, the C57L
mouse develops severe lesions of both the glandular and nonglandular
stomach in response to H. pylori infection and the lithogenic diet,
respectively.
lithogenic; bile; cholesterol crystals; mucin; gastritis
GALLSTONES are an exceptionally common cause of morbidity
worldwide, and cholelithiasis with or without cholecystitis is
the most common gastrointestinal disease requiring in-patient
treatment in the United States (45). Despite five decades of
intense basic, clinical, and epidemiological research (6, 11, 27,
41, 42), there is currently no definitive nonsurgical treatment
for the management of gallstones; therefore, the disease is a
serious surgical and economic burden with the median per
patient cost exceeding 10,000 US dollars (45).
The term gallstones or cholelithiasis is a generic description
encompassing both pigment and cholesterol gallstones (41).
Cholesterol gallstones are the most common gallstones en-
* M. C. Carey and J. G. Fox contributed equally to this work.
Address for reprint requests and other correspondence: K. J. Maurer,
Massachusetts Institute of Technology, 77 Massachusetts Ave., Cambridge,
MA 02139 (e-mail: kmaurer@mit.edu).
countered in the Western world (41). These stones result from
liver-induced cholesterol supersaturation of bile and phase
separation of cholesterol-rich liquid crystals and solid crystals
with subsequent crystal agglomeration and stone growth within
the gallbladder in a mucoglycoprotein gel (8, 9, 41). Choles-
terol gallstone formation is a polyfactorial disease with heter-
ogeneous contributions from both genetics and environment
(41). Specifically, genetic susceptibility to cholesterol gall-
stones is, with very rare exceptions, inherited as a polygenic
trait (6, 10, 11, 27, 41, 42, 54). Cholesterol gallstone suscep-
tibility genes require environmental triggers including diet,
obesity, estrogenic drugs, and other complex and unknown
factors to express the cholesterol gallstone phenotype (41).
The C57L/J mouse is studied extensively as a model to
investigate cholesterol gallstone genetics and pathogenesis (25,
42, 51, 52, 54). When fed a lithogenic diet containing 1.0%
cholesterol and 0.5% cholic acid for 8 wk, this animal histor-
ically develops cholesterol gallstones with an 80% prevalence
rate (25, 51). Our initial studies with this mouse model were
conducted at facilities where the mice were enzootically in-
fected with enterohepatic Helicboacter spp. (33). Recently, we
(33) demonstrated that, in the absence of infection with specific
enterohepatic Helicobacter spp., the prevalence of cholesterol
gallstones in mice despite them being fed a lithogenic diet for
8 wk was much less than what we reported previously, approx-
imating 10%.
We and others (3, 15, 30, 32, 38, 50) have found serological
and molecular evidence in humans that enterohepatic Helico-
bacter spp. may be associated with several chronic hepatobili-
ary diseases. Others (7, 39, 47) have reported the identification
of H. pylori in hepatobiliary tissues from patients with benign
and malignant hepatobiliary disease. In some of these studies,
bile procurement and sample processing had the potential to
bias the results toward identification of H. pylori. For example,
endoscopic retrograde cholangiopancreatography was utilized
to collect bile samples from patients with known gastric H.
pylori colonization, leading to potential contamination with H.
pylori from the gastric mucosa (7). Moreover, in some cases,
H. pylori was identified on the basis of sequencing segments of
its 16S rRNA gene (47). However, this method is unsatisfac-
tory for speciating Helicobacters due to the high 16S rRNA
sequence homology among organisms in this genus (40).
Moreover, in vitro studies have revealed that H. pylori is
sensitive to bile and is chemotactically repelled by solutions of
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both conjugated and unconjugated bile salts (22, 55). Because
of these equivocal findings in humans and our recent identifi-
cation of a number of enterohepatic Helicobacter spp. that
promote murine cholelithogenesis, we wanted to ascertain
whether H. pylori infection exhibited the ability to induce
cholesterol gallstones in the C57L mouse model (33).
MATERIALS AND METHODS
Animal Sources and Husbandry
All animal protocols were reviewed and approved by the Massa-
chusetts Institute of Technology Committee on Animal Care. Three-
to four-week-old male Helicobacter spp.-free C57L/J mice were
purchased from The Jackson Laboratory (Bar Harbor, ME). Mice
were divided into three groups for study. In the first group, mice
remained uninfected and were fed a standard lithogenic diet contain-
ing 1.0% cholesterol, 0.5% cholic acid, and 15% dairy fat (n = 10)
(25). The second group was infected with H. pylori SS 1 (28) and fed
a rodent chow diet (n = 5), and the third group was infected with H.
pylori SS 1I and fed a lithogenic diet (n = 10). Group numbers were
chosen based on a 90-95% power to statistically detect similar
changes in the gallstone prevalence rate compared with changes noted
in our initial study (33). Mice were housed in polycarbonate microiso-
lator cages under specific pathogen-free conditions (free of Helico-
bacter spp., Citrobacter rodentium, Salmonella spp., endoparasites,
ectoparasites, and known murine viral pathogens) in an Association
for the Assessment and Accreditation of Laboratory Animal Care-
accredited facility. Mouse rooms were kept at constant temperature
and humidity on a 12:12-h regular light-dark cycle, and mice received
food and water ad libitum. Animals were fasted for 12 h before
CO2-induced euthanasia. Mice were fed a standard rodent chow(Purina Mills; St. Louis MO) containing <0.05% cholesterol until 8
wk of age. At this time point, mice were either continued on a
standard rodent chow or converted to the lithogenic diet.
Helicobacter pylori Infection
H. pylori SSI (28) was grown for 24-48 h in Brucella broth
(Becton Dickinson; Franklin Lakes, NJ) containing 5% heat-inacti-
vated fetal calf serum. Broth cultures were centrifuged at 8,000 rpm
for 20 min at 4VC, and the bacterial pellet was resuspended in Brucella
broth at a turbidometric (optical density = 660 nm) reading of
between 0.6 and 1.2. Four- to five-wk-old mice were infected by oral
gavage with 0.2 ml of resuspended bacteria (n = 15) or sham dosed
with 0.2 ml Brucella broth (n = 10) three times over a 5-day period.
At monthly intervals thereafter, mice were given two more doses of H.
pylori SSI by gavage using the same protocol.
Bile Analyses and Tissue Processing
Mice were euthanatized with CO2 in the fasted state at 16 wk of
age. A ventral midline incision was made, and the gallbladder was
removed intact. Full gallbladders were weighed, and their contents
were examined under direct and polarized light microscopy by a
microscopist (K. J. Maurer) blinded to sample identity. Bile was
scored for mucin gel content, presence of liquid crystals, solid cho-
lesterol monohydrate crystals, sandy stones, and true cholesterol
gallstones as previously described (27, 52). Statistical analyses of
mucin gel score and gallbladder weight were performed by one-way
ANOVA with the Tukey-Kramer posttest using Instat 3.0 software
(GraphPad; San Diego, CA). The frequency of cholesterol monohy-
drate crystals as well as sandy and true gallstone formation were
analyzed by Fisher's exact test using the same software. Mouse
stomachs were removed aseptically and opened longitudinally along
the greater curvature. Approximately 30 mg of glandular stomach
were flash frozen in liquid N2 and stored at -80 0 C for subsequent
quantitative PCR. Three 10-mg segments of the liver from different
liver lobes were collected aseptically and frozen at -200C for sub-
sequent PCR.
Histopathological Examinations
At necropsy, the liver, gallbladder, stomach, duodenum, pancreas,
and ileocecocolic junction were collected, trimmed, and fixed in 10%
neutral buffered formalin. Tissues were processed routinely, paraffin
embedded, cut into 4-pm-thick slices, and stained with hematoxylin
and eosin. Additional stomach and gallbladder sections were stained
with Alcian blue/periodic acid Schiff (PAS; pH 2.5) for acidic and
neutral mucins (18). Tissues were evaluated by a comparative pathol-
ogist (A. B. Rogers) blinded to sample identity. Gastritis was scored
on an ascending 0-4 scale using previously defined criteria (17).
Inflammation of the squamous forestomach was scored using criteria
similar to those for the glandular compartment. Epithelial hypertro-
phy/hyperkeratosis of the squamous stomach was scored as follows: 0,
normal thickness; 1, two times normal thicknes; 2, three times normal
thickness; 3, four times normal thickness; or 4, greater than four times
normal thickness. The presence or absence of intraepithelial micro-
abscesses was also recorded. Mean histological grades were compared
between multiple groups by Kruskal-Wallis one-way ANOVA fol-
lowed by Dunn's posttest using Prism 3.0c for Macintosh (GraphPad).
Direct comparisons were made with the Mann Whitney U-test. The
prevalence of microabscesses was evaluated using Fisher's exact test.
P values of 50.05 were considered statistically significant.
Real-Time Quantitative PCR
Chromosomal DNA from broth-grown H. pylori SSI and total
DNA from mouse stomachs was prepared using the High Pure
Template Preparation Kit according to the instructions of the supplier
(Roche Molecular Biochemicals; Indianapolis, IN). To quantify col-
onization levels of H. pylori strain SSI within the gastric mucosa, a
real-time quantitative PCR assay was developed based on the nucle-
otide sequence of the H. pylori ureB gene in the ABI Prism TaqMan
7700 sequence detection system (A/B Applied Biosystems; Foster
City, CA). Two primers (forward: 5'-CAAAATCGCTGGCATT-
GGT-3' and reverse: 5'-CTTCACCGGCTAAGGCTTCA-3') and an
internal probe (5'-AACAAAGACATGCAAGATGGCGTTAAAA-
ACA-3') were designed to hybridize within the 100-bp region (nu-
cleotides 273-373) of the single-copy ureB gene (AF508016) of H.
pylori SSI using Primer Express software (Applied Biosystems) (40).
Quantitative PCR conditions were as described previously (20). The
specificity of these oligonucleotides for H. pylori was tested using
DNA isolated from H. felis (ATC49179), H. mustelae (ATCC43772),
and "H. heilmannii." To generate a standard curve, serial 10-fold
dilutions (from 5 x 105 to 5) of H. pylori SS1 genome copies,
estimated from an average mass value (1.66 Mb) obtained from the
two published H. pylori genomes, were used (2, 49). Copy numbers of
gastric mucosal H. pylori SS1 DNA in mice were then calculated and
normalized to micrograms of murine chromosomal DNA determined
by quantitative PCR using a mammalian 18S rRNA gene-based
primers and probe mixture (Applied Biosystems) as described else-
where (53).
Liver PCR
Livers were harvested, and DNA was extracted using the Roche
DNA High Pure Template Preparation Kit (Roche Molecular Bio-
chemicals) per the manufacturer's instructions. Two rounds of PCR
amplification were performed. The first round of amplification used
the genus-specific primer set C97 and C05, which amplifies an
amplicon of -1,200 bp (16, 19). PCRs were performed using 5 jPl
template DNA and "PuRe Taq Ready To-Go PCR beads" (Amersham
Biosciences; Uppsula, Sweden) with previously described conditions
(16, 19). After this, a nested amplification was performed using the
genus-specific C97 and C98 primer sets, which amplify an amplicon
AJP-Gastrointest Liver Physiol * VOL 290 * JANUARY 2006 * www.ajpgi.org
G176
HELICOBACTER PYLORI AND CHOLESTEROL CHOLELITHOGENESIS
infcct'd + l.ithogcnic Dict
U lninfected + lithogcnic Dict
Fig. 1. Biliary phenotype determined by polarized light mi-
croscopy of gallbladder bile. Mice infected with Helicobacter
pylori and fed a lithogenic diet do not differ in biliary pheno-
type compared with uninfected animals fed the same diet. Data
for H. pylori-infected animals fed a chow diet are not displayed
because chow-fed C57L mice fail to supersaturate their gall-
bladder bile with cholesterol and therefore do not demonstrate
any of the ascribed biliary phenotypes.
Cholesterol
Liquid C(rystals Monohlvdrate Sand" SttnL, Cholesterol
C(:stals Gallstones
of -400 bp (16, 19). This reaction used 1 pl template DNA from the
first reaction and followed the conditions described previously (16,
19). Included as a positive control was known H. pylori SS 1 colonized
murine gastric tissue, and proven uninfected mouse tissue was used as
a negative control.
RESULTS
Biliary Phenotype
Regardless of the infection status, the gallbladder bile of all
mice fed the lithogenic diet displayed cholesterol-phospholipid
liquid crystals, indicating phase-separated supersaturated bile
(Fig. 1). Mice fed a chow diet did not develop liquid crystals
in bile, confirming the well-known requirement for a modified
diet to supersaturate gallbladder bile and induce both liquid and
solid crystal phase separation in this mouse model (33, 51). H.
pylori-infected mice fed the lithogenic diet developed more
cholesterol monohydrate crystals (20%) and true cholesterol
gallstones (20%) compared with control animals (10% for
each), but these changes were not statistically significant (P =
1.0; Fig. 1). Moreover, no differences in sandy stone formation
were noted (0% for both groups; Fig. 1). Mucin gel scores and
normalized gallbladder weight for animals fed the lithogenic
diet were significantly greater than those fed a standard chow
diet (P - 0.05); however, neither differed among animals fed
the lithogenic diet regardless of infection status (P > 0.05; Fig.
2). H. pylori-infected animals fed a chow diet did not develop
mucin gel formation (score of 0; Fig. 2) and exhibited normal-
ized gallbladder weights comparable with uninfected mice fed
a chow diet (Fig. 2) based on our previous study (33).
Real-Time Quantitative PCR
To validate the specificity and sensitivity of the quantitative
PCR assay for H. pylori, H. pylori SS I DNA in parallel with
the DNA templates from three gastric Helicobacters (H. felis,
H. mustelae, and H. "heilmanii") was detected using the
primers and probes designed for the ureB gene. The quantita-
tive PCR assay detected a minimum of five copies of the H.
pylori SS1 genome (Fig. 3, lane 6), whereas there was no
amplification from 10 ng (approximately equal to 5 x 105
genome copies based on the size of the H. pylori genome) of
DNA from H. felis, H. mustelae, or H. "heilmanii" (Fig. 3,
lanes 7-9). The mean number of H. pylori organisms per
microgram of host DNA in the gastric corpus of chow-fed
animals was 2.5 x 105, whereas in lithogenic diet-fed infected
animals these values were reduced by -- 1 log unit (P < 0.05)
with 6.0 x 104 organisms/pLg host DNA (Fig. 4).
Liver PCR
Livers from H. pylori-infected animals were uniformly neg-
ative on initial PCR screening. Subsequently, nested amplifi-
cation also failed to amplify any H. pylori DNA from either the
infected group fed chow or the infected group fed the litho-
genic diet (data not shown). This result contrasts markedly
with the positive PCR results from the livers of enterohepatic
Helicobacter-infected C57L mice in our earlier study (33)
Histopathology
Liver and gallbladder. Livers of C57L mice fed the litho-
genic diet demonstrated a lobular pattern of hepatocellular
microsteatosis concentrated in acinar zones 2 and 3 (mid-zonal
and centrilobular, respectively; Fig. 5a). In contrast, macroste-
atosis characterized by medium to large round clear cytoplas-
mic lipid vacuoles was mild, patchy, and mostly prominent in
the periportal regions. Mild to moderate portal mononuclear
cell inflammation was noted in a subset of mice fed the
lithogenic diet, but its occurrence was recorded equally in H.
pylori-infected and uninfected animals (Fig. 5a). Small li-
pogranulomata comprised of macrophages with phagocytosed
lipofuscin-like material were sometimes seen (Fig. 5a). Mild
and inconsistent gallbladder lesions were evident in some mice
Infecred + Chow Diet
1 '"nf "to 4- 1 ifhe" i f,-
Normalized
Gallbladder Mucin Gel Score
Weight
Fig. 2. Mucus gel score and normalized gallbladder weight (mg gallbladder/g
mouse body wt) for all groups of mice. Lithogenic diet feeding of mice
independent of H. pylori status increases mucin accumulation and normalized
gallbladder weight (P < 0.05*) compared with animals fed a standard chow
diet. H. pylori infection does not significantly increase mucin gel content or
normalized gallbladder weight compared with uninfected animals fed the same
diet (P > 0.05). All data are presented as means t SE.
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Fig. 3. Standard curve detailing the sensitivity
and specificity of the quantitative PCR assay
developed. In plots 1-6, 5 x 105, 5 X 104, 5 X
103, 5 x 102, 50, and 5 copies of the H. pylori
SSI genome were used as the initial template in
these reactions. In plots 7-9, 10 ng of genomic
DNA from H. felis, H. "heilmannii," and H.
mustelae were the initial template. All of these
failed to amplify and are illustrated by the red
symbols after the y-intercept. The r2 from the
linear regression is >0.99.
fed the lithogenic diet. Microscopic findings included eosino-
philic and lymphocytic cholecystitis (Fig. 5b), small islands of
mucous metaplasia, and scattered epithelial cell hyalinosis with
rare intraluminal crystals (data not shown). Unlike the severe
gallbladder lesions in mice fed the lithogenic diet infected with
specific enterohepatic Helicobacter spp. (33), gallbladder le-
sions in the present study were inconsistent, mild, and unas-
sociated with H. pylori infection status. Moreover, there were
no hepatobiliary lesions in H. pylori-infected mice on the chow
diet. The duodenum, pancreas, and ileocecocolic junction were
within normal limits in all mice regardless of diet or infection
status.
Stomach. Two distinct histopathological patterns were pro-
duced in the stomach: one associated with H. pylori infection
and the other with the lithogenic diet. Compared with unin-
fected mice fed the lithogenic diet (Fig. 5c), H. pylori-infected
mice fed either chow or the lithogenic diet developed moderate
mixed mononuclear and granulocytic cell proliferative gastritis
of the cardia and corpus with atrophy of oxyntic glands and
mucous metaplasia (Fig. 5d). No appreciable intestinal meta-
plasia or dysplasia were evident. With the use of staining by
hematoxylin and eosin, the mucous metaplasia of the oxyntic
mucosa was characterized by a foamy change in the cytoplasm
of parietal cells (Fig. 5e). Mucous metaplasia was confirmed by
1 Ilntected + Chow Diet
C
'U
as
C.
as
C
Fig. 4. Data are presented as log numbers of H. pylori organisms per micro-
gram of host DNA ± SE. Lithogenic diet-fed animals show significantly fewer
organisms (by a log unit) present in the gastric mucosa compared with the
situation in rodent-chow fed animals (*P - 0.05).
Alcian blue/PAS staining at pH 2.5, demonstrating transfor-
mation of surface mucins from the neutral gastric type (red) to
the acidic intestinal type (blue). Additionally, there was heavy
production of mixed mucins in the parietal cell zone, with
intestinal-type mucins concentrated at the upper and lower
boundaries of the cellular columns and gastric-type mucins in
the middle (Fig. 5J). Compared with uninfected controls, scores
of the lesions in the glandular stomach incorporating all criteria
were significantly increased in H. pylori-infected mice regard-
less of diet (P 5 0.05; Fig. 6). However, there were no
differences in mean scores between infected groups fed differ-
ent diets except for an additive effect of the lithogenic diet on
mucous metaplasia (P - 0.05; Fig. 6).
The second pattern of gastritis, associated with the litho-
genic diet, affected the anterior squamous compartment (fore-
stomach). Histological changes consisted of moderate mixed
inflammation and edema of the lamina propria and submucosa
and hypertrophy of the squamous epithelium with orthokera-
totic hyperkeratosis and frequent intraepithelial microabscesses
(Fig. 5h). Microabscesses, generally 1-2 mm, were composed
of degenerate neutrophils and epithelial cells, often with a
central core of keratotic debris (Fig. 5h). In contrast, no
squamous defects developed in H. pylori-infected mice fed the
chow diet (Fig. 5g). However, in mice fed the lithogenic diet,
there was a statistically significant additive effect of H. pylori
infection on the degree of squamous hyperkeratosis (P - 0.05;
Fig. 7) and inflammation (P - 0.05). H. pylori-infected mice
fed the lithogenic diet were twice as likely to develop micro-
abscesses of the squamous stomach as uninfected mice (80%
vs. 40%, respectively), although this difference did not reach
statistical significance (P = 0.17).
DISCUSSION
The literature ascribing a putative role for H. pylori in
causing human hepatobiliary disease has been both confusing
and inconclusive (4, 7, 13, 39, 47). In this study, we demon-
strated that H. pylori, unlike some enterohepatic Helicobacter
spp. (33), does not promote cholesterol cholelithogenesis in the
C57L mouse model. Moreover, H. pylori does not promote any
of the preliminary stages (cholesterol monohydrate crystals,
sandy stones) in the physical chemistry of cholelithogenesis.
One might argue that a doubling of the prevalence of choles-
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terol gallstone formation in infected mice would be important
when dealing with a large population (such as humans with H.
pylori); however, because H. pylori does not increase gallblad-
der mass (a surrogate marker of gallbladder hypomotility) or
mucin gel accumulation (infected animals had, in fact, less
mucin gel accumulation than uninfected animals), which are
markers of cholelithogenesis, it is likely that this increase is
merely due to population variation (as our statistical analyses
indicate). In addition, the PCR results indicate that H. pylori
does not colonize the murine hepatobiliary tree. This finding is
not surprising because to date there is not a single report of
successful bacterial isolation of these organisms from the liver
or biliary tree of experimentally infected animals and only a
single communication (44) reporting the isolation of H. pylori
from a human liver damaged by Wilson's disease.
In the past, authors claimed to have identified H. pylori-like
organisms in hepatobiliary tissue by 16S rRNA amplification
Fig. 5. Histopathology of the liver, gallbladder, and stomach
from mice fed lithogenic diet and/or infected with H. pylori and
euthanized at 16 wk of age. a: Hepatic lobule in the liver of a
H. pylori-infected mouse fed the lithogenic diet with centrilobu-
lar and midzonal microsteatosis (arrow), patchy macrosteatosis
(larger clear vacuoles), mild portal mononuclear inflammation
(right arrowhead), and lipogranulomas (bottom left arrow-
heads). Identical lesions were present in uninfected mice fed the
lithogenic diet (not shown). b: Gallbladder from the same
mouse shown in a with mild eosinophilic and lymphocytic
inflammation in the lamina propria (arrows). c: Histologically
normal gastric corpus from an uninfected mouse fed the litho-
genic diet. d: Moderate to severe inflammation and hyperplasia
in a H. pylori-infected C57L mouse fed the chow diet. e:
Marked mucous metaplasia in a H. pylori-infected mouse fed
the lithogenic diet. Note the cytoplasmic foamy change in the
parietal cell zone. f: pH 2.5 Alcian blue/periodic acid Schiff
stain of the same mouse shown in e. Note the bnormal intesti-
nal-type acidic mucins (blue) on the gastric surface and cyto-
plasmic accumulation of both acidic and neutral mucins in the
parietal cell zone. g: Histologically normal squamous stomach
in a H. pylori-infected mouse fed the chow diet. h: Hypertrophic
pleating and marked hyperkeratosis associated with mucosal
and submucosal inflammation and edema of the squamous
stomach from a H. pylori-infected mouse fed the lithogenic diet.
Note the intraepithelial microabscess comprosed of degenerate
epithelial and polymorphonuclear inflammatory cells (arrow).
and sequencing. (47). Unfortunately, speciating Helicobacters
based on sequencing a small (400-1,000 bp) segment of the
16S rRNA gene is fraught with error, because this region is
highly conserved among Helicobacter spp. (40). Highlighting
this concern, Avenaud and colleagues (4) identified organisms
that appeared to be H. pylori based on sequencing of the 16S
rRNA gene from the liver of humans. On the basis of stringent
followup tests, these investigators discovered that these organ-
isms were a previously unidentified (and still unclassified)
Helicobacter sp. that is phylogenetically related to, but not, H.
pylori (4).
We hypothesize that the presence of H. pylori in the biliary
tree and liver of human patients with cholesterol gallstones is
either a secondary colonizer (due to biliary changes from
gallstones, cholestasis, or chronic cholecystitis) or the DNA
denotes one or more related Helicobacter spp. Perhaps, in the
presence of disease induced by other Helicobacter spp. or other
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Fig. 6. Comparison of lesion grades in the glandular
;tomach of C57L mice. Mean grades of all lesion criteria
were increased by H. pylori infection compared with
rham inoculation (*P S 0.05). An additive effect of the
lithogenic diet with H. pylori infection was observed in
the case of mucous metaplasia (tP 5 0.03).
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factors, the biliary microenvironment changes to allow for
secondary invasion by H. pylori. For example, we (33) dem-
onstrated previously that some cholelithogenic Helicobacter
spp. increase gallbladder mucin gel accumulation significantly
as well as contribute to mucinous metaplasia of the gallbladder
in C57L mice fed the lithogenic diet. An increase in mucin gel
accumulation or a change in mucin species may promote
attachment of H. pylori to the biliary epithelium. Interestingly,
others have noted that the type of mucin produced in the
stomach is pivotal for H. pylori colonization, and, in fact, some
normal gastric mucins are bactericidal (24). Consistent with a
possible alteration of the biliary microenvironment leading to
secondary invasion by H. pylori, Myung and colleagues (39)
found that patients that are PCR positive for H. pylori exhibited
a significantly lower biliary pH than those that were PCR
negative. Further evidence for secondary invasion by H. pylori
was recently demonstrated by multiplex PCR in an Iranian
population (14). In this work, H. pylori-like DNA could be
amplified from bile of gallstone patients with histological
evidence of chronic cholecystitis but not from the bile of
asymptomatic gallstone patients (14). These authors did not
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Fig. 7. Comparison of the lesion grades in the squamous stomach of C57L
mice. The lithogenic diet induced squamous hypertrophy and hyperkeratosis,
inflammation, and intraepithelial abscesses. H. pylori infection increased the
severity of lesions in mice fed the lithogenic diet (tP 5 0.05). In contrast, H.
pylori-infected mice fed the chow diet did not develop lesions in the squamous
forestomach. *Significance compared with either infected group (P < 0.05).
attempt to culture for bacteria other than Helicobacter spp.
However, others (21, 37, 46) have cultured the biliary tree and
bile from humans and experimental animal models with cho-
lecystitis and demonstrated numerous bacterial species that are
considered part of the normal distal gastrointestinal tract and
nasopharyngeal microbiota. These organisms often colonize
the biliary tree secondarily to biliary disease, especially after
obstructive cholestasis or sphincter of Oddi ablation. It is likely
that H. pylori behaves in a similar manner and may colonize
the biliary tree due to impaired biliary drainage, changes in
mucus content or character, and other biochemical alterations
affecting the chemistry and concentration of biliary lipids. To
validate or disprove these hypotheses, a thorough chemical and
physical-chemical analysis of bile in the presence and absence
H. pylori DNA in the hepatobiliary tree would be necessary.
In planning the present experiments, we were concerned that
the lithogenic diet would inhibit H. pylori colonization, be-
cause in vitro studies have demonstrated bactericidal effects of
bile acids on H. pylori (22). Consistent with this notion, there
was a significant log unit decrease in the present work in the
number of H. pylori organisms in the stomachs of lithogenic
diet-fed infected mice compared with the chow-fed group (Fig.
4). Interestingly, there was no significant change in the extent
or severity of glandular gastritis between the two infected
groups. In fact, in both lithogenic diet-fed and chow-fed mice,
a robust gastritis was noted. Historically, the H. pylori SS1
strain causes minimal lesions in susceptible mouse strains at 3
mo postinfection, and C57BL/6 mice, which are characterized
as a susceptible strain, often require 6 mo of H. pylori infection
to demonstrate moderate gastric inflammation (28). The C57L
mouse appears to be exquisitely susceptible to H. pylori-
induced gastritis (regardless of the type of diet fed) and
displays similar lesions and scores to INS-GAS hypergastrine-
mic mice at this early time point (17). This observation merits
further investigation in view of the known fact that INS-GAS
mice progress to adenocarcinoma after 6 mo of colonization
with H. pylori (17).
In addition to infectious gastritis, noninfected mice that
ingested the lithogenic diet developed lesions of the squamous
forestomach. These lesions included hypertrophy, hyperkera-
tosis, and inflammation with microabscess formation of the
epithelium. Furthermore, some of these diet-induced lesions
were exacerbated significantly by infection with H. pylori.
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Moreover, the squamous epithelial lesions are reminiscent of
the lesions caused in part by diet and stress in the pars
esophagea of swine, which consist of hyperkeratosis and
ulceration (12). Swine stomachs are commonly colonized by
H. suis; however, the contribution of these helicobacters to
gastric disease is not completely understood (26, 43). Like the
inbred mice in this study, we propose that in domestic swine,
dietary composition induces lesions in the pars esophogea and
that H. suis exacerbates these lesions. The lesions in the
squamous stomach of mice demonstrate that under modified
dietary conditions, H. pylori can exacerbate disease in areas in
close anatomic proximity to where these organisms colonize
typically, i.e., the glandular stomach. The squamous forestom-
ach of the mouse is lined by stratified squamous epithelium
(29) and hence is a nonglandular zone, which is essentially an
extension of the mouse esophagus separated anatomically from
the glandular gastric compartment by the "limiting ridge" (29).
These concepts raise the possibility that this mouse model
could be used to study the contributions of diet and H. pylori
infection to chronic esophageal diseases such as esophagitis
and even esophageal cancer.
Any explanation for the synergism of diet and H. pylori
infection in causing lesions of the glandular stomach in C57L
mice, most notably metaplasia, must be speculative. The cholic
acid triglyceride and cholesterol components of the diet may
either singly or together be contributing to gastric lesions. For
example, cholic acid promotes azoxymethane-induced aberrant
crypt foci in rats (5, 48). However, analysis of the forestomach
of bile acid-fed rats did not demonstrate any notable lesions
(56). Interestingly, in humans, diets high in fat and cholesterol
(so-called "Western diets") correlate with the risk for esopha-
geal adenocarcinoma, gastric cardia adenocarcinoma, esopha-
geal squamous cell carcinoma, and common gastric adenocar-
cinoma (31, 34, 35). Additionally, cholesterol free radicals are
believed to promote a variety of diseases in mice and humans
including atherogenesis (1, 23, 36). It is reasonable, therefore,
to hypothesize that gastric inflammation from H. pylori may
promote oxidation and free radical derivatives of cholesterol or
fatty acids in humans consuming high dietary levels of these
lipids and that these oxidized products could further contribute
to chronic gastric and potentially esophageal diseases.
In summary, H. pylori infection in this prospective study
does not contribute to cholesterol gallstone formation in the
C57L mouse model. We believe that the purported suggestions
in the literature that H. pylori causes cholesterol gallstones in
humans are suspect and that, in parallel with many other
bacteria, H. pylori is likely to be a secondary colonizer of the
hepatobiliary tree after complicated gallstone disease and/or
iatrogenic interventions. In addition, the C57L mouse is highly
susceptible to H. pylori-induced gastritis and dietary-induced
nonglandular lesions of the squamous forestomach, an ana-
tomic region analogous in structure and function to the esoph-
agus. This mouse strain may provide an important new model
to study the effects of diet and chronic H. pylori infection on
the development of chronic gastric and esophageal inflamma-
tion and perhaps neoplasia.
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